MENU
The Electronic Scholarly Publishing Project: Providing world-wide, free access to classic scientific papers and other scholarly materials, since 1993.
More About: ESP | OUR CONTENT | THIS WEBSITE | WHAT'S NEW | WHAT'S HOT
ESP: PubMed Auto Bibliography 17 Nov 2026 at 01:53 Created:
Microbiome
It has long been known that every multicellular organism coexists with large prokaryotic ecosystems — microbiomes — that completely cover its surfaces, external and internal. Recent studies have shown that these associated microbiomes are not mere contamination, but instead have profound effects upon the function and fitness of the multicellular organism. We now know that all MCEs are actually functional composites, holobionts, composed of more prokaryotic cells than eukaryotic cells and expressing more prokaryotic genes than eukaryotic genes. A full understanding of the biology of "individual" eukaryotes will now depend on an understanding of their associated microbiomes.
Created with PubMed® Query: microbiome[tiab] NOT pmcbook NOT ispreviousversion
Citations The Papers (from PubMed®)
RevDate: 2026-11-14
CmpDate: 2026-11-14
Immunopathology of metabolic syndrome: effects on gut microbiota and antibiotic resistance.
Frontiers in immunology, 17:1926461.
The cluster of related metabolically derived disorders that confer increased risk of developing type 2 diabetes mellitus (T2D) and cardiovascular disease (CVD) is termed the Metabolic syndrome (MetS). Despite two decades of growing evidence on MetS pathogenesis, the immunopathological links between gut microbiota (GM) dysbiosis and metabolic derangements remain only partially elucidated. This review focuses on the complex nexus among MetS, GM composition and function, and the emerging antibiotic-resistance predicament. The gut commensal microbiome-defined as approximately 10[14] microorganisms that have been termed endocrine organs with key roles beyond gastrointestinal homeostasis, such as immune-mediated host inflammatory and metabolic regulation and barrier homeostasis- undergoes dysbiosis in MetS, characterized by marked losses of beneficial short-chain fatty acid (SCFA)-producing bacteria and overgrowth of pathobiont Proteobacteria, such as those bearing lipopolysaccharide. Increased gut permeability and Toll-like receptor 4 (TLR-4) activation, driven by increased luminal products, are termed metabolic endotoxemia and form the immunopathological bridge between gut dysbiosis and systemic low-grade inflammation and insulin resistance. Disturbances in microbial-mediated host metabolism of bile acids, tryptophan catabolism, and the regulatory T cell/T helper 17 axis further promote inflammation in adipose tissue, liver, and skeletal muscle. Antibiotic-driven dysbiosis, which reduces diversity and increases antibiotic-resistant gene elements within the host gut resistome, exacerbates metabolic abnormalities and is a key focus for developing personalized treatment approaches.
Additional Links: PMID-43032363
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43032363,
year = {2026},
author = {Namadian, N and Oksenych, V and Asadi, Z and Kiaheyrati, N and Tahmasebi, H},
title = {Immunopathology of metabolic syndrome: effects on gut microbiota and antibiotic resistance.},
journal = {Frontiers in immunology},
volume = {17},
number = {},
pages = {1926461},
pmid = {43032363},
issn = {1664-3224},
mesh = {Humans ; *Metabolic Syndrome/immunology/microbiology/metabolism ; Animals ; *Gastrointestinal Microbiome/immunology/drug effects ; Dysbiosis/immunology ; *Drug Resistance, Microbial ; Anti-Bacterial Agents/therapeutic use/pharmacology ; },
abstract = {The cluster of related metabolically derived disorders that confer increased risk of developing type 2 diabetes mellitus (T2D) and cardiovascular disease (CVD) is termed the Metabolic syndrome (MetS). Despite two decades of growing evidence on MetS pathogenesis, the immunopathological links between gut microbiota (GM) dysbiosis and metabolic derangements remain only partially elucidated. This review focuses on the complex nexus among MetS, GM composition and function, and the emerging antibiotic-resistance predicament. The gut commensal microbiome-defined as approximately 10[14] microorganisms that have been termed endocrine organs with key roles beyond gastrointestinal homeostasis, such as immune-mediated host inflammatory and metabolic regulation and barrier homeostasis- undergoes dysbiosis in MetS, characterized by marked losses of beneficial short-chain fatty acid (SCFA)-producing bacteria and overgrowth of pathobiont Proteobacteria, such as those bearing lipopolysaccharide. Increased gut permeability and Toll-like receptor 4 (TLR-4) activation, driven by increased luminal products, are termed metabolic endotoxemia and form the immunopathological bridge between gut dysbiosis and systemic low-grade inflammation and insulin resistance. Disturbances in microbial-mediated host metabolism of bile acids, tryptophan catabolism, and the regulatory T cell/T helper 17 axis further promote inflammation in adipose tissue, liver, and skeletal muscle. Antibiotic-driven dysbiosis, which reduces diversity and increases antibiotic-resistant gene elements within the host gut resistome, exacerbates metabolic abnormalities and is a key focus for developing personalized treatment approaches.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Metabolic Syndrome/immunology/microbiology/metabolism
Animals
*Gastrointestinal Microbiome/immunology/drug effects
Dysbiosis/immunology
*Drug Resistance, Microbial
Anti-Bacterial Agents/therapeutic use/pharmacology
RevDate: 2026-11-15
CmpDate: 2026-11-14
The Indole-AhR-Treg axis as a microbiome-encoded immune checkpoint in type 1 diabetes.
Frontiers in immunology, 17:1949305.
Type 1 diabetes (T1D) is an autoimmune disease driven by the progressive destruction of pancreatic β-cells following failure of peripheral immune tolerance. Increasing evidence identifies the gut microbiome as a critical upstream regulator of this process through its control of microbiota-derived immunoregulatory metabolites. Among these, tryptophan-derived indole metabolites have emerged as central modulators of the aryl hydrocarbon receptor (AhR)-regulatory T cell (Treg) axis, a key checkpoint governing mucosal and systemic immune homeostasis. In individuals at risk for T1D, gut dysbiosis has been associated with altered commensal composition and tryptophan metabolism that may reduce the availability of selected AhR-active indole metabolites, including indole-3-acetic acid (IAA), indole-3-carboxaldehyde (ICA), and indole-3-propionic acid (IPA). These metabolites regulate Treg differentiation, macrophage polarization, epithelial barrier integrity, and effector T cell activation through context-dependent AhR- and PPAR-mediated signaling pathways. Disruption of this axis promotes inflammatory Th1/Th17 responses, intestinal barrier dysfunction, and progression of islet autoimmunity. A central concept emerging from recent studies is that the immunological outcome of AhR activation depends not only on ligand identity, but also on delivery compartment, concentration, cellular target, and inflammatory context - a framework we term the "Indole Paradox." This paradigm helps reconcile why some AhR-targeting interventions exacerbate autoimmunity whereas others restore immune tolerance. In this review, we synthesize current mechanistic and translational evidence linking microbiome-derived indole signaling to T1D pathogenesis and evaluate emerging therapeutic strategies targeting this axis, including dietary modulation, postbiotic metabolites, pharmacological AhR agonists, fecal microbiota transplantation, and engineered bacterial therapeutics. We propose that context-directed modulation of the indole-AhR-Treg axis represents a promising next-generation strategy for restoring immune tolerance and preventing autoimmune progression in T1D.
Additional Links: PMID-43032381
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43032381,
year = {2026},
author = {Delgado, K and Espitia, A and PopeJoy, K and Mace, L and Lew, M and Song, BS and Kumar, R and Song, J},
title = {The Indole-AhR-Treg axis as a microbiome-encoded immune checkpoint in type 1 diabetes.},
journal = {Frontiers in immunology},
volume = {17},
number = {},
pages = {1949305},
pmid = {43032381},
issn = {1664-3224},
support = {R01 CA273002/CA/NCI NIH HHS/United States ; R21 AI167793/AI/NIAID NIH HHS/United States ; },
mesh = {Humans ; *Receptors, Aryl Hydrocarbon/metabolism/immunology ; *Diabetes Mellitus, Type 1/immunology/metabolism/microbiology ; *T-Lymphocytes, Regulatory/immunology/metabolism ; *Indoles/metabolism/immunology ; Animals ; *Gastrointestinal Microbiome/immunology ; *Basic Helix-Loop-Helix Proteins/metabolism/immunology ; Signal Transduction ; Dysbiosis/immunology ; },
abstract = {Type 1 diabetes (T1D) is an autoimmune disease driven by the progressive destruction of pancreatic β-cells following failure of peripheral immune tolerance. Increasing evidence identifies the gut microbiome as a critical upstream regulator of this process through its control of microbiota-derived immunoregulatory metabolites. Among these, tryptophan-derived indole metabolites have emerged as central modulators of the aryl hydrocarbon receptor (AhR)-regulatory T cell (Treg) axis, a key checkpoint governing mucosal and systemic immune homeostasis. In individuals at risk for T1D, gut dysbiosis has been associated with altered commensal composition and tryptophan metabolism that may reduce the availability of selected AhR-active indole metabolites, including indole-3-acetic acid (IAA), indole-3-carboxaldehyde (ICA), and indole-3-propionic acid (IPA). These metabolites regulate Treg differentiation, macrophage polarization, epithelial barrier integrity, and effector T cell activation through context-dependent AhR- and PPAR-mediated signaling pathways. Disruption of this axis promotes inflammatory Th1/Th17 responses, intestinal barrier dysfunction, and progression of islet autoimmunity. A central concept emerging from recent studies is that the immunological outcome of AhR activation depends not only on ligand identity, but also on delivery compartment, concentration, cellular target, and inflammatory context - a framework we term the "Indole Paradox." This paradigm helps reconcile why some AhR-targeting interventions exacerbate autoimmunity whereas others restore immune tolerance. In this review, we synthesize current mechanistic and translational evidence linking microbiome-derived indole signaling to T1D pathogenesis and evaluate emerging therapeutic strategies targeting this axis, including dietary modulation, postbiotic metabolites, pharmacological AhR agonists, fecal microbiota transplantation, and engineered bacterial therapeutics. We propose that context-directed modulation of the indole-AhR-Treg axis represents a promising next-generation strategy for restoring immune tolerance and preventing autoimmune progression in T1D.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Receptors, Aryl Hydrocarbon/metabolism/immunology
*Diabetes Mellitus, Type 1/immunology/metabolism/microbiology
*T-Lymphocytes, Regulatory/immunology/metabolism
*Indoles/metabolism/immunology
Animals
*Gastrointestinal Microbiome/immunology
*Basic Helix-Loop-Helix Proteins/metabolism/immunology
Signal Transduction
Dysbiosis/immunology
RevDate: 2026-11-14
CmpDate: 2026-11-14
Immunomodulatory mechanisms of gut microbiota-derived metabolites in non-small cell lung cancer: a gut-lung axis perspective.
Frontiers in immunology, 17:1999117.
Immunotherapy has emerged as a crucial component in the treatment of non-small cell lung cancer (NSCLC). Nevertheless, interindividual variability in efficacy, along with both primary and acquired resistance, as well as immune-related adverse events, continue to limit the benefits for patients. The gut microbiota and its associated metabolites are believed to play a significant role in pulmonary immune regulation via the gut-lung axis, with alterations in this system being associated with NSCLC development and progression, as well as the outcomes of immunotherapy. This review summarizes the key features of gut microbial and metabolic profiles in patients with NSCLC, focusing particularly on the mechanisms by which short-chain fatty acids, bile acids, gut microbiota-associated Trp metabolites, and other microbial metabolites may influence the tumor immune microenvironment and responses to immunotherapy. Furthermore, we consider their potential value in supporting NSCLC diagnosis, prognostic assessment, and treatment-response prediction. Therapies aimed at targeting metabolic pathways, fecal microbiota transplantation, dietary interventions, and microbiome-based preparations present additional avenues for enhancing the efficacy of NSCLC immunotherapy and managing treatment-related toxicity. However, current evidence primarily stems from small clinical studies and animal models, while methodological discrepancies and limited causal evidence impede clinical translation. Future research that integrates longitudinal multi-omics analyses, metabolic tracing, and controlled clinical trials is essential to elucidate the clinical significance of the gut microbiota-metabolite axis in NSCLC immunotherapy and precision medicine.
Additional Links: PMID-43032549
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43032549,
year = {2026},
author = {Ye, S and Tian, T and Huangfu, J and Liu, H and Liu, P and Zhou, J},
title = {Immunomodulatory mechanisms of gut microbiota-derived metabolites in non-small cell lung cancer: a gut-lung axis perspective.},
journal = {Frontiers in immunology},
volume = {17},
number = {},
pages = {1999117},
pmid = {43032549},
issn = {1664-3224},
mesh = {Humans ; *Carcinoma, Non-Small-Cell Lung/immunology/therapy/metabolism/microbiology ; *Gastrointestinal Microbiome/immunology ; *Lung Neoplasms/immunology/therapy/metabolism/microbiology ; Animals ; Tumor Microenvironment/immunology ; Immunotherapy/methods ; *Immunomodulation ; *Lung/immunology/metabolism ; Metabolome ; },
abstract = {Immunotherapy has emerged as a crucial component in the treatment of non-small cell lung cancer (NSCLC). Nevertheless, interindividual variability in efficacy, along with both primary and acquired resistance, as well as immune-related adverse events, continue to limit the benefits for patients. The gut microbiota and its associated metabolites are believed to play a significant role in pulmonary immune regulation via the gut-lung axis, with alterations in this system being associated with NSCLC development and progression, as well as the outcomes of immunotherapy. This review summarizes the key features of gut microbial and metabolic profiles in patients with NSCLC, focusing particularly on the mechanisms by which short-chain fatty acids, bile acids, gut microbiota-associated Trp metabolites, and other microbial metabolites may influence the tumor immune microenvironment and responses to immunotherapy. Furthermore, we consider their potential value in supporting NSCLC diagnosis, prognostic assessment, and treatment-response prediction. Therapies aimed at targeting metabolic pathways, fecal microbiota transplantation, dietary interventions, and microbiome-based preparations present additional avenues for enhancing the efficacy of NSCLC immunotherapy and managing treatment-related toxicity. However, current evidence primarily stems from small clinical studies and animal models, while methodological discrepancies and limited causal evidence impede clinical translation. Future research that integrates longitudinal multi-omics analyses, metabolic tracing, and controlled clinical trials is essential to elucidate the clinical significance of the gut microbiota-metabolite axis in NSCLC immunotherapy and precision medicine.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Carcinoma, Non-Small-Cell Lung/immunology/therapy/metabolism/microbiology
*Gastrointestinal Microbiome/immunology
*Lung Neoplasms/immunology/therapy/metabolism/microbiology
Animals
Tumor Microenvironment/immunology
Immunotherapy/methods
*Immunomodulation
*Lung/immunology/metabolism
Metabolome
RevDate: 2026-11-15
CmpDate: 2026-11-14
Burkholderia cepacia complex and Burkholderia gladioli in large animals, dairy products, and livestock ticks: A systematic review of an emerging One Health concern.
One health (Amsterdam, Netherlands), 23:101647.
Burkholderia mallei is an established zoonotic pathogen that causes glanders, whereas B. pseudomallei is primarily an environmental pathogen that causes melioidosis in humans and animals. Most other Burkholderia species are environmental or plant-associated organisms; however, members of the Burkholderia cepacia complex (BCC) and B. gladioli are recognized opportunistic pathogens, particularly in susceptible humans. We conducted a PRISMA-guided systematic review of Web of Science, Scopus, and PubMed, supplemented by Google Scholar citation searching, through January 2025. We included eligible primary studies reporting naturally occurring infection, colonization, microbiome detection, or contamination involving large animals, dairy products, or livestock-associated ticks; we excluded animal-model and experimental-infection studies. Forty-eight unique studies met the eligibility criteria: 36 involving large animals, 10 involving dairy products, and two involving livestock-associated ticks. Reported organisms included B. cepacia, B. cenocepacia, B. contaminans, B. vietnamiensis, and B. gladioli, as well as Burkholderia identified only at the genus or complex level. Clinical disease was reported more often in horses and small ruminants, whereas findings in cattle and pigs were more often nonclinical or of uncertain clinical significance. BCC organisms and B. gladioli were also detected in raw milk and other dairy products, although detection frequencies varied substantially among studies and sample types. No study has demonstrated direct transmission from contaminated dairy products to human cases. The evidence was predominantly low-level and heterogeneous, indicating potential One Health relevance but precluding firm causal conclusions. Prospective surveillance, validated species-level identification, and genomic comparisons are needed to clarify pathogenicity, prevalence, and potential transmission pathways.
Additional Links: PMID-43032592
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43032592,
year = {2026},
author = {Baradaran-Seyed, Z and Mosavari, N},
title = {Burkholderia cepacia complex and Burkholderia gladioli in large animals, dairy products, and livestock ticks: A systematic review of an emerging One Health concern.},
journal = {One health (Amsterdam, Netherlands)},
volume = {23},
number = {},
pages = {101647},
pmid = {43032592},
issn = {2352-7714},
abstract = {Burkholderia mallei is an established zoonotic pathogen that causes glanders, whereas B. pseudomallei is primarily an environmental pathogen that causes melioidosis in humans and animals. Most other Burkholderia species are environmental or plant-associated organisms; however, members of the Burkholderia cepacia complex (BCC) and B. gladioli are recognized opportunistic pathogens, particularly in susceptible humans. We conducted a PRISMA-guided systematic review of Web of Science, Scopus, and PubMed, supplemented by Google Scholar citation searching, through January 2025. We included eligible primary studies reporting naturally occurring infection, colonization, microbiome detection, or contamination involving large animals, dairy products, or livestock-associated ticks; we excluded animal-model and experimental-infection studies. Forty-eight unique studies met the eligibility criteria: 36 involving large animals, 10 involving dairy products, and two involving livestock-associated ticks. Reported organisms included B. cepacia, B. cenocepacia, B. contaminans, B. vietnamiensis, and B. gladioli, as well as Burkholderia identified only at the genus or complex level. Clinical disease was reported more often in horses and small ruminants, whereas findings in cattle and pigs were more often nonclinical or of uncertain clinical significance. BCC organisms and B. gladioli were also detected in raw milk and other dairy products, although detection frequencies varied substantially among studies and sample types. No study has demonstrated direct transmission from contaminated dairy products to human cases. The evidence was predominantly low-level and heterogeneous, indicating potential One Health relevance but precluding firm causal conclusions. Prospective surveillance, validated species-level identification, and genomic comparisons are needed to clarify pathogenicity, prevalence, and potential transmission pathways.},
}
RevDate: 2026-11-15
CmpDate: 2026-11-14
Periodontitis and pancreatic cancer: the oral-gut microbial axis, pathogenic mechanisms, and potential therapeutic implications.
Journal of oral microbiology, 18(1):2758491.
BACKGROUND: Pancreatic cancer is a highly aggressive malignancy with a poor prognosis. Epidemiological studies have suggested a possible association between periodontitis and pancreatic cancer, while microbiome studies have reported alterations in the oral, gut, and pancreatic microbiota.
OBJECTIVE: This review examines the evidence linking periodontitis to pancreatic cancer, with particular attention to microbial interactions along the proposed oral-gut microbial axis.
DESIGN: This narrative review synthesizes current epidemiological, microbiome, and experimental evidence relevant to the potential association between periodontitis and pancreatic cancer.
RESLUTS: Experimental studies suggest that periodontitis-associated microorganisms, including Porphyromonas gingivalis and Fusobacterium nucleatum, or their products, may reach the pancreas via digestive or circulatory routes. These microorganisms may influence the development and progression of pancreatic ductal adenocarcinoma through chronic inflammation, immune evasion, virulence factors, microbial metabolites, and the activation of oncogenic signaling pathways. Specific oral and gut microbial features have been investigated as candidate biomarkers. Periodontal treatment, dietary modification, and probiotics have also been studied for their effects on microbial composition and inflammation-related pathways potentially relevant to pancreatic cancer. The clinical relevance of these candidate biomarkers remains to be established, and microbial alterations may either contribute to pancreatic cancer or occur as a consequence of the disease.
CONCLUSIONS: Current evidence supports a possible link between periodontitis and pancreatic cancer, although the role of microbiota in this relationship remains under investigation.
Additional Links: PMID-43032645
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43032645,
year = {2026},
author = {Fan, L and Hong, G and Sun, J and Zhou, Y and Shi, J},
title = {Periodontitis and pancreatic cancer: the oral-gut microbial axis, pathogenic mechanisms, and potential therapeutic implications.},
journal = {Journal of oral microbiology},
volume = {18},
number = {1},
pages = {2758491},
pmid = {43032645},
issn = {2000-2297},
abstract = {BACKGROUND: Pancreatic cancer is a highly aggressive malignancy with a poor prognosis. Epidemiological studies have suggested a possible association between periodontitis and pancreatic cancer, while microbiome studies have reported alterations in the oral, gut, and pancreatic microbiota.
OBJECTIVE: This review examines the evidence linking periodontitis to pancreatic cancer, with particular attention to microbial interactions along the proposed oral-gut microbial axis.
DESIGN: This narrative review synthesizes current epidemiological, microbiome, and experimental evidence relevant to the potential association between periodontitis and pancreatic cancer.
RESLUTS: Experimental studies suggest that periodontitis-associated microorganisms, including Porphyromonas gingivalis and Fusobacterium nucleatum, or their products, may reach the pancreas via digestive or circulatory routes. These microorganisms may influence the development and progression of pancreatic ductal adenocarcinoma through chronic inflammation, immune evasion, virulence factors, microbial metabolites, and the activation of oncogenic signaling pathways. Specific oral and gut microbial features have been investigated as candidate biomarkers. Periodontal treatment, dietary modification, and probiotics have also been studied for their effects on microbial composition and inflammation-related pathways potentially relevant to pancreatic cancer. The clinical relevance of these candidate biomarkers remains to be established, and microbial alterations may either contribute to pancreatic cancer or occur as a consequence of the disease.
CONCLUSIONS: Current evidence supports a possible link between periodontitis and pancreatic cancer, although the role of microbiota in this relationship remains under investigation.},
}
RevDate: 2026-11-15
CmpDate: 2026-11-14
Current status and trends of gut microbiota in the study of cognitive impairment in the elderly.
Frontiers in microbiology, 17:1910406.
BACKGROUND: Cognitive impairment in older persons has become a major public health concern as the world's population ages more quickly. A reduction in thinking, learning, and memory skills that affects a person's day-to-day activities or social functioning is referred to as cognitive impairment. The connection between gut microbiota and cognitive decline has attracted a lot of interest lately. However, this rapidly expanding interdisciplinary field presents an increasingly complex knowledge structure, with existing evidence being highly fragmented and subject to significant methodological and sample size limitations.
GOAL: This study adopts a bibliometrics perspective, summarising and outlining the current state and developmental trends within the field to provide a reference framework and recommendations for subsequent research.
METHOD: Based on the Web of Science Core Collection (WoSCC) database and Scopus database. In WOSCC database, literature related to gut microbiota and cognitive impairment in the elderly from 1995 to 8 September 2025 was retrieved. Similarly, search for relevant literature from 1995 to 2025 in the Scopus database. Bibliometric analysis was conducted using VOSviewer software to examine data on countries, institutions, authors, journals, keywords, citations, and generate visual maps.
RESULT: A total of 406 relevant publications were retrieved from the WOSCC database. The overall publication trend is increasing. China is the country with the most published papers, and Nanjing Medical University and Zhejiang University are joint top institutions in terms of output, while in the WOS database, Hariom Yadav is the most prolific author, while Luo Ailin has the highest total link strength. In the Scopus database, Zhang, Y is the most prolific author, while Hisada, T et al. have the highest total link strength. The most common keyword is gut microbiota, followed by Alzheimer's disease, aging, probiotics, dementia, and neuroinflammation. In addition, a total of 180 relevant literatures were retrieved from the Scopus database. Among them, the most common keywords are intestine flora, aged, cognitive defect, cognition, and gastrointestinal microbiome.
CONCLUSION: Research into the relationship between the gut microbiota and cognitive impairment is advancing steadily, yet there remains a need to strengthen collaboration between authors and institutions across different regions. Sustained interaction and exchange are essential to further explore the mechanisms of action of the gut microbiota. Based on the identified research hotspots and gaps, we suggest that future investigations could benefit from integrating multi-omics approaches to explore potential biomarkers and nutritional intervention strategies. However, these directions remain speculative and should be pursued through rigorous experimental and clinical research.
Additional Links: PMID-43032671
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43032671,
year = {2026},
author = {Sun, MY and Wang, Y and Jiang, J and Feng, S and Sun, YG},
title = {Current status and trends of gut microbiota in the study of cognitive impairment in the elderly.},
journal = {Frontiers in microbiology},
volume = {17},
number = {},
pages = {1910406},
pmid = {43032671},
issn = {1664-302X},
abstract = {BACKGROUND: Cognitive impairment in older persons has become a major public health concern as the world's population ages more quickly. A reduction in thinking, learning, and memory skills that affects a person's day-to-day activities or social functioning is referred to as cognitive impairment. The connection between gut microbiota and cognitive decline has attracted a lot of interest lately. However, this rapidly expanding interdisciplinary field presents an increasingly complex knowledge structure, with existing evidence being highly fragmented and subject to significant methodological and sample size limitations.
GOAL: This study adopts a bibliometrics perspective, summarising and outlining the current state and developmental trends within the field to provide a reference framework and recommendations for subsequent research.
METHOD: Based on the Web of Science Core Collection (WoSCC) database and Scopus database. In WOSCC database, literature related to gut microbiota and cognitive impairment in the elderly from 1995 to 8 September 2025 was retrieved. Similarly, search for relevant literature from 1995 to 2025 in the Scopus database. Bibliometric analysis was conducted using VOSviewer software to examine data on countries, institutions, authors, journals, keywords, citations, and generate visual maps.
RESULT: A total of 406 relevant publications were retrieved from the WOSCC database. The overall publication trend is increasing. China is the country with the most published papers, and Nanjing Medical University and Zhejiang University are joint top institutions in terms of output, while in the WOS database, Hariom Yadav is the most prolific author, while Luo Ailin has the highest total link strength. In the Scopus database, Zhang, Y is the most prolific author, while Hisada, T et al. have the highest total link strength. The most common keyword is gut microbiota, followed by Alzheimer's disease, aging, probiotics, dementia, and neuroinflammation. In addition, a total of 180 relevant literatures were retrieved from the Scopus database. Among them, the most common keywords are intestine flora, aged, cognitive defect, cognition, and gastrointestinal microbiome.
CONCLUSION: Research into the relationship between the gut microbiota and cognitive impairment is advancing steadily, yet there remains a need to strengthen collaboration between authors and institutions across different regions. Sustained interaction and exchange are essential to further explore the mechanisms of action of the gut microbiota. Based on the identified research hotspots and gaps, we suggest that future investigations could benefit from integrating multi-omics approaches to explore potential biomarkers and nutritional intervention strategies. However, these directions remain speculative and should be pursued through rigorous experimental and clinical research.},
}
RevDate: 2026-11-14
Management Strategies for Recurrent Urinary Tract Infections in Children With Bowel and Bladder Dysfunction.
Journal of paediatrics and child health [Epub ahead of print].
AIM: This paper is not a guideline, but aims to discuss practical considerations in managing children with recurrent urinary tract infections (UTIs) in the context of bowel and bladder dysfunction (BBD).
METHODS: This clinically focussed narrative review, supported by references, discusses and highlights important points for clinicians to consider when managing UTI in the context of BBD in children.
RESULTS: To address the problem, clinicians should undertake holistic assessment of the authenticity, nature, frequency and severity of previous UTIs; as well as carefully assess for and characterise UTI risk factors, especially BBD. Dysbiosis of the urobiome and microbiome may be associated with bladder dysfunction and UTIs in children, an area under research. Optimal treatment of BBD reduces UTI risk, and practical aspects of BBD management are discussed. The role of continuous antibiotic prophylaxis (CAP) in reducing UTI risk is assessed; as well as the options of non-antibiotic UTI risk reduction measures.
CONCLUSION: BBD management reduces UTI risk overall. CAP is reasonable to consider until BBD management is optimal. Non-antibiotic prophylaxis may also contribute to UTI risk reduction.
Additional Links: PMID-43032965
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43032965,
year = {2026},
author = {Samnakay, N},
title = {Management Strategies for Recurrent Urinary Tract Infections in Children With Bowel and Bladder Dysfunction.},
journal = {Journal of paediatrics and child health},
volume = {},
number = {},
pages = {},
doi = {10.1111/jpc.70639},
pmid = {43032965},
issn = {1440-1754},
abstract = {AIM: This paper is not a guideline, but aims to discuss practical considerations in managing children with recurrent urinary tract infections (UTIs) in the context of bowel and bladder dysfunction (BBD).
METHODS: This clinically focussed narrative review, supported by references, discusses and highlights important points for clinicians to consider when managing UTI in the context of BBD in children.
RESULTS: To address the problem, clinicians should undertake holistic assessment of the authenticity, nature, frequency and severity of previous UTIs; as well as carefully assess for and characterise UTI risk factors, especially BBD. Dysbiosis of the urobiome and microbiome may be associated with bladder dysfunction and UTIs in children, an area under research. Optimal treatment of BBD reduces UTI risk, and practical aspects of BBD management are discussed. The role of continuous antibiotic prophylaxis (CAP) in reducing UTI risk is assessed; as well as the options of non-antibiotic UTI risk reduction measures.
CONCLUSION: BBD management reduces UTI risk overall. CAP is reasonable to consider until BBD management is optimal. Non-antibiotic prophylaxis may also contribute to UTI risk reduction.},
}
RevDate: 2026-11-15
CmpDate: 2026-11-14
Next-Generation Probiotics: Emerging Mechanisms, Therapeutic Innovations, and Future Perspectives.
BioMed research international, 2026(1):.
Probiotic research is shifting from the empirical use of broadly beneficial microorganisms toward functionally defined microbial therapeutics. Advances in microbiome science, multiomics, formulation technologies, and synthetic biology have expanded the field from conventional strains to next-generation organisms, engineered microbes, and defined microbial effectors. This review critically examines this transition by linking mechanisms of probiotic action with the barriers that determine clinical translation. Although probiotics can influence ecological, metabolic, epithelial, immune, and host-signaling pathways, biological activity alone does not ensure therapeutic benefit. We define this disconnect as the probiotic efficacy gap, arising when strain or function selection, delivery, functional engagement, host responsiveness, or clinical outcomes fail to align. Emerging strategies-including protective formulations, mucosa-targeted delivery, programmable microbial platforms, nonviable microbial products, and microbiome-guided patient selection-address distinct points of failure along this translational pathway. We further examine the manufacturing, potency, safety, biocontainment, and regulatory challenges associated with increasingly complex microbial products. Future progress will require a function-first framework that integrates mechanism-linked potency measures, prospective responder identification, targeted delivery, and clinically meaningful evidence of target engagement. Rather than seeking a universally effective probiotic, the field must determine which microbial function is required, how and where it should be delivered, and in which host it is most likely to produce benefit.
Additional Links: PMID-43032967
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43032967,
year = {2026},
author = {Agarwal, S and Prabhakar, YS and Katiyar, P and Das, B and Sur, S and Kumar, H and Gupta, BP},
title = {Next-Generation Probiotics: Emerging Mechanisms, Therapeutic Innovations, and Future Perspectives.},
journal = {BioMed research international},
volume = {2026},
number = {1},
pages = {},
pmid = {43032967},
issn = {2314-6141},
mesh = {*Probiotics/therapeutic use ; Humans ; Microbiota ; Animals ; Gastrointestinal Microbiome ; },
abstract = {Probiotic research is shifting from the empirical use of broadly beneficial microorganisms toward functionally defined microbial therapeutics. Advances in microbiome science, multiomics, formulation technologies, and synthetic biology have expanded the field from conventional strains to next-generation organisms, engineered microbes, and defined microbial effectors. This review critically examines this transition by linking mechanisms of probiotic action with the barriers that determine clinical translation. Although probiotics can influence ecological, metabolic, epithelial, immune, and host-signaling pathways, biological activity alone does not ensure therapeutic benefit. We define this disconnect as the probiotic efficacy gap, arising when strain or function selection, delivery, functional engagement, host responsiveness, or clinical outcomes fail to align. Emerging strategies-including protective formulations, mucosa-targeted delivery, programmable microbial platforms, nonviable microbial products, and microbiome-guided patient selection-address distinct points of failure along this translational pathway. We further examine the manufacturing, potency, safety, biocontainment, and regulatory challenges associated with increasingly complex microbial products. Future progress will require a function-first framework that integrates mechanism-linked potency measures, prospective responder identification, targeted delivery, and clinically meaningful evidence of target engagement. Rather than seeking a universally effective probiotic, the field must determine which microbial function is required, how and where it should be delivered, and in which host it is most likely to produce benefit.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Probiotics/therapeutic use
Humans
Microbiota
Animals
Gastrointestinal Microbiome
RevDate: 2026-11-14
CmpDate: 2026-11-14
Oral Microbiome-Host Immune Crosstalk in Oral Wound Healing and Tissue Regeneration: Mechanisms and Therapeutic Opportunities.
Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society, 34(6):.
Dental caries, periodontitis, tumours, trauma and congenital defects can cause significant damage to oral tissues leading to impaired oral function and adverse systemic health effects. This review analyses the existing knowledge on biological mechanisms underlying oral wound healing and tissue regeneration, particularly focusing on the crosstalk among the oral microbiome and host immune responses. Tissue regeneration is regulated by several intracellular signalling pathways including the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt), janus kinase and signal transducer and activator of transcription (JAK-STAT), rat sarcoma protein (Ras)/mitogen-activated protein kinase (MAPK), transforming growth factor-beta (TGF-β)/Sma and mad related protein (SMAD), wingless-related integration site (Wnt)/beta (β)-catenin and oxygen-regulated signalling pathways. Collectively, these pathways coordinate epithelial migration, angiogenesis and extracellular matrix remodelling during tissue regeneration. Oral wound healing and tissue regeneration are critically impacted by the interaction between the oral microbiome and host immune mechanisms. Commensal microorganisms contribute to epithelial barrier integrity and immune regulation, whereas pathogenic species such as Streptococcus mutans, Porphyromonas gingivalis, Fusobacterium nucleatum, Treponema denticola and fungal pathogen Candida albicans can disrupt tissue repair through biofilm formation and inflammatory activation. Therapeutic strategies such as probiotics, prebiotics, synbiotics, microbiome responsive biomaterials have emerged as promising approaches to enhance craniofacial and tissue regeneration for improved healing possibilities. This review provides an integrated perspective linking oral microbial ecology, immune regulation, and intracellular regenerative signalling networks to highlight emerging microbiome-based and biomaterial-assisted strategies for promoting oral tissue repair and regeneration.
Additional Links: PMID-43033099
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43033099,
year = {2026},
author = {Das, AK and Mohamad, S},
title = {Oral Microbiome-Host Immune Crosstalk in Oral Wound Healing and Tissue Regeneration: Mechanisms and Therapeutic Opportunities.},
journal = {Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society},
volume = {34},
number = {6},
pages = {},
doi = {10.1111/wrr.70239},
pmid = {43033099},
issn = {1524-475X},
support = {R501-LR-RND002-0000000017-0000//Universiti Sains Malaysia/ ; },
mesh = {Humans ; *Wound Healing/immunology/physiology ; *Microbiota/immunology ; *Regeneration/immunology ; Signal Transduction/immunology ; *Mouth/microbiology/immunology ; Animals ; },
abstract = {Dental caries, periodontitis, tumours, trauma and congenital defects can cause significant damage to oral tissues leading to impaired oral function and adverse systemic health effects. This review analyses the existing knowledge on biological mechanisms underlying oral wound healing and tissue regeneration, particularly focusing on the crosstalk among the oral microbiome and host immune responses. Tissue regeneration is regulated by several intracellular signalling pathways including the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt), janus kinase and signal transducer and activator of transcription (JAK-STAT), rat sarcoma protein (Ras)/mitogen-activated protein kinase (MAPK), transforming growth factor-beta (TGF-β)/Sma and mad related protein (SMAD), wingless-related integration site (Wnt)/beta (β)-catenin and oxygen-regulated signalling pathways. Collectively, these pathways coordinate epithelial migration, angiogenesis and extracellular matrix remodelling during tissue regeneration. Oral wound healing and tissue regeneration are critically impacted by the interaction between the oral microbiome and host immune mechanisms. Commensal microorganisms contribute to epithelial barrier integrity and immune regulation, whereas pathogenic species such as Streptococcus mutans, Porphyromonas gingivalis, Fusobacterium nucleatum, Treponema denticola and fungal pathogen Candida albicans can disrupt tissue repair through biofilm formation and inflammatory activation. Therapeutic strategies such as probiotics, prebiotics, synbiotics, microbiome responsive biomaterials have emerged as promising approaches to enhance craniofacial and tissue regeneration for improved healing possibilities. This review provides an integrated perspective linking oral microbial ecology, immune regulation, and intracellular regenerative signalling networks to highlight emerging microbiome-based and biomaterial-assisted strategies for promoting oral tissue repair and regeneration.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Wound Healing/immunology/physiology
*Microbiota/immunology
*Regeneration/immunology
Signal Transduction/immunology
*Mouth/microbiology/immunology
Animals
RevDate: 2026-11-14
Preharvest Application of Bacillus tequilensis PZB-0006 Controls Sweet Cherry Postharvest Disease via Altering the Epiphytic Microbiota and Inducing Fruit Resistance.
Plant disease [Epub ahead of print].
Postharvest diseases severely limit sweet cherry quality and shelf life, causing substantial economic losses worldwide. Although microbial antagonists are promising eco-friendly alternatives to synthetic fungicides, their role in modulating the fruit microbiome remains unclear. Herein, we investigated the biocontrol potential and underlying mechanisms of Bacillus tequilensis PZB-0006 in suppressing sweet cherry postharvest decay. Combined preharvest spraying and postharvest storage experiments showed that PZB-0006 application significantly mitigated cherry fruit rot. High-throughput sequencing confirmed that PZB-0006 stably colonized the cherry fruit surface, reshaping the epiphytic microbial community structure by reducing the abundance of pathogenic microorganisms. Linear discriminant analysis effect size (LEfSe) and Specificity-Occupancy (SPEC-OCCU) analyses further identified PZB-0006 as the specialist taxon in the treated fruit microbiome, highlighting its central role in community modulation. Additionally, PZB-0006 treatment significantly enhanced the activities of defense-related enzymes in cherry fruits, indicating the induction of host resistance. These findings collectively reveal that B. tequilensis PZB-0006 exerts biocontrol effects through a multifaceted mechanism involving stable colonization, microbial community modulation, and host defense activation. This study provides novel microecological insights into the biocontrol of fruit postharvest diseases and supports the potential application of B. tequilensis PZB-0006 as a sustainable alternative to synthetic fungicides for sweet cherry postharvest management.
Additional Links: PMID-43033129
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43033129,
year = {2026},
author = {Wang, JY and Mao, MX and Li, CG and Jiao, KX and Lu, QK and Liu, Z and Hu, SQ and Zou, M and Zhou, B and Zhang, Q},
title = {Preharvest Application of Bacillus tequilensis PZB-0006 Controls Sweet Cherry Postharvest Disease via Altering the Epiphytic Microbiota and Inducing Fruit Resistance.},
journal = {Plant disease},
volume = {},
number = {},
pages = {PDIS04260795RE},
doi = {10.1094/PDIS-04-26-0795-RE},
pmid = {43033129},
issn = {0191-2917},
abstract = {Postharvest diseases severely limit sweet cherry quality and shelf life, causing substantial economic losses worldwide. Although microbial antagonists are promising eco-friendly alternatives to synthetic fungicides, their role in modulating the fruit microbiome remains unclear. Herein, we investigated the biocontrol potential and underlying mechanisms of Bacillus tequilensis PZB-0006 in suppressing sweet cherry postharvest decay. Combined preharvest spraying and postharvest storage experiments showed that PZB-0006 application significantly mitigated cherry fruit rot. High-throughput sequencing confirmed that PZB-0006 stably colonized the cherry fruit surface, reshaping the epiphytic microbial community structure by reducing the abundance of pathogenic microorganisms. Linear discriminant analysis effect size (LEfSe) and Specificity-Occupancy (SPEC-OCCU) analyses further identified PZB-0006 as the specialist taxon in the treated fruit microbiome, highlighting its central role in community modulation. Additionally, PZB-0006 treatment significantly enhanced the activities of defense-related enzymes in cherry fruits, indicating the induction of host resistance. These findings collectively reveal that B. tequilensis PZB-0006 exerts biocontrol effects through a multifaceted mechanism involving stable colonization, microbial community modulation, and host defense activation. This study provides novel microecological insights into the biocontrol of fruit postharvest diseases and supports the potential application of B. tequilensis PZB-0006 as a sustainable alternative to synthetic fungicides for sweet cherry postharvest management.},
}
RevDate: 2026-11-14
Beyond monoamines: a multi-systems molecular framework for major depressive disorder.
Psychopharmacology [Epub ahead of print].
For over five decades, the monoamine hypothesis has anchored the conceptual and pharmacological approach to major depressive disorder (MDD), yet nearly one-third of patients fail to achieve remission with standard antidepressants, and therapeutic response is delayed by weeks. This narrative review offers a critical synthesis of recent high-impact literature drawn on evidence from genomic, molecular, and translational studies across six domains: genomic architecture, epigenetic dysregulation, neuroinflammation, neurotrophic signalling, gut-brain axis, and rapid-acting antidepressant mechanisms, to construct a multi-systems framework of MDD pathophysiology and, as a secondary and explicitly scoped aim, to identify translational priorities for South Asian, particularly Indian, populations; the evidence reviewed is global in scope. A 2025 genome-wide association study (GWAS) of 688,808 cases identified 697 independent associations mapping to 635 genomic risk loci implicating glutamatergic, GABAergic, and neuropeptidergic systems. Environmental stressors converge on this genetic susceptibility through DNA methylation, histone modification, and non-coding RNA-mediated epigenetic reprogramming. An inflammatory MDD subgroup, characterised by kynurenine pathway disruption and microglial dysregulation, is of interest for patient stratification. Rapid-acting antidepressants proposed to act through TrkB-BDNF-dependent synaptic plasticity offer a mechanistic account of their fast onset, although the direct-binding theory awaits independent replication. Gut microbiome dysbiosis, particularly among neurotransmitter-producing taxa, further extends the pathophysiological map beyond the brain itself. Together, these findings support a shift from a unidimensional monoaminergic model to an integrated, multi-systems molecular framework of MDD. Realising the clinical potential of this framework will require validated precision biomarker panels, dedicated South Asian GWAS cohorts, and longitudinal multi-omics studies.
Additional Links: PMID-43033265
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43033265,
year = {2026},
author = {Goel, I and Hans, G and Kumar, N and Karmakar, S},
title = {Beyond monoamines: a multi-systems molecular framework for major depressive disorder.},
journal = {Psychopharmacology},
volume = {},
number = {},
pages = {},
pmid = {43033265},
issn = {1432-2072},
support = {5/4-4/187/M/2020-NCD-II//Indian Council of Medical Research/ ; },
abstract = {For over five decades, the monoamine hypothesis has anchored the conceptual and pharmacological approach to major depressive disorder (MDD), yet nearly one-third of patients fail to achieve remission with standard antidepressants, and therapeutic response is delayed by weeks. This narrative review offers a critical synthesis of recent high-impact literature drawn on evidence from genomic, molecular, and translational studies across six domains: genomic architecture, epigenetic dysregulation, neuroinflammation, neurotrophic signalling, gut-brain axis, and rapid-acting antidepressant mechanisms, to construct a multi-systems framework of MDD pathophysiology and, as a secondary and explicitly scoped aim, to identify translational priorities for South Asian, particularly Indian, populations; the evidence reviewed is global in scope. A 2025 genome-wide association study (GWAS) of 688,808 cases identified 697 independent associations mapping to 635 genomic risk loci implicating glutamatergic, GABAergic, and neuropeptidergic systems. Environmental stressors converge on this genetic susceptibility through DNA methylation, histone modification, and non-coding RNA-mediated epigenetic reprogramming. An inflammatory MDD subgroup, characterised by kynurenine pathway disruption and microglial dysregulation, is of interest for patient stratification. Rapid-acting antidepressants proposed to act through TrkB-BDNF-dependent synaptic plasticity offer a mechanistic account of their fast onset, although the direct-binding theory awaits independent replication. Gut microbiome dysbiosis, particularly among neurotransmitter-producing taxa, further extends the pathophysiological map beyond the brain itself. Together, these findings support a shift from a unidimensional monoaminergic model to an integrated, multi-systems molecular framework of MDD. Realising the clinical potential of this framework will require validated precision biomarker panels, dedicated South Asian GWAS cohorts, and longitudinal multi-omics studies.},
}
RevDate: 2026-11-14
An engineered probiotic yeast converts extracellular ATP into adenosine to alleviate experimental colitis.
Microbiological research, 315:128819 pii:S0944-5013(26)00383-6 [Epub ahead of print].
Inflammatory bowel disease (IBD) is a chronic relapsing intestinal disorder characterized by mucosal inflammation, epithelial barrier disruption, and gut microbial dysbiosis. Excessive extracellular ATP (eATP) accumulates in inflamed intestinal tissues and amplifies immune activation through purinergic signaling, whereas adenosine generated from extracellular nucleotide metabolism exerts immunoregulatory effects. Here, we engineered the probiotic yeast Saccharomyces boulardii to sense eATP and convert it into adenosine through a CRISPR-engineered dual-enzyme pathway consisting of apyrase and 5'-nucleotidase. The engineered strain showed ATP-responsive pathway activation and efficiently generated adenosine from eATP, allowing extracellular nucleotide metabolism to be modulated in inflammatory settings. Oral administration of this strain significantly alleviated disease severity in acute dextran sulfate sodium (DSS)-induced colitis and showed beneficial effects in a repeated-DSS model, improved barrier-related epithelial features, reduced pro-inflammatory cytokine production, and supported mucosal recovery. Integrated microbiome and transcriptome analyses further showed partial restoration of gut microbial community structure, partial recovery of predicted microbial purine-related pathways, and attenuation of mucosal T-cell activation. Together, these findings indicate that engineered Saccharomyces boulardii can regulate extracellular purine metabolism in the inflamed gut and provide a microbial strategy for modulating intestinal inflammation.
Additional Links: PMID-43033677
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43033677,
year = {2026},
author = {Liu, H and Zhang, M and Wu, W and Deng, Q and Li, X and Ma, R and Bai, L and Huang, B},
title = {An engineered probiotic yeast converts extracellular ATP into adenosine to alleviate experimental colitis.},
journal = {Microbiological research},
volume = {315},
number = {},
pages = {128819},
doi = {10.1016/j.micres.2026.128819},
pmid = {43033677},
issn = {1618-0623},
abstract = {Inflammatory bowel disease (IBD) is a chronic relapsing intestinal disorder characterized by mucosal inflammation, epithelial barrier disruption, and gut microbial dysbiosis. Excessive extracellular ATP (eATP) accumulates in inflamed intestinal tissues and amplifies immune activation through purinergic signaling, whereas adenosine generated from extracellular nucleotide metabolism exerts immunoregulatory effects. Here, we engineered the probiotic yeast Saccharomyces boulardii to sense eATP and convert it into adenosine through a CRISPR-engineered dual-enzyme pathway consisting of apyrase and 5'-nucleotidase. The engineered strain showed ATP-responsive pathway activation and efficiently generated adenosine from eATP, allowing extracellular nucleotide metabolism to be modulated in inflammatory settings. Oral administration of this strain significantly alleviated disease severity in acute dextran sulfate sodium (DSS)-induced colitis and showed beneficial effects in a repeated-DSS model, improved barrier-related epithelial features, reduced pro-inflammatory cytokine production, and supported mucosal recovery. Integrated microbiome and transcriptome analyses further showed partial restoration of gut microbial community structure, partial recovery of predicted microbial purine-related pathways, and attenuation of mucosal T-cell activation. Together, these findings indicate that engineered Saccharomyces boulardii can regulate extracellular purine metabolism in the inflamed gut and provide a microbial strategy for modulating intestinal inflammation.},
}
RevDate: 2026-11-14
Comparative properties of antimicrobial peptides from human (host), bacterial, and milk (food) origins selectively active against bacteria.
Food chemistry, 533(Pt 3):152100 pii:S0308-8146(26)04260-3 [Epub ahead of print].
Antimicrobial peptides (AMPs) are expressed widely by living organisms and support the anti-infection response of the innate immune system. AMPs from human, bacterial and cow milk (food) sources with confirmed in vitro bioactivity were retrieved from databases and their amino acid (AA) sequences used to conduct in silico prediction of selected physicochemical, conformational and functional properties related to AMP bioactivity. Compared with human and cow milk, bacterial AMPs contained fewer charged AAs, higher glycine and hydrophobic residues. Key functional properties of membrane penetration depth (F1), propensity to form PPII coil and in vitro aggregation were differentiated between the AMP types and also depending on whether the AMP localised within membrane (F1 < 30) or within the cell (F1 = 30), after membrane penetration. Human, bacterial or food AMPs displayed distinct predicted property and functional characteristics that may have reflected their different mechanisms of AMP bioactivity and divergent evolutionary origins.
Additional Links: PMID-43033707
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43033707,
year = {2026},
author = {Li, F and Baniel, A and Hearn, MTW and Martin, LL and Moro, J and Bennett, LE},
title = {Comparative properties of antimicrobial peptides from human (host), bacterial, and milk (food) origins selectively active against bacteria.},
journal = {Food chemistry},
volume = {533},
number = {Pt 3},
pages = {152100},
doi = {10.1016/j.foodchem.2026.152100},
pmid = {43033707},
issn = {1873-7072},
abstract = {Antimicrobial peptides (AMPs) are expressed widely by living organisms and support the anti-infection response of the innate immune system. AMPs from human, bacterial and cow milk (food) sources with confirmed in vitro bioactivity were retrieved from databases and their amino acid (AA) sequences used to conduct in silico prediction of selected physicochemical, conformational and functional properties related to AMP bioactivity. Compared with human and cow milk, bacterial AMPs contained fewer charged AAs, higher glycine and hydrophobic residues. Key functional properties of membrane penetration depth (F1), propensity to form PPII coil and in vitro aggregation were differentiated between the AMP types and also depending on whether the AMP localised within membrane (F1 < 30) or within the cell (F1 = 30), after membrane penetration. Human, bacterial or food AMPs displayed distinct predicted property and functional characteristics that may have reflected their different mechanisms of AMP bioactivity and divergent evolutionary origins.},
}
RevDate: 2026-11-14
Silent threats, microbial shifts: Changes in amphibian skin microbiome in the presence of ranavirus and co-occurrence of Bd in asymptomatic populations.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases pii:S1567-1348(26)00186-3 [Epub ahead of print].
Two emerging infectious diseases, chytridiomycosis and ranavirosis, pose serious threats to amphibian biodiversity. Investigating asymptomatic carriers and the adaptive responses of their skin microbiome, a key component of host immunity, can improve understanding of pathogen occurrence and support disease mitigation. We surveyed ranavirus occurrence across 48 localities and 2619 individuals in the French Pyrenees, in 2008, 2015-2018, and 2021-2022. We analyzed the skin microbiome of 283 Rana temporaria and Alytes obstetricans tadpoles to investigate the adaptive microbiome hypothesis, which posits that host-associated microbial communities can dynamically shift in composition and function to enhance resistance or tolerance to pathogens, here ranavirus and Batrachochytrium dendrobatidis (Bd). Although amphibians were asymptomatic of ranaviral infection, viral DNA was detected on animals in 61.3% of localities and in all sampling years, generally at low prevalence and viral loads. Ranavirus presence was linked with significant shifts in microbiome composition (Jaccard and Bray-Curtis dissimilarity) in both hosts. Dispersion was also generally higher in ranavirus positive populations, especially in A. obstetricans, and better witnessed by Jaccard dissimilarity. Effects of ranavirus presence on alpha-diversity differed between host species. With ranavirus occurrence changing over time, we observed dynamic shifts of microbiome composition and sometimes dispersion. However, Bd was a stronger predictor of the skin microbiome structure compared to ranavirus, possibly reflecting its greater pathogenic impact in our populations. These findings reveal that amphibian skin microbiomes can fine-tune their defenses against multiple simultaneous threats, suggesting a powerful, and potentially harnessable mechanism for disease resistance.
Additional Links: PMID-43033886
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43033886,
year = {2026},
author = {Loyau, A and Bouchali, R and Bernardo-Cravo, A and Schmeller, DS},
title = {Silent threats, microbial shifts: Changes in amphibian skin microbiome in the presence of ranavirus and co-occurrence of Bd in asymptomatic populations.},
journal = {Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases},
volume = {},
number = {},
pages = {106062},
doi = {10.1016/j.meegid.2026.106062},
pmid = {43033886},
issn = {1567-7257},
abstract = {Two emerging infectious diseases, chytridiomycosis and ranavirosis, pose serious threats to amphibian biodiversity. Investigating asymptomatic carriers and the adaptive responses of their skin microbiome, a key component of host immunity, can improve understanding of pathogen occurrence and support disease mitigation. We surveyed ranavirus occurrence across 48 localities and 2619 individuals in the French Pyrenees, in 2008, 2015-2018, and 2021-2022. We analyzed the skin microbiome of 283 Rana temporaria and Alytes obstetricans tadpoles to investigate the adaptive microbiome hypothesis, which posits that host-associated microbial communities can dynamically shift in composition and function to enhance resistance or tolerance to pathogens, here ranavirus and Batrachochytrium dendrobatidis (Bd). Although amphibians were asymptomatic of ranaviral infection, viral DNA was detected on animals in 61.3% of localities and in all sampling years, generally at low prevalence and viral loads. Ranavirus presence was linked with significant shifts in microbiome composition (Jaccard and Bray-Curtis dissimilarity) in both hosts. Dispersion was also generally higher in ranavirus positive populations, especially in A. obstetricans, and better witnessed by Jaccard dissimilarity. Effects of ranavirus presence on alpha-diversity differed between host species. With ranavirus occurrence changing over time, we observed dynamic shifts of microbiome composition and sometimes dispersion. However, Bd was a stronger predictor of the skin microbiome structure compared to ranavirus, possibly reflecting its greater pathogenic impact in our populations. These findings reveal that amphibian skin microbiomes can fine-tune their defenses against multiple simultaneous threats, suggesting a powerful, and potentially harnessable mechanism for disease resistance.},
}
RevDate: 2026-11-14
Amitriptyline alters gut microbial composition and compromises host resistance to enteropathogenic infection.
Brain, behavior, and immunity pii:S0889-1591(26)01027-5 [Epub ahead of print].
Amitriptyline, a tricyclic antidepressant commonly prescribed for depression and various other disorders, has been reported to possess both anti-inflammatory and antimicrobial properties. Paradoxically, clinical evidence suggests that patients with depressive disorders receiving pharmacological treatment exhibit an increased susceptibility to infections, though the mechanisms behind this increased susceptibility remain unclear. This study investigates the impact of amitriptyline on intestinal homeostasis and vulnerability to enteropathogenic infection in a murine model. Oral administration of amitriptyline was found to significantly reduce gut microbial diversity and alter microbiota composition under both homeostatic and infectious conditions, as determined by 16S rRNA gene sequencing. Importantly, there was a marked depletion of butyrate-producing bacteria, accompanied by decreased fecal butyrate levels. Additionally, amitriptyline treatment led to a reduction in colonic regulatory T cells and cytokine production in specific pathogen-free mice, but not in germ-free animals. These results indicate that amitriptyline directly modulates host-microbiota interactions, and suggest that disruption of the gut microbiota may underlie the increased susceptibility to infection. Overall, this study underscores the critical role of the gut microbiome in shaping host responses to pharmacological interventions and identifies it as a potential therapeutic target to mitigate infection risks associated with amitriptyline use.
Additional Links: PMID-43033943
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43033943,
year = {2026},
author = {Lange, E and Pastille, E and Kehrmann, J and Basic, M and Bolsega, S and Schumacher, F and Kleuser, B and Klopfleisch, R and Buer, J and Hansen, W and Mekes-Adamczyk, A and Westendorf, AM},
title = {Amitriptyline alters gut microbial composition and compromises host resistance to enteropathogenic infection.},
journal = {Brain, behavior, and immunity},
volume = {},
number = {},
pages = {107279},
doi = {10.1016/j.bbi.2026.107279},
pmid = {43033943},
issn = {1090-2139},
abstract = {Amitriptyline, a tricyclic antidepressant commonly prescribed for depression and various other disorders, has been reported to possess both anti-inflammatory and antimicrobial properties. Paradoxically, clinical evidence suggests that patients with depressive disorders receiving pharmacological treatment exhibit an increased susceptibility to infections, though the mechanisms behind this increased susceptibility remain unclear. This study investigates the impact of amitriptyline on intestinal homeostasis and vulnerability to enteropathogenic infection in a murine model. Oral administration of amitriptyline was found to significantly reduce gut microbial diversity and alter microbiota composition under both homeostatic and infectious conditions, as determined by 16S rRNA gene sequencing. Importantly, there was a marked depletion of butyrate-producing bacteria, accompanied by decreased fecal butyrate levels. Additionally, amitriptyline treatment led to a reduction in colonic regulatory T cells and cytokine production in specific pathogen-free mice, but not in germ-free animals. These results indicate that amitriptyline directly modulates host-microbiota interactions, and suggest that disruption of the gut microbiota may underlie the increased susceptibility to infection. Overall, this study underscores the critical role of the gut microbiome in shaping host responses to pharmacological interventions and identifies it as a potential therapeutic target to mitigate infection risks associated with amitriptyline use.},
}
RevDate: 2026-11-15
CmpDate: 2026-11-15
Microbial community multi-omic analysis of marsh sediment following enrichment with crustacean shell compost.
ISME communications, 6(1):ycag307.
Nutrient availability influences microbial processes in natural environments, notably biogeochemical cycling and community structure. Short-term, functional responses of microbial communities to nutrient pulses in coastal communities are not fully understood, especially in temperate environments undergoing climate driven changes. A 48 hour microcosm experiment was carried out in which paired metagenomic and metatranscriptomic sequencing was employed to elucidate how decomposition of chitin rich substrates, namely, crab and lobster shell compost, alter salt marsh microbiome structure and function. Within 48 hours of amendment, a notable shift in community function was observed, including increased chitin degradation, altered stress-response, and enhanced sporulation. These responses coincided with marked decreases in genes regulating key biogeochemical processes, including carbon fixation, sulfur oxidation and reduction, and other metabolic pathways. After addition of shell compost, changes in microbial community structure and increased incidence of virulence-associated genes were also observed, accompanied by measurable transcriptional activation, notably aerolysin A (aerA), which encodes the pore-forming exotoxin aerolysin. These results support shifts in both community composition and function in temperate salt marsh sediment microbiomes following chitin-rich nutrient addition. It is concluded that temperate coastal systems are sensitive to organic nutrient enrichment, with the potential for ecological and public-health relevant consequences. These effects may be particularly significant given chitin is among the most abundant and readily available bionutrients in aquatic ecosystems.
Additional Links: PMID-43034448
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43034448,
year = {2026},
author = {Yancey, CE and Brumfield, KD and Ettwiller, L and Colwell, RR},
title = {Microbial community multi-omic analysis of marsh sediment following enrichment with crustacean shell compost.},
journal = {ISME communications},
volume = {6},
number = {1},
pages = {ycag307},
pmid = {43034448},
issn = {2730-6151},
abstract = {Nutrient availability influences microbial processes in natural environments, notably biogeochemical cycling and community structure. Short-term, functional responses of microbial communities to nutrient pulses in coastal communities are not fully understood, especially in temperate environments undergoing climate driven changes. A 48 hour microcosm experiment was carried out in which paired metagenomic and metatranscriptomic sequencing was employed to elucidate how decomposition of chitin rich substrates, namely, crab and lobster shell compost, alter salt marsh microbiome structure and function. Within 48 hours of amendment, a notable shift in community function was observed, including increased chitin degradation, altered stress-response, and enhanced sporulation. These responses coincided with marked decreases in genes regulating key biogeochemical processes, including carbon fixation, sulfur oxidation and reduction, and other metabolic pathways. After addition of shell compost, changes in microbial community structure and increased incidence of virulence-associated genes were also observed, accompanied by measurable transcriptional activation, notably aerolysin A (aerA), which encodes the pore-forming exotoxin aerolysin. These results support shifts in both community composition and function in temperate salt marsh sediment microbiomes following chitin-rich nutrient addition. It is concluded that temperate coastal systems are sensitive to organic nutrient enrichment, with the potential for ecological and public-health relevant consequences. These effects may be particularly significant given chitin is among the most abundant and readily available bionutrients in aquatic ecosystems.},
}
RevDate: 2026-11-15
CmpDate: 2026-11-15
Probiotics and Prebiotics in Restoring Gastrointestinal Microbiota Dysbiosis: Emerging Alternatives to Antibiotic Therapy.
International journal of food science, 2026:6956918.
The human gastrointestinal (GI) microbiota is a complex and dynamic microbial ecosystem that plays a fundamental role in maintaining host metabolism, immune homeostasis, intestinal barrier integrity, and protection against pathogenic microorganisms. Disruption of this microbial community, known as gut dysbiosis, has been implicated in the pathogenesis of numerous GI and systemic diseases, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), Clostridioides difficile infection, obesity, type 2 diabetes mellitus, colorectal cancer, and nonalcoholic fatty liver disease. Although antibiotics remain indispensable for the treatment of bacterial infections, their indiscriminate use frequently disrupts gut microbial composition, reduces microbial diversity, promotes opportunistic pathogen overgrowth, and accelerates the emergence of antimicrobial resistance. These limitations have stimulated increasing interest in microbiota-targeted interventions as safer and more sustainable therapeutic strategies. Probiotics and prebiotics have emerged as promising approaches for restoring gut microbial homeostasis through complementary mechanisms. Probiotics inhibit pathogen colonization, enhance intestinal barrier function, produce antimicrobial metabolites, and modulate host immune responses. Prebiotics selectively stimulate the growth and metabolic activity of beneficial microorganisms, promoting the production of short-chain fatty acids (SCFAs) that support intestinal and systemic health. Increasing evidence from experimental studies, randomized clinical trials, and meta-analyses demonstrates that these microbiota-directed interventions can reduce antibiotic-associated diarrhea, improve symptoms of IBD and IBS, enhance Helicobacter pylori eradication, decrease recurrence of C. difficile infection, and contribute to the management of several metabolic disorders. Despite these promising findings, important challenges remain regarding strain specificity, optimal dosage, treatment duration, product standardization, regulatory oversight, and interindividual variability in treatment response. Emerging advances in metagenomics, metabolomics, artificial intelligence, and precision medicine are facilitating the development of personalized microbiome-based therapies that may further enhance clinical outcomes. This review critically summarizes the current understanding of GI microbiota dysbiosis, discusses the mechanisms through which probiotics and prebiotics restore microbial balance, evaluates their clinical applications as alternatives or adjuncts to antibiotic therapy, and highlights existing challenges and future research directions for microbiome-based therapeutics.
Additional Links: PMID-43034624
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43034624,
year = {2026},
author = {Goa, T and Wolde, T and Sahilu, E},
title = {Probiotics and Prebiotics in Restoring Gastrointestinal Microbiota Dysbiosis: Emerging Alternatives to Antibiotic Therapy.},
journal = {International journal of food science},
volume = {2026},
number = {},
pages = {6956918},
pmid = {43034624},
issn = {2314-5765},
abstract = {The human gastrointestinal (GI) microbiota is a complex and dynamic microbial ecosystem that plays a fundamental role in maintaining host metabolism, immune homeostasis, intestinal barrier integrity, and protection against pathogenic microorganisms. Disruption of this microbial community, known as gut dysbiosis, has been implicated in the pathogenesis of numerous GI and systemic diseases, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), Clostridioides difficile infection, obesity, type 2 diabetes mellitus, colorectal cancer, and nonalcoholic fatty liver disease. Although antibiotics remain indispensable for the treatment of bacterial infections, their indiscriminate use frequently disrupts gut microbial composition, reduces microbial diversity, promotes opportunistic pathogen overgrowth, and accelerates the emergence of antimicrobial resistance. These limitations have stimulated increasing interest in microbiota-targeted interventions as safer and more sustainable therapeutic strategies. Probiotics and prebiotics have emerged as promising approaches for restoring gut microbial homeostasis through complementary mechanisms. Probiotics inhibit pathogen colonization, enhance intestinal barrier function, produce antimicrobial metabolites, and modulate host immune responses. Prebiotics selectively stimulate the growth and metabolic activity of beneficial microorganisms, promoting the production of short-chain fatty acids (SCFAs) that support intestinal and systemic health. Increasing evidence from experimental studies, randomized clinical trials, and meta-analyses demonstrates that these microbiota-directed interventions can reduce antibiotic-associated diarrhea, improve symptoms of IBD and IBS, enhance Helicobacter pylori eradication, decrease recurrence of C. difficile infection, and contribute to the management of several metabolic disorders. Despite these promising findings, important challenges remain regarding strain specificity, optimal dosage, treatment duration, product standardization, regulatory oversight, and interindividual variability in treatment response. Emerging advances in metagenomics, metabolomics, artificial intelligence, and precision medicine are facilitating the development of personalized microbiome-based therapies that may further enhance clinical outcomes. This review critically summarizes the current understanding of GI microbiota dysbiosis, discusses the mechanisms through which probiotics and prebiotics restore microbial balance, evaluates their clinical applications as alternatives or adjuncts to antibiotic therapy, and highlights existing challenges and future research directions for microbiome-based therapeutics.},
}
RevDate: 2026-11-15
CmpDate: 2026-11-15
Respecting, Protecting, or Restoring: An Ecobiology Conceptual Framework for Supporting the Skin Microbiota in Healthy, Exposed, and Diseased Skin.
Clinical, cosmetic and investigational dermatology, 19:632345.
BACKGROUND: The skin microbiota interacts with the epidermal barrier and supports cutaneous immunity, defence, and homeostasis. Stressors may alter microbial composition and function, contributing to dysbiosis, although its causal role in many skin diseases and conditions (SDC) remains unclear.
OBJECTIVE: To review the evidence linking alterations of the skin microbiota to different SDC, explicitly distinguishing correlation, temporal association, mechanistic support, and causal evidence, and to propose a Respect-Protect-Restore Ecobiology conceptual framework according to skin status.
METHODS: A literature search on SDC and the skin microbiota resulted in 172 selected and 71 used publications. Evidence was classified by study design and inferential strength as: (i) cross-sectional/observational correlation; (ii) longitudinal temporal association; (iii) mechanistic support; or (iv) experimental/interventional evidence supporting causality. SDC were classified according to ICD-11 categories and stratified using predefined operational criteria for the strength and consistency of evidence linking dysbiosis to disease.
RESULTS: Evidence linking microbiota alterations to SDC is heterogeneous. The strongest evidence, including mechanistic or interventional support, was identified for selected aspects of acne, atopic dermatitis, and wound healing, whereas evidence for rosacea and several other SDC remained predominantly associative or mechanistic and did not consistently establish directionality. The Respect-Protect-Restore framework is presented as an expert-informed conceptual model.
CONCLUSION: The skin microbiota and its interactions with the skin barrier are relevant to cutaneous homeostasis, but association should not be interpreted as causation. The proposed Respect-Protect-Restore axes constitute a conceptual, expert-opinion framework intended to organize available evidence and support discussion of skin care according to skin status.
Additional Links: PMID-43034625
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43034625,
year = {2026},
author = {Guelorget, C and Callejon, S and Giraud, F and Perrier, E and Burty-Valin, E and Dréno, B},
title = {Respecting, Protecting, or Restoring: An Ecobiology Conceptual Framework for Supporting the Skin Microbiota in Healthy, Exposed, and Diseased Skin.},
journal = {Clinical, cosmetic and investigational dermatology},
volume = {19},
number = {},
pages = {632345},
pmid = {43034625},
issn = {1178-7015},
abstract = {BACKGROUND: The skin microbiota interacts with the epidermal barrier and supports cutaneous immunity, defence, and homeostasis. Stressors may alter microbial composition and function, contributing to dysbiosis, although its causal role in many skin diseases and conditions (SDC) remains unclear.
OBJECTIVE: To review the evidence linking alterations of the skin microbiota to different SDC, explicitly distinguishing correlation, temporal association, mechanistic support, and causal evidence, and to propose a Respect-Protect-Restore Ecobiology conceptual framework according to skin status.
METHODS: A literature search on SDC and the skin microbiota resulted in 172 selected and 71 used publications. Evidence was classified by study design and inferential strength as: (i) cross-sectional/observational correlation; (ii) longitudinal temporal association; (iii) mechanistic support; or (iv) experimental/interventional evidence supporting causality. SDC were classified according to ICD-11 categories and stratified using predefined operational criteria for the strength and consistency of evidence linking dysbiosis to disease.
RESULTS: Evidence linking microbiota alterations to SDC is heterogeneous. The strongest evidence, including mechanistic or interventional support, was identified for selected aspects of acne, atopic dermatitis, and wound healing, whereas evidence for rosacea and several other SDC remained predominantly associative or mechanistic and did not consistently establish directionality. The Respect-Protect-Restore framework is presented as an expert-informed conceptual model.
CONCLUSION: The skin microbiota and its interactions with the skin barrier are relevant to cutaneous homeostasis, but association should not be interpreted as causation. The proposed Respect-Protect-Restore axes constitute a conceptual, expert-opinion framework intended to organize available evidence and support discussion of skin care according to skin status.},
}
RevDate: 2026-11-15
CmpDate: 2026-11-15
Essential methods for swine nutrition studies: A review.
Animal nutrition (Zhongguo xu mu shou yi xue hui), 27:620-636.
This review provides an overview of some of the major methodologies needed and commonly employed in swine nutrition studies, both before an experiment even commences and in the conduct of experiments. Proper methodology is critical for accurately assessing the effects of dietary interventions on a range of outcomes such as pig performance, nutrient utilisation and efficiency, and increasingly, the environmental footprint impacts and evaluation of pork production. Swine nutrition experiments typically involve controlled feeding trials using well-defined animal groups based on age, body weight, and/or production stage (weaners, growers, finishers, and sows). Experimental designs such as randomised complete block or factorial arrangements are frequently used to examine different treatments, minimise variability, and ensure statistical reliability. Ingredient evaluation and feed formulation are central to these studies, relying on precise calculations of the contents of energy and/or nutrients according to established nutritional standards and measurements. Ingredients for studies are generally selected based on nutrient composition, digestibility, and availability, although other influences such as palatability and anti-nutritional factors can be contemplated, and test diets are formulated to isolate the effect of, for instance, specific nutrients or feed additives on a range of outcomes. Ingredient and feed samples should be analysed according to the type of study being conducted, e.g., for proximate composition, amino acid profiles, energy content using standardised laboratory techniques including near-infrared spectroscopy (NIRS), bomb calorimetry, or Kjeldahl nitrogen analysis. Animal performance is typically evaluated through measurements of feed intake, weight gain, and feed conversion efficiency, while digestibility trials typically include faecal and/or ileal sampling to determine nutrient and/or energy absorption efficiency and whole-body utilisation. Blood, tissue, microbiome and/or 'omics' analyses may be conducted concurrently to assess, for example, the metabolic, immune, and/or intestinal health responses to different nutritional interventions. Housing conditions, environmental control, and animal welfare standards are maintained according to institutional and ethical regulations for adherence to jurisdictional regulations and to ensure reproducibility and validity of results. Overall, swine nutrition research and the myriad methodologies that underpin it are a cornerstone for global pork production, integrating rigorous experimental design, accurate feed formulation, and comprehensive analytical methods to evaluate dietary effects on a host of different outcomes including growth performance, nutrient efficiency, and animal health; therefore providing critical data to improve feeding strategies and promote sustainable pork production globally.
Additional Links: PMID-43034680
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43034680,
year = {2026},
author = {Pluske, JR},
title = {Essential methods for swine nutrition studies: A review.},
journal = {Animal nutrition (Zhongguo xu mu shou yi xue hui)},
volume = {27},
number = {},
pages = {620-636},
pmid = {43034680},
issn = {2405-6383},
abstract = {This review provides an overview of some of the major methodologies needed and commonly employed in swine nutrition studies, both before an experiment even commences and in the conduct of experiments. Proper methodology is critical for accurately assessing the effects of dietary interventions on a range of outcomes such as pig performance, nutrient utilisation and efficiency, and increasingly, the environmental footprint impacts and evaluation of pork production. Swine nutrition experiments typically involve controlled feeding trials using well-defined animal groups based on age, body weight, and/or production stage (weaners, growers, finishers, and sows). Experimental designs such as randomised complete block or factorial arrangements are frequently used to examine different treatments, minimise variability, and ensure statistical reliability. Ingredient evaluation and feed formulation are central to these studies, relying on precise calculations of the contents of energy and/or nutrients according to established nutritional standards and measurements. Ingredients for studies are generally selected based on nutrient composition, digestibility, and availability, although other influences such as palatability and anti-nutritional factors can be contemplated, and test diets are formulated to isolate the effect of, for instance, specific nutrients or feed additives on a range of outcomes. Ingredient and feed samples should be analysed according to the type of study being conducted, e.g., for proximate composition, amino acid profiles, energy content using standardised laboratory techniques including near-infrared spectroscopy (NIRS), bomb calorimetry, or Kjeldahl nitrogen analysis. Animal performance is typically evaluated through measurements of feed intake, weight gain, and feed conversion efficiency, while digestibility trials typically include faecal and/or ileal sampling to determine nutrient and/or energy absorption efficiency and whole-body utilisation. Blood, tissue, microbiome and/or 'omics' analyses may be conducted concurrently to assess, for example, the metabolic, immune, and/or intestinal health responses to different nutritional interventions. Housing conditions, environmental control, and animal welfare standards are maintained according to institutional and ethical regulations for adherence to jurisdictional regulations and to ensure reproducibility and validity of results. Overall, swine nutrition research and the myriad methodologies that underpin it are a cornerstone for global pork production, integrating rigorous experimental design, accurate feed formulation, and comprehensive analytical methods to evaluate dietary effects on a host of different outcomes including growth performance, nutrient efficiency, and animal health; therefore providing critical data to improve feeding strategies and promote sustainable pork production globally.},
}
RevDate: 2026-11-15
CmpDate: 2026-11-15
Non-Sugar Sweetener Consumption and Glycemic Control in Middle-Aged and Older Adults with Prediabetes: Background, Design, and Methods of a Controlled Feeding Trial.
Contemporary clinical trials communications, 54:101707.
Type 2 diabetes (T2D) and prediabetes are rising globally and constitute a significant metabolic disease burden. Development of these conditions involves insulin resistance, declining β-cell function, chronic low-grade inflammation, and gut microbiome disruption. Middle-aged and older adults comprise over one-third of individuals with T2D and 50% of those with prediabetes. Non-sugar sweeteners (NSS) are widely promoted as a strategy to reduce added sugar intake and help manage blood glucose concentrations. Adults with or at risk for T2D are among the highest users of NSS. However, the impact of NSS on glucose homeostasis remains unclear due to heterogeneity across trials, including short duration, inconsistent dosing, predominantly healthy participants, and infrequent assessment of individual NSS, which limits the ability to establish clear intake recommendations. To address these gaps, two three-arm randomized controlled feeding trials were designed to test four NSS. Adults aged ≥40 years with prediabetes will follow a 6-week standardized eucaloric diet reflecting typical U.S. intake, which includes a 2-week lead-in diet followed by a 4-week intervention period. In Trial 1, participants will be randomized to one of two intervention groups (sucralose or aspartame) or a control group receiving no NSS. In Trial 2, participants will be randomized to one of two intervention groups (acesulfame potassium or saccharin) or a control group receiving no NSS. The intervention groups will receive the respective NSS at 25% of the FDA-established acceptable daily intake (ADI), adjusted for body weight (mg/kg). The primary outcome for both trials is 24-h glycemic control and insulin sensitivity in response to intake of specific NSS types compared with an identical control condition. Secondary outcomes include markers of inflammation (e.g., TNF-α and MCP-1) and changes in gut microbiome composition.
Additional Links: PMID-43034695
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43034695,
year = {2026},
author = {Boone, JT and Capra, BT and Davy, BM and Davy, KP and Marinik, EL and Savla, J and Hedrick, VE},
title = {Non-Sugar Sweetener Consumption and Glycemic Control in Middle-Aged and Older Adults with Prediabetes: Background, Design, and Methods of a Controlled Feeding Trial.},
journal = {Contemporary clinical trials communications},
volume = {54},
number = {},
pages = {101707},
pmid = {43034695},
issn = {2451-8654},
support = {R21 AG075344/AG/NIA NIH HHS/United States ; R21 AG080358/AG/NIA NIH HHS/United States ; },
abstract = {Type 2 diabetes (T2D) and prediabetes are rising globally and constitute a significant metabolic disease burden. Development of these conditions involves insulin resistance, declining β-cell function, chronic low-grade inflammation, and gut microbiome disruption. Middle-aged and older adults comprise over one-third of individuals with T2D and 50% of those with prediabetes. Non-sugar sweeteners (NSS) are widely promoted as a strategy to reduce added sugar intake and help manage blood glucose concentrations. Adults with or at risk for T2D are among the highest users of NSS. However, the impact of NSS on glucose homeostasis remains unclear due to heterogeneity across trials, including short duration, inconsistent dosing, predominantly healthy participants, and infrequent assessment of individual NSS, which limits the ability to establish clear intake recommendations. To address these gaps, two three-arm randomized controlled feeding trials were designed to test four NSS. Adults aged ≥40 years with prediabetes will follow a 6-week standardized eucaloric diet reflecting typical U.S. intake, which includes a 2-week lead-in diet followed by a 4-week intervention period. In Trial 1, participants will be randomized to one of two intervention groups (sucralose or aspartame) or a control group receiving no NSS. In Trial 2, participants will be randomized to one of two intervention groups (acesulfame potassium or saccharin) or a control group receiving no NSS. The intervention groups will receive the respective NSS at 25% of the FDA-established acceptable daily intake (ADI), adjusted for body weight (mg/kg). The primary outcome for both trials is 24-h glycemic control and insulin sensitivity in response to intake of specific NSS types compared with an identical control condition. Secondary outcomes include markers of inflammation (e.g., TNF-α and MCP-1) and changes in gut microbiome composition.},
}
RevDate: 2026-11-15
CmpDate: 2026-11-15
A review on the beneficial and detrimental roles of gut microbiota-derived trimethylamine-N-oxide (TMAO).
Infectious medicine, 5(4):100290.
In recent years, increasing attention has focused on the role of the gut microbiome in converting dietary substances into bioactive metabolites implicated in the etiology of various diseases. Among these metabolites, trimethylamine-N-oxide (TMAO), a gut microbial metabolite derived from choline, carnitine, and betaine, has emerged as a novel molecule of interest as an alternative messenger with multiple, tissue-specific effects on human physiology. Once considered a benign osmolyte in marine organisms, TMAO is now implicated in human health risks through mechanisms involving oxidative stress, inflammation, and metabolic regulation. While elevated TMAO levels are associated with cardiovascular disease, chronic kidney disease, and neurodegeneration, evidence also highlights its cytoprotective properties, including protein stabilization and osmoprotection. This review provides a comprehensive analysis of TMAO's dual role in oxidative stress, inflammation, and endothelial mechanisms, clarifying its context-dependent effects and therapeutic implications.
Additional Links: PMID-43034801
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43034801,
year = {2026},
author = {Rajabi, E and Pourramezan Seyedi, Z and Ghamari, M and Mohammadzadeh, R and Mansouri, M and Götz, F and Bostanghadiri, N},
title = {A review on the beneficial and detrimental roles of gut microbiota-derived trimethylamine-N-oxide (TMAO).},
journal = {Infectious medicine},
volume = {5},
number = {4},
pages = {100290},
pmid = {43034801},
issn = {2772-431X},
abstract = {In recent years, increasing attention has focused on the role of the gut microbiome in converting dietary substances into bioactive metabolites implicated in the etiology of various diseases. Among these metabolites, trimethylamine-N-oxide (TMAO), a gut microbial metabolite derived from choline, carnitine, and betaine, has emerged as a novel molecule of interest as an alternative messenger with multiple, tissue-specific effects on human physiology. Once considered a benign osmolyte in marine organisms, TMAO is now implicated in human health risks through mechanisms involving oxidative stress, inflammation, and metabolic regulation. While elevated TMAO levels are associated with cardiovascular disease, chronic kidney disease, and neurodegeneration, evidence also highlights its cytoprotective properties, including protein stabilization and osmoprotection. This review provides a comprehensive analysis of TMAO's dual role in oxidative stress, inflammation, and endothelial mechanisms, clarifying its context-dependent effects and therapeutic implications.},
}
RevDate: 2026-11-15
CmpDate: 2026-11-15
Datasets of small intestine and systemic immune components, transcriptomics in jejunal tissue, fecal 16S rRNA gene amplicon sequences, and fecal and plasma metabolome, in young female and male progeny dietary exposed to food additive E171 from preconception.
Data in brief, 69:113380.
We recently demonstrated in mice that exposure from gestation to early post-weaning windows to a common food additive, food-grade titanium dioxide (E171), increased the susceptibility to food allergy of the young male progeny - but not that of females. Moreover, we evidenced alteration in intestinal homeostasis at baseline in males. To go further in analyzing sex-related effect, this article describes multi-omics datasets obtained from both male and female young progeny exposed to E171 and from control mice. BALB/cAnNRj future dams were exposed to E171 from pre-pregnancy to the end of lactation (post-natal day 20, PNDD20) through E171-enriched (10 mg/kg of body weight/day) or control pellets. Then, the progeny was exposed to the same diet as their mother until euthanasia on PND30. Various samples were obtained from female and male progenies in order to assess intestinal and systemic homeostasis in exposed versus control young mice. The article includes the protocols used to process samples for the different analysis and the multi-omics datasets obtained: i) raw flow cytometry data (.fcs) obtained on cells extracted from lamina propria, Peyer's patches and spleen, ii) concentrations of Th1/Th2/Th17 cytokines and of total IgGs, IgA and IgM antibodies in plasma, iii) raw 16S rRNA gene amplicon sequencing data obtained from feces, iv) peak intensities and characteristics of the metabolites annotated through unsupervised metabolomics analysis of plasma and feces, and v) raw transcriptomics data obtained on jejunum tissue. Each dataset is available in the INRAE data repository (https://entrepot.recherche.data.gouv.fr/dataverse/inrae) with respective DOI: MICROBIOTA: doi:10.57745/CNCI1D, METABOLITES: doi:10.57745/OUEPQM, IMMUNE COMPONENTS: Flow cytometry data, cytokines and antibody concentrations: doi:10.57745/VUDUMU; TRANSCRIPTOMICS: doi:10.57745/JYWYGV. These unique multi-omic datasets provide valuable resources for further investigating the molecular mechanisms underlying E171 immunotoxicity, and its associated biomarkers. Datasets can be reused to compare with other experimental protocols assessing toxicity of food additives. Data from non-exposed mice can also be re-use on its own as a comparator for inter-laboratory analysis in young male and female BALB/cAnNRj mice. We would like to mention that additional organs were collected at euthanasia from male and female progeny (brain, liver, kidney, reproductive tracts, lungs) and can be provided upon request to authors.
Additional Links: PMID-43034828
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43034828,
year = {2026},
author = {Issa, M and Michaudel, C and Guillon, B and Guinot, M and Grauso, M and Lecardonnel, J and Jouneau, L and Chapuis, C and Bernard, H and Hazebrouck, S and Castelli, F and Fenaille, F and Gaultier, E and Rivière, G and Houdeau, E and Adel-Patient, K},
title = {Datasets of small intestine and systemic immune components, transcriptomics in jejunal tissue, fecal 16S rRNA gene amplicon sequences, and fecal and plasma metabolome, in young female and male progeny dietary exposed to food additive E171 from preconception.},
journal = {Data in brief},
volume = {69},
number = {},
pages = {113380},
pmid = {43034828},
issn = {2352-3409},
abstract = {We recently demonstrated in mice that exposure from gestation to early post-weaning windows to a common food additive, food-grade titanium dioxide (E171), increased the susceptibility to food allergy of the young male progeny - but not that of females. Moreover, we evidenced alteration in intestinal homeostasis at baseline in males. To go further in analyzing sex-related effect, this article describes multi-omics datasets obtained from both male and female young progeny exposed to E171 and from control mice. BALB/cAnNRj future dams were exposed to E171 from pre-pregnancy to the end of lactation (post-natal day 20, PNDD20) through E171-enriched (10 mg/kg of body weight/day) or control pellets. Then, the progeny was exposed to the same diet as their mother until euthanasia on PND30. Various samples were obtained from female and male progenies in order to assess intestinal and systemic homeostasis in exposed versus control young mice. The article includes the protocols used to process samples for the different analysis and the multi-omics datasets obtained: i) raw flow cytometry data (.fcs) obtained on cells extracted from lamina propria, Peyer's patches and spleen, ii) concentrations of Th1/Th2/Th17 cytokines and of total IgGs, IgA and IgM antibodies in plasma, iii) raw 16S rRNA gene amplicon sequencing data obtained from feces, iv) peak intensities and characteristics of the metabolites annotated through unsupervised metabolomics analysis of plasma and feces, and v) raw transcriptomics data obtained on jejunum tissue. Each dataset is available in the INRAE data repository (https://entrepot.recherche.data.gouv.fr/dataverse/inrae) with respective DOI: MICROBIOTA: doi:10.57745/CNCI1D, METABOLITES: doi:10.57745/OUEPQM, IMMUNE COMPONENTS: Flow cytometry data, cytokines and antibody concentrations: doi:10.57745/VUDUMU; TRANSCRIPTOMICS: doi:10.57745/JYWYGV. These unique multi-omic datasets provide valuable resources for further investigating the molecular mechanisms underlying E171 immunotoxicity, and its associated biomarkers. Datasets can be reused to compare with other experimental protocols assessing toxicity of food additives. Data from non-exposed mice can also be re-use on its own as a comparator for inter-laboratory analysis in young male and female BALB/cAnNRj mice. We would like to mention that additional organs were collected at euthanasia from male and female progeny (brain, liver, kidney, reproductive tracts, lungs) and can be provided upon request to authors.},
}
RevDate: 2026-11-16
CmpDate: 2026-11-15
Koinetic: a graph-based distance as a new ecological metric for microbial community differential analysis.
Briefings in bioinformatics, 27(6):.
Phylogeny-aware beta diversity measures are essential in microbiome research, yet widely used metrics such as UniFrac and its variants rely on independent branch-length contributions and do not satisfy the Euclidean property, leading to distortions in ordination and kernel-based tests. These limitations underscore the need for a distance that is both phylogenetically coherent and geometrically valid. We introduce the Koinos Kinetic Distance (Koinetic), a phylogeny-aware dissimilarity that views microbial communities as interconnected assemblies rather than isolated taxa. "Koinos" emphasizes collective evaluation, while "kinetic" reflects how differences propagate dynamically across ecological networks and phylogenetic lineages. Koinetic leverages a graph Laplacian-based kernel to weight community differences by shared phylogeny, capturing ecological connectivity and clade relatedness. This design ensures Euclidean validity and enables seamless integration with kernel-based methods as well as geometry-preserving ordination. Controlled simulations and analyses of eight microbiome datasets spanning diverse body sites, disease contexts, and microbial profiling modalities demonstrate Koinetic's broad applicability. Compared with classical and phylogenetic metrics, including weighted, unweighted, and generalized UniFrac, unweighted Koinetic can improve power for phylogenetically localized prevalence shifts in the simulated settings, while weighted Koinetic performs comparably with weighted and generalized UniFrac under abundance-driven signals. Koinetic also shows strong performance in PERMANOVA and MiRKAT analyses assessing associations between microbial community composition and host phenotypes. Koinetic thus provides a general foundation for phylogeny-aware analysis, with a consistent geometric basis for visualization and statistical inference.
Additional Links: PMID-43034901
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43034901,
year = {2026},
author = {Zhu, Z and Zhang, Y and Liu, R and Duan, Y and Li, W and Huang, Z and Chen, X and Zhang, L},
title = {Koinetic: a graph-based distance as a new ecological metric for microbial community differential analysis.},
journal = {Briefings in bioinformatics},
volume = {27},
number = {6},
pages = {},
pmid = {43034901},
issn = {1477-4054},
support = {BGT630267//School of Medicine at Case Western Reserve University/ ; 2025YFC3408500//National Key Research and Development Program of China/ ; QYPY20230033//Center for Advanced Interdisciplinary Science and Biomedicine of IHM/ ; WK9100000063//Fundamental Research Funds for the Central Universities/ ; XDB0940000//Strategic Priority Research Program of the Chinese Academy of Sciences/ ; 2025YFC3608300//National Key R&D Project/ ; },
mesh = {Phylogeny ; *Microbiota/genetics ; Algorithms ; *Computational Biology/methods ; Humans ; },
abstract = {Phylogeny-aware beta diversity measures are essential in microbiome research, yet widely used metrics such as UniFrac and its variants rely on independent branch-length contributions and do not satisfy the Euclidean property, leading to distortions in ordination and kernel-based tests. These limitations underscore the need for a distance that is both phylogenetically coherent and geometrically valid. We introduce the Koinos Kinetic Distance (Koinetic), a phylogeny-aware dissimilarity that views microbial communities as interconnected assemblies rather than isolated taxa. "Koinos" emphasizes collective evaluation, while "kinetic" reflects how differences propagate dynamically across ecological networks and phylogenetic lineages. Koinetic leverages a graph Laplacian-based kernel to weight community differences by shared phylogeny, capturing ecological connectivity and clade relatedness. This design ensures Euclidean validity and enables seamless integration with kernel-based methods as well as geometry-preserving ordination. Controlled simulations and analyses of eight microbiome datasets spanning diverse body sites, disease contexts, and microbial profiling modalities demonstrate Koinetic's broad applicability. Compared with classical and phylogenetic metrics, including weighted, unweighted, and generalized UniFrac, unweighted Koinetic can improve power for phylogenetically localized prevalence shifts in the simulated settings, while weighted Koinetic performs comparably with weighted and generalized UniFrac under abundance-driven signals. Koinetic also shows strong performance in PERMANOVA and MiRKAT analyses assessing associations between microbial community composition and host phenotypes. Koinetic thus provides a general foundation for phylogeny-aware analysis, with a consistent geometric basis for visualization and statistical inference.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Phylogeny
*Microbiota/genetics
Algorithms
*Computational Biology/methods
Humans
RevDate: 2026-11-15
Thermophilic intensification governs abiotic fragmentation and microbiome restructuring during anaerobic co-digestion of bioplastics with OFMSW and waste activated sludge.
Journal of environmental management, 420:131382 pii:S0301-4797(26)02842-2 [Epub ahead of print].
Anaerobic co-digestion (Co-AD) of the organic fraction of municipal solid waste (OFMSW) and waste-activated sludge (WAS) is a promising strategy for waste valorisation and renewable energy recovery; however, the increasing presence of compostable bioplastics in organic waste streams raises concerns regarding their degradation behaviour and impact on anaerobic digestion (AD) performance. In this study, semi-continuous mesophilic-to-thermophilic Co-AD of OFMSW and WAS containing Mater-Bi, crystallised polylactic acid (CPLA), and polyhydroxyalkanoate (PHA) was investigated under progressively intensified operating conditions, with and without graphite supplementation. Reactor performance was monitored through methane production, volatile fatty acids (VFAs), pH, and FOS/TAC ratio, while complementary abiotic assays and ATR-FTIR analyses were used to assess physicochemical polymer transformation in the absence and presence of microbial activity. Long-read metagenomics was further applied to evaluate microbial community restructuring during thermophilic operation. Thermophilic intensification strongly affected polymer transformation pathways and microbial composition. Among the tested materials, CPLA showed the highest abiotic solubilisation at 55 °C, reaching 1280 mg COD L[-1] and exhibiting clear fragmentation under thermophilic conditions. In contrast, P(3HB-co-4HB) showed limited solubilisation and structural transformation. Graphite supplementation produced limited and condition-dependent effects on reactor performance. Metagenomic analysis revealed a marked transition from mesophilic Bacillota-dominated communities toward thermophilic enrichment of Patescibacteria, Thermotogota, and syntrophy-associated Pseudomonadota taxa. Overall, thermophilic intensification was associated with material-specific physicochemical transformation and marked microbial community restructuring, highlighting parallel responses of bioplastics and the anaerobic microbiome to changing operating conditions.
Additional Links: PMID-43035085
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43035085,
year = {2026},
author = {Pedullà, A and Pavlović, J and Ferreri, M and Pangallo, D and Galová, D and Pangallo, D and Kraková, L and Calabrò, PS},
title = {Thermophilic intensification governs abiotic fragmentation and microbiome restructuring during anaerobic co-digestion of bioplastics with OFMSW and waste activated sludge.},
journal = {Journal of environmental management},
volume = {420},
number = {},
pages = {131382},
doi = {10.1016/j.jenvman.2026.131382},
pmid = {43035085},
issn = {1095-8630},
abstract = {Anaerobic co-digestion (Co-AD) of the organic fraction of municipal solid waste (OFMSW) and waste-activated sludge (WAS) is a promising strategy for waste valorisation and renewable energy recovery; however, the increasing presence of compostable bioplastics in organic waste streams raises concerns regarding their degradation behaviour and impact on anaerobic digestion (AD) performance. In this study, semi-continuous mesophilic-to-thermophilic Co-AD of OFMSW and WAS containing Mater-Bi, crystallised polylactic acid (CPLA), and polyhydroxyalkanoate (PHA) was investigated under progressively intensified operating conditions, with and without graphite supplementation. Reactor performance was monitored through methane production, volatile fatty acids (VFAs), pH, and FOS/TAC ratio, while complementary abiotic assays and ATR-FTIR analyses were used to assess physicochemical polymer transformation in the absence and presence of microbial activity. Long-read metagenomics was further applied to evaluate microbial community restructuring during thermophilic operation. Thermophilic intensification strongly affected polymer transformation pathways and microbial composition. Among the tested materials, CPLA showed the highest abiotic solubilisation at 55 °C, reaching 1280 mg COD L[-1] and exhibiting clear fragmentation under thermophilic conditions. In contrast, P(3HB-co-4HB) showed limited solubilisation and structural transformation. Graphite supplementation produced limited and condition-dependent effects on reactor performance. Metagenomic analysis revealed a marked transition from mesophilic Bacillota-dominated communities toward thermophilic enrichment of Patescibacteria, Thermotogota, and syntrophy-associated Pseudomonadota taxa. Overall, thermophilic intensification was associated with material-specific physicochemical transformation and marked microbial community restructuring, highlighting parallel responses of bioplastics and the anaerobic microbiome to changing operating conditions.},
}
RevDate: 2026-11-15
Stress Memory and Adaptive Intelligence in Plants from Signaling Networks to Crop Improvement under Climate Change.
Plant science : an international journal of experimental plant biology pii:S0168-9452(26)00624-2 [Epub ahead of print].
Plants, as sessile organisms, have evolved sophisticated decentralized signaling networks that enable perception, integration, and memory of environmental stresses despite lacking a nervous system. This review examines current understanding of plant intelligence, stress memory, and adaptive plasticity, highlighting how these processes enhance survival and productivity under increasingly variable climates. Key mechanisms include sensory receptors for diverse stimuli, rapid signaling via calcium, reactive oxygen species (ROS), electrical, and hydraulic waves, and extensive hormonal crosstalk Abscisic acid (ABA), Jasmonic acid (JA), Salicylic acid (SA), Ethylene (E). Stress memory operates through epigenetic modifications (DNA methylation, histone changes, chromatin remodeling), transcriptional reprogramming (Type I sustained and Type II hyper-induced patterns), and metabolic adjustments that create primed states for faster responses upon recurrent stress. These processes underpin cross-tolerance, systemic acquired resistance (SAR), induced systemic resistance (ISR), and transgenerational inheritance. In crops, priming, microbiome recruitment, and phenotypic plasticity, such as root foraging, shade avoidance, improve resilience to combined abiotic and biotic stresses. Advances in multi-omics, AI-driven phenomics, and systems biology are accelerating the identification of memory-associated genes and regulatory networks. Translational strategies such as seed priming, CRISPR-based editing, and epigenetic-informed breeding offer promising tools for developing climate-resilient varieties with enhanced yield stability. Integrating stress memory and adaptive intelligence concepts offers a comprehensive framework for sustainable agriculture. Future research should prioritize multi-environment field validation, quantification of fitness trade-offs, and integration of multi-stress networks to translate these mechanisms into robust crop improvement strategies.
Additional Links: PMID-43035178
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43035178,
year = {2026},
author = {Chauhan, J and Behera, PP and Jha, R and Rana, A and Singhal, RK and Ahmed, S and Zimik, M},
title = {Stress Memory and Adaptive Intelligence in Plants from Signaling Networks to Crop Improvement under Climate Change.},
journal = {Plant science : an international journal of experimental plant biology},
volume = {},
number = {},
pages = {113596},
doi = {10.1016/j.plantsci.2026.113596},
pmid = {43035178},
issn = {1873-2259},
abstract = {Plants, as sessile organisms, have evolved sophisticated decentralized signaling networks that enable perception, integration, and memory of environmental stresses despite lacking a nervous system. This review examines current understanding of plant intelligence, stress memory, and adaptive plasticity, highlighting how these processes enhance survival and productivity under increasingly variable climates. Key mechanisms include sensory receptors for diverse stimuli, rapid signaling via calcium, reactive oxygen species (ROS), electrical, and hydraulic waves, and extensive hormonal crosstalk Abscisic acid (ABA), Jasmonic acid (JA), Salicylic acid (SA), Ethylene (E). Stress memory operates through epigenetic modifications (DNA methylation, histone changes, chromatin remodeling), transcriptional reprogramming (Type I sustained and Type II hyper-induced patterns), and metabolic adjustments that create primed states for faster responses upon recurrent stress. These processes underpin cross-tolerance, systemic acquired resistance (SAR), induced systemic resistance (ISR), and transgenerational inheritance. In crops, priming, microbiome recruitment, and phenotypic plasticity, such as root foraging, shade avoidance, improve resilience to combined abiotic and biotic stresses. Advances in multi-omics, AI-driven phenomics, and systems biology are accelerating the identification of memory-associated genes and regulatory networks. Translational strategies such as seed priming, CRISPR-based editing, and epigenetic-informed breeding offer promising tools for developing climate-resilient varieties with enhanced yield stability. Integrating stress memory and adaptive intelligence concepts offers a comprehensive framework for sustainable agriculture. Future research should prioritize multi-environment field validation, quantification of fitness trade-offs, and integration of multi-stress networks to translate these mechanisms into robust crop improvement strategies.},
}
RevDate: 2026-11-15
MAIT cells in tumor contexts: Functional diversity and regulatory hierarchies.
Mucosal associated invariant T (MAIT) cells are a unique subset of innate T lymphocytes that play a critical role in the host's defense against bacterial and viral pathogens. However, its function in the tumor microenvironment (TME) remains controversial. This review systematically explores the dual role of MAIT cells in tumor immunity by integrating existing literature evidence, and proposes a three-level causal hierarchy that determines the functional fate of MAIT cells. In order to solve the prognostic paradox across cancer types, we introduced the barrier and systemic tumor classification criteria. Based on the above mechanisms, we explored clinical translation pathways such as MR1 targeted intervention, iPSC derived reMAIT cells, and CAR-MAIT engineering. Future research should utilize spatial omics and dynamic tracking techniques to achieve a shift from descriptive observations to precise predictive healthcare driven by biomarkers.
Additional Links: PMID-43035334
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43035334,
year = {2026},
author = {Wang, K and Jin, K and Fei, Q and Li, T and Wang, S and Yu, X and Wu, W and Ye, L},
title = {MAIT cells in tumor contexts: Functional diversity and regulatory hierarchies.},
journal = {Critical reviews in oncology/hematology},
volume = {},
number = {},
pages = {105682},
doi = {10.1016/j.critrevonc.2026.105682},
pmid = {43035334},
issn = {1879-0461},
abstract = {Mucosal associated invariant T (MAIT) cells are a unique subset of innate T lymphocytes that play a critical role in the host's defense against bacterial and viral pathogens. However, its function in the tumor microenvironment (TME) remains controversial. This review systematically explores the dual role of MAIT cells in tumor immunity by integrating existing literature evidence, and proposes a three-level causal hierarchy that determines the functional fate of MAIT cells. In order to solve the prognostic paradox across cancer types, we introduced the barrier and systemic tumor classification criteria. Based on the above mechanisms, we explored clinical translation pathways such as MR1 targeted intervention, iPSC derived reMAIT cells, and CAR-MAIT engineering. Future research should utilize spatial omics and dynamic tracking techniques to achieve a shift from descriptive observations to precise predictive healthcare driven by biomarkers.},
}
RevDate: 2026-11-15
CmpDate: 2026-11-15
Precision Prediction of Microbial Ecosystem Impact on Host Metabolism Using Genome-Resolved Metagenomics.
NPJ biofilms and microbiomes, 12(1):.
Mammalian gut dysbiosis is recognized to influence host metabolism, yet key microbiota and mechanisms governing their effects remain poorly understood. Here we developed a genome-resolved ecology-aware, systems-level workflow to predict how gut microbial metabolism affects mammalian health, and we apply it to a "spinal cord-gut axis" dataset. By scaling and integrating temporally resolved network analytics and consensus statistical approaches, we identified 19 microbial species that best predict host physiology following neurological impairment. In silico validation through pathway-centric and comparative genomic analyses revealed that among these species, the biggest encoded microbial metabolic changes were in pathways linked to host nitrogen balance, varying by host sex and microbial ecotype/species. Further inference identified the specific bacteria (and their draft genomes) potentially driving urease-dependent versus amino acid-dependent nitrogen metabolism-findings that can explain previously mechanistically-ambiguous, but clinically relevant, ammonia-driven host nitrogen imbalance. This provides a generalizable data-driven hypothesis generation workflow for longitudinal microbiome data.
Additional Links: PMID-43035523
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43035523,
year = {2026},
author = {Mohssen, M and Zayed, AA and Kigerl, KA and Du, J and Smith, GJ and Schwab, JM and Sullivan, MB and Popovich, PG},
title = {Precision Prediction of Microbial Ecosystem Impact on Host Metabolism Using Genome-Resolved Metagenomics.},
journal = {NPJ biofilms and microbiomes},
volume = {12},
number = {1},
pages = {},
pmid = {43035523},
issn = {2055-5008},
support = {890085//Craig H. Nielsen Foundation/ ; ABI#2149505 and DBI#2022070//National Science Foundation/ ; 1R35NS111582//National Institutes of Neurological Disorders and Stroke R35/ ; },
mesh = {*Metagenomics/methods ; Animals ; Nitrogen/metabolism ; *Bacteria/genetics/classification/metabolism ; *Microbiota ; Genome, Bacterial ; Ecosystem ; Humans ; Metagenome ; Host Microbial Interactions ; },
abstract = {Mammalian gut dysbiosis is recognized to influence host metabolism, yet key microbiota and mechanisms governing their effects remain poorly understood. Here we developed a genome-resolved ecology-aware, systems-level workflow to predict how gut microbial metabolism affects mammalian health, and we apply it to a "spinal cord-gut axis" dataset. By scaling and integrating temporally resolved network analytics and consensus statistical approaches, we identified 19 microbial species that best predict host physiology following neurological impairment. In silico validation through pathway-centric and comparative genomic analyses revealed that among these species, the biggest encoded microbial metabolic changes were in pathways linked to host nitrogen balance, varying by host sex and microbial ecotype/species. Further inference identified the specific bacteria (and their draft genomes) potentially driving urease-dependent versus amino acid-dependent nitrogen metabolism-findings that can explain previously mechanistically-ambiguous, but clinically relevant, ammonia-driven host nitrogen imbalance. This provides a generalizable data-driven hypothesis generation workflow for longitudinal microbiome data.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Metagenomics/methods
Animals
Nitrogen/metabolism
*Bacteria/genetics/classification/metabolism
*Microbiota
Genome, Bacterial
Ecosystem
Humans
Metagenome
Host Microbial Interactions
RevDate: 2026-11-15
CmpDate: 2026-11-15
Diversity and enzymatic activities of the bacterial microbiome associated with Amygdalum anoxicolum from a hypoxic seamount summit in the Arabian Sea.
World journal of microbiology & biotechnology, 42(12):.
Deep-sea seamounts that intersect oxygen minimum zones represent understudied habitats where host-associated microorganisms may contribute to ecosystem functioning and serve as sources of biotechnologically relevant enzymes. This study characterized the bacterial microbiome and enzymatic activities of culturable bacterial isolates of the hypoxia-adapted bivalve mollusc Amygdalum anoxicolum collected from a seamount summit in the southeastern Arabian Sea. Full-length 16 S rRNA gene amplicon sequencing using the Oxford Nanopore platform revealed a diverse bacterial community dominated by Pseudomonadota (53.05%), Bacteroidota (19.50%), and Planctomycetota (8.34%), with Pseudomonas (11.41%) and Ancylomarina (10.21%) as the most abundant genera. Culture-dependent isolation recovered 107 bacterial isolates, representing 1.8% of the genera detected by amplicon sequencing, indicating that the isolate collection reflects the culturable fraction rather than the complete host-associated microbiome. Phenotypic screening showed variable biofilm formation and extracellular enzyme activities, including β-glucosidase, aminopeptidase, lipase, phosphatase, laminarinase, and tyrosinase. These activities suggest a capacity for organic matter transformation and surface-associated lifestyles among selected culturable bacteria and identify potential candidates for marine enzymes. The findings provide the first baseline description of the bacterial diversity associated with A. anoxicolum from a hypoxic Arabian Sea seamount and highlight its culturable bacterial associates as a resource for enzyme purification and biotechnological applications.
Additional Links: PMID-43035586
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43035586,
year = {2026},
author = {Anas, A and Raj, KD and Navya, MJ and Ashraf, N and James, J and Jaleel, KUA},
title = {Diversity and enzymatic activities of the bacterial microbiome associated with Amygdalum anoxicolum from a hypoxic seamount summit in the Arabian Sea.},
journal = {World journal of microbiology & biotechnology},
volume = {42},
number = {12},
pages = {},
pmid = {43035586},
issn = {1573-0972},
support = {MoES/36/OOIS/Extra/81/2021//Ministry of Earth Sciences/ ; },
mesh = {Animals ; *Bacteria/classification/isolation & purification/genetics/enzymology ; *Microbiota/genetics ; RNA, Ribosomal, 16S/genetics ; Phylogeny ; Biofilms/growth & development ; Seawater/microbiology ; Biodiversity ; DNA, Bacterial/genetics ; Sequence Analysis, DNA ; Ecosystem ; beta-Glucosidase/metabolism ; },
abstract = {Deep-sea seamounts that intersect oxygen minimum zones represent understudied habitats where host-associated microorganisms may contribute to ecosystem functioning and serve as sources of biotechnologically relevant enzymes. This study characterized the bacterial microbiome and enzymatic activities of culturable bacterial isolates of the hypoxia-adapted bivalve mollusc Amygdalum anoxicolum collected from a seamount summit in the southeastern Arabian Sea. Full-length 16 S rRNA gene amplicon sequencing using the Oxford Nanopore platform revealed a diverse bacterial community dominated by Pseudomonadota (53.05%), Bacteroidota (19.50%), and Planctomycetota (8.34%), with Pseudomonas (11.41%) and Ancylomarina (10.21%) as the most abundant genera. Culture-dependent isolation recovered 107 bacterial isolates, representing 1.8% of the genera detected by amplicon sequencing, indicating that the isolate collection reflects the culturable fraction rather than the complete host-associated microbiome. Phenotypic screening showed variable biofilm formation and extracellular enzyme activities, including β-glucosidase, aminopeptidase, lipase, phosphatase, laminarinase, and tyrosinase. These activities suggest a capacity for organic matter transformation and surface-associated lifestyles among selected culturable bacteria and identify potential candidates for marine enzymes. The findings provide the first baseline description of the bacterial diversity associated with A. anoxicolum from a hypoxic Arabian Sea seamount and highlight its culturable bacterial associates as a resource for enzyme purification and biotechnological applications.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
*Bacteria/classification/isolation & purification/genetics/enzymology
*Microbiota/genetics
RNA, Ribosomal, 16S/genetics
Phylogeny
Biofilms/growth & development
Seawater/microbiology
Biodiversity
DNA, Bacterial/genetics
Sequence Analysis, DNA
Ecosystem
beta-Glucosidase/metabolism
RevDate: 2026-11-15
Clostridioides difficile-commensal interactions are impacted by diet more than differences between strains.
Molecular systems biology [Epub ahead of print].
The primary risk factor for C. difficile infection (CDI) is broad-spectrum antibiotic use which clears the intestinal microbiome leaving an open niche for C. difficile to colonize. During infection, C. difficile metabolism is highly responsive to its nutritional environment. For example, in mice with CDI, a high protein diet exacerbates disease severity while a high carbohydrate, high fiber diet ameliorates disease. However, C. difficile is a genetically and metabolically diverse species with often significant differences between strains. To investigate how C. difficile metabolism differs between strains as a function of diet, we reconstructed genome-scale metabolic models of 105 C. difficile strains from publicly available, whole-genome sequencing data and then simulated metabolic flux for each model under three unique diet conditions. We found that strains cluster in two metabolically distinct groups by diet. Metabolomics of spent media from C. difficile strains grown in diet conditions found both unique and shared metabolic pathways across conditions. We also simulated the growth of the C. difficile strains in the presence of 8 different commensals to understand the impact of diet on common microbiome interactions in the large intestine. We found that C. difficile-commensal interactions were more impacted by diet than by differences between C. difficile strains. Overall, the diverse metabolic responses of both C. difficile strains and commensals to different diet conditions have therapeutic implications, particularly for fecal microbiota transplants where differences in metabolism could impact the effectiveness of treatment and as an important parameter to incorporate in the design of therapeutic synthetic bacterial communities to resolve CDI.
Additional Links: PMID-43035616
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43035616,
year = {2026},
author = {Powers, DA and Papin, JA},
title = {Clostridioides difficile-commensal interactions are impacted by diet more than differences between strains.},
journal = {Molecular systems biology},
volume = {},
number = {},
pages = {},
pmid = {43035616},
issn = {1744-4292},
support = {SIF 162//UVA TransUniversity Microbiome Initiative (TUMI)/ ; 5R01GM147257//NIH NIGMS/ ; },
abstract = {The primary risk factor for C. difficile infection (CDI) is broad-spectrum antibiotic use which clears the intestinal microbiome leaving an open niche for C. difficile to colonize. During infection, C. difficile metabolism is highly responsive to its nutritional environment. For example, in mice with CDI, a high protein diet exacerbates disease severity while a high carbohydrate, high fiber diet ameliorates disease. However, C. difficile is a genetically and metabolically diverse species with often significant differences between strains. To investigate how C. difficile metabolism differs between strains as a function of diet, we reconstructed genome-scale metabolic models of 105 C. difficile strains from publicly available, whole-genome sequencing data and then simulated metabolic flux for each model under three unique diet conditions. We found that strains cluster in two metabolically distinct groups by diet. Metabolomics of spent media from C. difficile strains grown in diet conditions found both unique and shared metabolic pathways across conditions. We also simulated the growth of the C. difficile strains in the presence of 8 different commensals to understand the impact of diet on common microbiome interactions in the large intestine. We found that C. difficile-commensal interactions were more impacted by diet than by differences between C. difficile strains. Overall, the diverse metabolic responses of both C. difficile strains and commensals to different diet conditions have therapeutic implications, particularly for fecal microbiota transplants where differences in metabolism could impact the effectiveness of treatment and as an important parameter to incorporate in the design of therapeutic synthetic bacterial communities to resolve CDI.},
}
RevDate: 2026-11-15
CmpDate: 2026-11-16
Alterations in the cervicovaginal microbiome and their diagnostic potential in cervical cancer.
BMC cancer, 26(1):.
BACKGROUND: The cervicovaginal microbiome is increasingly implicated in cervical carcinogenesis, yet practical diagnostic tools leveraging microbial signatures remain underdeveloped. This study aimed to characterize the cervicovaginal microbial ecology in cervical disease and evaluate the feasibility of a microbiome-based machine learning model for clinical classification.
METHODS: We conducted 16 S rRNA gene sequencing on vaginal swabs from 163 patients (cervical cancer and precancerous lesions) and 70 healthy controls. Microbial diversity, taxonomic composition, and functional pathways were compared between groups. A random forest classifier was constructed using selected microbial biomarkers, with performance validated across training, test, and independent cohorts.
RESULTS: Patients exhibited significantly increased alpha diversity (Shannon, Chao1, ACE) and distinct beta diversity (PCoA/NMDS, p < 0.05) versus controls. Taxonomic analysis revealed enrichment of Prevotella, Streptococcus, and Pseudomonas, alongside depletion of Fannyhessea and Sneathia. Functional predictions showed upregulation of amino acid and energy metabolism, and downregulation of transport/signaling pathways in patients. The nine-biomarker random forest model achieved robust AUCs of 0.891 (training), 0.896 (test), and 0.825 (independent validation).
CONCLUSIONS: Cervical disease is associated with a distinct and dysbiotic cervicovaginal microbiome, with compositional and functional reprogramming. The microbial biomarker model demonstrates strong diagnostic accuracy, supporting its potential as a complementary, non-invasive screening tool for cervical cancer and precursors.
Additional Links: PMID-43035676
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43035676,
year = {2026},
author = {Zhai, Q and Ye, M and Li, M and Fu, X and Yan, Z and Meng, Y and Li, L},
title = {Alterations in the cervicovaginal microbiome and their diagnostic potential in cervical cancer.},
journal = {BMC cancer},
volume = {26},
number = {1},
pages = {},
pmid = {43035676},
issn = {1471-2407},
support = {No.24JSZ15//The Family Planning Special Fund of the People's Liberation Army of China/ ; },
mesh = {Humans ; Female ; *Microbiota/genetics ; *Uterine Cervical Neoplasms/microbiology/diagnosis ; *Vagina/microbiology ; *Cervix Uteri/microbiology ; RNA, Ribosomal, 16S/genetics ; Adult ; Middle Aged ; Bacteria/genetics/classification/isolation & purification ; Biomarkers, Tumor ; Case-Control Studies ; Random Forest ; Machine Learning ; },
abstract = {BACKGROUND: The cervicovaginal microbiome is increasingly implicated in cervical carcinogenesis, yet practical diagnostic tools leveraging microbial signatures remain underdeveloped. This study aimed to characterize the cervicovaginal microbial ecology in cervical disease and evaluate the feasibility of a microbiome-based machine learning model for clinical classification.
METHODS: We conducted 16 S rRNA gene sequencing on vaginal swabs from 163 patients (cervical cancer and precancerous lesions) and 70 healthy controls. Microbial diversity, taxonomic composition, and functional pathways were compared between groups. A random forest classifier was constructed using selected microbial biomarkers, with performance validated across training, test, and independent cohorts.
RESULTS: Patients exhibited significantly increased alpha diversity (Shannon, Chao1, ACE) and distinct beta diversity (PCoA/NMDS, p < 0.05) versus controls. Taxonomic analysis revealed enrichment of Prevotella, Streptococcus, and Pseudomonas, alongside depletion of Fannyhessea and Sneathia. Functional predictions showed upregulation of amino acid and energy metabolism, and downregulation of transport/signaling pathways in patients. The nine-biomarker random forest model achieved robust AUCs of 0.891 (training), 0.896 (test), and 0.825 (independent validation).
CONCLUSIONS: Cervical disease is associated with a distinct and dysbiotic cervicovaginal microbiome, with compositional and functional reprogramming. The microbial biomarker model demonstrates strong diagnostic accuracy, supporting its potential as a complementary, non-invasive screening tool for cervical cancer and precursors.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
Female
*Microbiota/genetics
*Uterine Cervical Neoplasms/microbiology/diagnosis
*Vagina/microbiology
*Cervix Uteri/microbiology
RNA, Ribosomal, 16S/genetics
Adult
Middle Aged
Bacteria/genetics/classification/isolation & purification
Biomarkers, Tumor
Case-Control Studies
Random Forest
Machine Learning
RevDate: 2026-11-15
CmpDate: 2026-11-15
Seasonal dietary shifts drive gut microbiome and metabolome adaptation in wild Northern Pike (Esox lucius).
BMC microbiology, 26(1):.
The gut microbiome of fish faces challenges in maintaining stability during seasonal dietary shifts, which directly impacts host nutrition and fitness. In this study, environmental DNA metabarcoding, metagenomics, and metabolomics were employed to characterize seasonal differences in diet, gut microbiome composition, metabolites, and digestive enzyme activity of Esox lucius between spring and autumn. E. lucius exhibited broadly and opportunistically in spring but shifted to a markedly narrower in autumn. Microbiome composition exhibited marked seasonality, with spring dominated by Mycoplasma and Yersinia, whereas autumn were characterized by Aeromonas, Acinetobacter, environmental bacteria, and were accompanied by increased trypsin and lipase activities, which suggested a capacity for enhanced lipid and protein digestion for winter energy storage. Metabolomic analysis revealed enrichment of sphingolipid metabolites in autumn, which implicated in lipid metabolism and immune regulation. Furthermore, the autumn exhibited a greater diversity and abundance of antibiotic resistance genes. Our results demonstrated that seasonal dietary variation, digestive enzyme adaptation, microbiota reshaping, metabolite-mediated signaling collectively enabled E. lucius to regulate digestive physiology, as well as efficiently assimilating nutrients and maintaining energy balance in response to fluctuating resource availability in wild. Our study offers valuable insights into the ecological adaptation mechanisms of cold-water fish species.
Additional Links: PMID-43035695
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43035695,
year = {2026},
author = {Yang, Y and Wu, X and Feng, H and Zheng, Y and Wang, Z and Wu, R and Zhang, J},
title = {Seasonal dietary shifts drive gut microbiome and metabolome adaptation in wild Northern Pike (Esox lucius).},
journal = {BMC microbiology},
volume = {26},
number = {1},
pages = {},
pmid = {43035695},
issn = {1471-2180},
support = {2026D14009//the Tianshan Innovation Team Fund Project of Xinjiang Uygur Autonomous Region/ ; 2025B02020-2-9//the Key Research and Development Program in Xinjiang Uygur Autonomous Region/ ; 32560265//the National Natural Science Foundation of China/ ; },
mesh = {Animals ; Seasons ; *Metabolome ; *Bacteria/classification/genetics/isolation & purification/metabolism ; *Gastrointestinal Microbiome/physiology ; Adaptation, Physiological ; *Diet/veterinary ; Metabolomics ; Metagenomics ; },
abstract = {The gut microbiome of fish faces challenges in maintaining stability during seasonal dietary shifts, which directly impacts host nutrition and fitness. In this study, environmental DNA metabarcoding, metagenomics, and metabolomics were employed to characterize seasonal differences in diet, gut microbiome composition, metabolites, and digestive enzyme activity of Esox lucius between spring and autumn. E. lucius exhibited broadly and opportunistically in spring but shifted to a markedly narrower in autumn. Microbiome composition exhibited marked seasonality, with spring dominated by Mycoplasma and Yersinia, whereas autumn were characterized by Aeromonas, Acinetobacter, environmental bacteria, and were accompanied by increased trypsin and lipase activities, which suggested a capacity for enhanced lipid and protein digestion for winter energy storage. Metabolomic analysis revealed enrichment of sphingolipid metabolites in autumn, which implicated in lipid metabolism and immune regulation. Furthermore, the autumn exhibited a greater diversity and abundance of antibiotic resistance genes. Our results demonstrated that seasonal dietary variation, digestive enzyme adaptation, microbiota reshaping, metabolite-mediated signaling collectively enabled E. lucius to regulate digestive physiology, as well as efficiently assimilating nutrients and maintaining energy balance in response to fluctuating resource availability in wild. Our study offers valuable insights into the ecological adaptation mechanisms of cold-water fish species.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
Seasons
*Metabolome
*Bacteria/classification/genetics/isolation & purification/metabolism
*Gastrointestinal Microbiome/physiology
Adaptation, Physiological
*Diet/veterinary
Metabolomics
Metagenomics
RevDate: 2026-11-15
CmpDate: 2026-11-15
Multi-compartment spatiotemporal metabolic modeling of the chicken gut guides the design of dietary interventions.
Microbiome, 14(1):.
BACKGROUND: Understanding the interactions between diet and the gut microbiome is critical for identifying dietary interventions that support gut health. This is of particular importance for poultry where the elimination of antibiotic growth promoters has resulted in an alarming rise in enteric infections with significant economic consequences. While research has identified promising interventions including prebiotics, probiotics, and organic acids, these produce inconsistent outcomes across farms and production systems. This variability reflects a fundamental challenge: intervention efficacy depends on baseline conditions including diet composition and microbiota structure. Computational metabolic models offer powerful tools for dissecting diet-microbiome interactions, yet current approaches remain limited, largely ignoring the physiological parameters and spatial organization of the gastrointestinal tract that critically shape microbial metabolism and community dynamics.
RESULTS: We developed the first multi-compartment, spatiotemporally resolved metabolic model of the chicken gastrointestinal tract. Our six-compartment framework integrates avian-specific physiological features including bidirectional flow through peristalsis and reverse peristalsis, feeding-fasting cycles with diurnal shifts in gut motility, and compartment-specific environmental parameters including pH gradients, oxygen levels, and transit times. The model captured distinct metabolic specialization along the gut, with upper compartments enriched for bile salt hydrolases, membrane lipid synthesis, and fatty acid biosynthesis, while cecal and colonic communities specialized in short-chain fatty acid synthesis pathways and polysaccharide degradation. In silico screening of 34 dietary supplements revealed context-dependent metabolic responses and predicted cellulose, starch, and L-threonine as robust enhancers of short-chain fatty acid production. A controlled feeding trial confirmed the model's directional predictions for butyrate production, with cellulose and starch supplementation producing significant increases consistent with predictions. Quantitative rank-order agreement across multiple metabolites improved substantially in a trial-informed two-compartment model, demonstrating that predictive accuracy is primarily determined by the match between modeled and in vivo microbial community composition.
CONCLUSIONS: Our findings demonstrate that microbial community composition is a primary determinant of metabolic outcomes and underscore the critical importance of context-specific modeling for precision nutrition strategies. This framework provides a mechanistic platform for rational design of dietary interventions that modulate gut microbial metabolism in poultry and is broadly adaptable to other livestock and human gastrointestinal systems. Video Abstract.
Additional Links: PMID-43035735
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43035735,
year = {2026},
author = {Utkina, I and Alizadeh, M and Sharif, S and Parkinson, J},
title = {Multi-compartment spatiotemporal metabolic modeling of the chicken gut guides the design of dietary interventions.},
journal = {Microbiome},
volume = {14},
number = {1},
pages = {},
pmid = {43035735},
issn = {2049-2618},
mesh = {Animals ; *Chickens/microbiology/metabolism ; *Gastrointestinal Microbiome/physiology ; *Gastrointestinal Tract/microbiology/metabolism ; *Diet/veterinary ; Models, Biological ; Prebiotics ; Probiotics ; Animal Feed/analysis ; },
abstract = {BACKGROUND: Understanding the interactions between diet and the gut microbiome is critical for identifying dietary interventions that support gut health. This is of particular importance for poultry where the elimination of antibiotic growth promoters has resulted in an alarming rise in enteric infections with significant economic consequences. While research has identified promising interventions including prebiotics, probiotics, and organic acids, these produce inconsistent outcomes across farms and production systems. This variability reflects a fundamental challenge: intervention efficacy depends on baseline conditions including diet composition and microbiota structure. Computational metabolic models offer powerful tools for dissecting diet-microbiome interactions, yet current approaches remain limited, largely ignoring the physiological parameters and spatial organization of the gastrointestinal tract that critically shape microbial metabolism and community dynamics.
RESULTS: We developed the first multi-compartment, spatiotemporally resolved metabolic model of the chicken gastrointestinal tract. Our six-compartment framework integrates avian-specific physiological features including bidirectional flow through peristalsis and reverse peristalsis, feeding-fasting cycles with diurnal shifts in gut motility, and compartment-specific environmental parameters including pH gradients, oxygen levels, and transit times. The model captured distinct metabolic specialization along the gut, with upper compartments enriched for bile salt hydrolases, membrane lipid synthesis, and fatty acid biosynthesis, while cecal and colonic communities specialized in short-chain fatty acid synthesis pathways and polysaccharide degradation. In silico screening of 34 dietary supplements revealed context-dependent metabolic responses and predicted cellulose, starch, and L-threonine as robust enhancers of short-chain fatty acid production. A controlled feeding trial confirmed the model's directional predictions for butyrate production, with cellulose and starch supplementation producing significant increases consistent with predictions. Quantitative rank-order agreement across multiple metabolites improved substantially in a trial-informed two-compartment model, demonstrating that predictive accuracy is primarily determined by the match between modeled and in vivo microbial community composition.
CONCLUSIONS: Our findings demonstrate that microbial community composition is a primary determinant of metabolic outcomes and underscore the critical importance of context-specific modeling for precision nutrition strategies. This framework provides a mechanistic platform for rational design of dietary interventions that modulate gut microbial metabolism in poultry and is broadly adaptable to other livestock and human gastrointestinal systems. Video Abstract.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
*Chickens/microbiology/metabolism
*Gastrointestinal Microbiome/physiology
*Gastrointestinal Tract/microbiology/metabolism
*Diet/veterinary
Models, Biological
Prebiotics
Probiotics
Animal Feed/analysis
RevDate: 2026-11-16
CmpDate: 2026-11-15
Gut microbiome heterogeneity in autism spectrum disorder: immune-brain interfaces, behavioral phenotypes, and translational implications.
Journal of translational medicine, 24(1):.
BACKGROUND: Autism spectrum disorder (ASD) is clinically heterogeneous, and gastrointestinal symptoms, immune perturbation, microbial metabolites, and behavioral variation may intersect in biologically informative ways. The gut microbiome has therefore attracted substantial translational interest, although interpretation remains constrained by marked between-study heterogeneity, uneven phenotyping, and causal claims that often exceed the available evidence.
MAIN TEXT: This review brings together human cohort studies, family-aware analyses, multi-omics datasets, preclinical mechanistic work, controlled interventions, and selected registered trials. We followed a transparent targeted narrative-synthesis approach, drawing on PubMed/MEDLINE, Embase, Web of Science Core Collection, and ClinicalTrials.gov searches performed on 2 July 2026 (bibliographic date range, 1 January 2012 to 30 June 2026), predefined inclusion criteria, and an explicit distinction between mechanistic layers and evidentiary strength.
CONCLUSIONS: Taken together, the evidence supports ASD microbiome heterogeneity as a framework for translational subgroup stratification, rather than as a basis for diagnostic or therapeutic claims. The revised framework outlines how host susceptibility, ecological organization, barrier-immune-metabolic relay biology, endophenotype expression, and translational responsiveness may be tested prospectively while accounting for diet, bowel phenotype, medication exposure, sex, developmental stage, and safety outcomes.
Additional Links: PMID-43035760
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43035760,
year = {2026},
author = {Fan, Q and Zhu, L and Li, X and Wu, Z and Shi, X and Yang, T and Zhang, Y and Chen, L},
title = {Gut microbiome heterogeneity in autism spectrum disorder: immune-brain interfaces, behavioral phenotypes, and translational implications.},
journal = {Journal of translational medicine},
volume = {24},
number = {1},
pages = {},
pmid = {43035760},
issn = {1479-5876},
support = {2022YFC2705201//National Key R&D Program of China/ ; 82572954//National Natural Science Foundation of China/ ; CSTB2022TIAD-CUX0003//Chongqing Technological Innovation and Application Development Sichuan-Chongqing Joint Implementation Key R&D Projects/ ; 2026MSXM086//Chongqing Science-Health Joint Medical Research Project/ ; },
mesh = {Humans ; *Autism Spectrum Disorder/microbiology/immunology ; Phenotype ; *Translational Research, Biomedical ; *Brain/pathology ; *Gastrointestinal Microbiome ; *Behavior ; Animals ; },
abstract = {BACKGROUND: Autism spectrum disorder (ASD) is clinically heterogeneous, and gastrointestinal symptoms, immune perturbation, microbial metabolites, and behavioral variation may intersect in biologically informative ways. The gut microbiome has therefore attracted substantial translational interest, although interpretation remains constrained by marked between-study heterogeneity, uneven phenotyping, and causal claims that often exceed the available evidence.
MAIN TEXT: This review brings together human cohort studies, family-aware analyses, multi-omics datasets, preclinical mechanistic work, controlled interventions, and selected registered trials. We followed a transparent targeted narrative-synthesis approach, drawing on PubMed/MEDLINE, Embase, Web of Science Core Collection, and ClinicalTrials.gov searches performed on 2 July 2026 (bibliographic date range, 1 January 2012 to 30 June 2026), predefined inclusion criteria, and an explicit distinction between mechanistic layers and evidentiary strength.
CONCLUSIONS: Taken together, the evidence supports ASD microbiome heterogeneity as a framework for translational subgroup stratification, rather than as a basis for diagnostic or therapeutic claims. The revised framework outlines how host susceptibility, ecological organization, barrier-immune-metabolic relay biology, endophenotype expression, and translational responsiveness may be tested prospectively while accounting for diet, bowel phenotype, medication exposure, sex, developmental stage, and safety outcomes.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Autism Spectrum Disorder/microbiology/immunology
Phenotype
*Translational Research, Biomedical
*Brain/pathology
*Gastrointestinal Microbiome
*Behavior
Animals
RevDate: 2026-11-15
CmpDate: 2026-11-16
Unifying functional experimental systems with clinical predictive technologies for personalized care in PDAC.
Molecular cancer, 25(1):.
Pancreatic ductal adenocarcinoma (PDAC) remains a clinical challenge, projected to become the second leading cause of cancer-related death by 2030. Traditional research has historically relied on established PDAC-derived cell lines to establish 2D in vitro models or in vivo xenografts for drug discovery. These approaches, however, fail to encompass the complexity of PDAC and few studies have been translated into game-changing treatments for patients with pancreatic cancer. This review advocates for a paradigm shift through the integration of complementary modeling strategies. We provide a comprehensive evaluation of more sophisticated in vitro systems, such as 3D models (spheroids and organoids), co-cultures and microfluidics, which offer scalable platforms for high-throughput screening and mechanistic analysis. Likewise, we emphasize the indispensable role of in vivo models, including genetically engineered mouse models (GEMMs) for studying stepwise progression and immune evasion, and patient-derived xenografts (PDXs) for capturing human-specific drug sensitivities and intratumoral heterogeneity. Beyond functional models, we explore the clinical utility of transcriptomic profiling to define PDAC subtypes, facilitating real-time patient stratification in landmark clinical trials. We further examine the role of liquid biopsy as a dynamic tool for monitoring minimal residual disease and the emergence of treatment resistance. Finally, we discuss the future of pharmacogenomics, the "tri-genomic" influence of the microbiome, and the integration of multi-omics through artificial intelligence to optimize individual therapeutic outcomes. By unifying these diverse predictive paradigms, we aim to bridge the gap between preclinical discovery and precision oncology, fostering more effective and individualized treatment strategies for all PDAC patients.
Additional Links: PMID-43035764
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43035764,
year = {2026},
author = {López-Gil, JC and Campa, D and Rizzato, C and Espinet, E and Barreto, E and Sainz, B and Earl, J},
title = {Unifying functional experimental systems with clinical predictive technologies for personalized care in PDAC.},
journal = {Molecular cancer},
volume = {25},
number = {1},
pages = {},
pmid = {43035764},
issn = {1476-4598},
mesh = {Humans ; Animals ; *Precision Medicine/methods ; *Carcinoma, Pancreatic Ductal/therapy/pathology/drug therapy/etiology/metabolism/diagnosis/genetics ; *Pancreatic Neoplasms/therapy/pathology/drug therapy ; Xenograft Model Antitumor Assays ; },
abstract = {Pancreatic ductal adenocarcinoma (PDAC) remains a clinical challenge, projected to become the second leading cause of cancer-related death by 2030. Traditional research has historically relied on established PDAC-derived cell lines to establish 2D in vitro models or in vivo xenografts for drug discovery. These approaches, however, fail to encompass the complexity of PDAC and few studies have been translated into game-changing treatments for patients with pancreatic cancer. This review advocates for a paradigm shift through the integration of complementary modeling strategies. We provide a comprehensive evaluation of more sophisticated in vitro systems, such as 3D models (spheroids and organoids), co-cultures and microfluidics, which offer scalable platforms for high-throughput screening and mechanistic analysis. Likewise, we emphasize the indispensable role of in vivo models, including genetically engineered mouse models (GEMMs) for studying stepwise progression and immune evasion, and patient-derived xenografts (PDXs) for capturing human-specific drug sensitivities and intratumoral heterogeneity. Beyond functional models, we explore the clinical utility of transcriptomic profiling to define PDAC subtypes, facilitating real-time patient stratification in landmark clinical trials. We further examine the role of liquid biopsy as a dynamic tool for monitoring minimal residual disease and the emergence of treatment resistance. Finally, we discuss the future of pharmacogenomics, the "tri-genomic" influence of the microbiome, and the integration of multi-omics through artificial intelligence to optimize individual therapeutic outcomes. By unifying these diverse predictive paradigms, we aim to bridge the gap between preclinical discovery and precision oncology, fostering more effective and individualized treatment strategies for all PDAC patients.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
Animals
*Precision Medicine/methods
*Carcinoma, Pancreatic Ductal/therapy/pathology/drug therapy/etiology/metabolism/diagnosis/genetics
*Pancreatic Neoplasms/therapy/pathology/drug therapy
Xenograft Model Antitumor Assays
RevDate: 2026-11-16
CmpDate: 2026-11-16
Lung microbiota in COPD: a double-edged sword.
Current research in microbial sciences, 11:100679.
The respiratory microbiota constitutes a dynamic, low-biomass microbial ecosystem whose composition and function are shaped by continuous immigration, elimination, local growth conditions and host-environment interactions. Chronic obstructive pulmonary disease (COPD) provides a clinically important model in which this ecological equilibrium is profoundly altered. This review examines the lung microbiota through a "double-edged sword" framework, proposing that its biological effects depend less on the presence of individual beneficial or pathogenic taxa than on community structure, ecological stability, microbial function and host context. We examine the organization of the lung microbial ecosystem in health and its transition toward dysbiotic, unstable and pathobiont-enriched states in COPD, together with the host, environmental and therapeutic factors that shape these transitions. Particular attention is given to microbial community dynamics, functional alterations, epithelial and immune interactions, antimicrobial defense, and the contribution of the gut-lung microbial axis. We further address the unresolved directionality of the dysbiosis-COPD relationship, considering evidence that COPD-associated changes in the airway environment can select for altered microbial communities while established dysbiosis may subsequently reinforce disease-associated conditions, generating a self-perpetuating ecological cycle. Longitudinal profiling, metagenomics, metatranscriptomics, metabolomics and integrated host-microbiome approaches are discussed as means of moving beyond taxonomic associations toward microbial function and mechanism. Finally, we critically evaluate emerging microbial signatures with potential prognostic or treatment-response relevance and microbiota-targeted interventions, while emphasizing current limitations in causality, methodological standardization, strain-level resolution and clinical validation. A microbiota-centered perspective may therefore help clarify how changes in the structure and function of the lung microbiota contribute to the transition from pulmonary homeostasis to COPD-associated dysbiosis and disease progression.
Additional Links: PMID-43036457
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43036457,
year = {2026},
author = {Bentaher, A},
title = {Lung microbiota in COPD: a double-edged sword.},
journal = {Current research in microbial sciences},
volume = {11},
number = {},
pages = {100679},
pmid = {43036457},
issn = {2666-5174},
abstract = {The respiratory microbiota constitutes a dynamic, low-biomass microbial ecosystem whose composition and function are shaped by continuous immigration, elimination, local growth conditions and host-environment interactions. Chronic obstructive pulmonary disease (COPD) provides a clinically important model in which this ecological equilibrium is profoundly altered. This review examines the lung microbiota through a "double-edged sword" framework, proposing that its biological effects depend less on the presence of individual beneficial or pathogenic taxa than on community structure, ecological stability, microbial function and host context. We examine the organization of the lung microbial ecosystem in health and its transition toward dysbiotic, unstable and pathobiont-enriched states in COPD, together with the host, environmental and therapeutic factors that shape these transitions. Particular attention is given to microbial community dynamics, functional alterations, epithelial and immune interactions, antimicrobial defense, and the contribution of the gut-lung microbial axis. We further address the unresolved directionality of the dysbiosis-COPD relationship, considering evidence that COPD-associated changes in the airway environment can select for altered microbial communities while established dysbiosis may subsequently reinforce disease-associated conditions, generating a self-perpetuating ecological cycle. Longitudinal profiling, metagenomics, metatranscriptomics, metabolomics and integrated host-microbiome approaches are discussed as means of moving beyond taxonomic associations toward microbial function and mechanism. Finally, we critically evaluate emerging microbial signatures with potential prognostic or treatment-response relevance and microbiota-targeted interventions, while emphasizing current limitations in causality, methodological standardization, strain-level resolution and clinical validation. A microbiota-centered perspective may therefore help clarify how changes in the structure and function of the lung microbiota contribute to the transition from pulmonary homeostasis to COPD-associated dysbiosis and disease progression.},
}
RevDate: 2026-11-16
CmpDate: 2026-11-16
Emerging therapies for autoimmunity, allergy and other chronic inflammatory conditions: From immune modulation to precision medicine [narrative and comprehensive review].
Sage open chronic disease, 17:27558428261488943.
Autoimmunity, allergic reactions and other chronic inflammatory diseases are caused by persistent overstimulation of the immune system, sometimes due to unknown triggers. In a state of chronic inflammation, the immune system can target even healthy, unaffected tissues, and may involve multiple organ systems including digestive, respiratory, musculoskeletal and skin. The currently available treatments, including antihistamines, immunosuppressants and corticosteroids, primarily focus on alleviating symptoms instead of targeting the root cause of inflammation, in addition to being associated with a variety of side effects. Emerging approaches in immunology and molecular medicine focus on the development of novel therapies, aimed at correcting the underlying disease cause. These new approaches encompass a vast array of treatments - from biologics and targeted therapies against specific cytokines or small-molecules inhibitors (e.g. IL-1, IL-6, JAK and BTK inhibitors) to novel drug delivery systems and modulation of gut microbiome (GM), thus paving the way towards more precise and personalized treatment. Novel therapies will potentially allow the management of chronic immune-mediated illnesses with greater efficacy, fewer side effects and eventually better outcomes. Our broad overview tackles the most recent innovations in the field and their potential to reshape the future of care for patients suffering from autoimmune diseases, allergies and other chronic inflammatory conditions, while highlighting the need for further research to ensure the safety and efficacy of such treatments along with ethical considerations.
Additional Links: PMID-43036549
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43036549,
year = {2026},
author = {Mansour, E and Karam, F and Al Nahas, K and Abboud, R and Rizk, N and El Douaihy, D and Al Ammouri, H and Ghadieh, HE and Abi Khattar, Z and Azar, S and Bazzi, S and Harb, F},
title = {Emerging therapies for autoimmunity, allergy and other chronic inflammatory conditions: From immune modulation to precision medicine [narrative and comprehensive review].},
journal = {Sage open chronic disease},
volume = {17},
number = {},
pages = {27558428261488943},
pmid = {43036549},
issn = {2978-1558},
abstract = {Autoimmunity, allergic reactions and other chronic inflammatory diseases are caused by persistent overstimulation of the immune system, sometimes due to unknown triggers. In a state of chronic inflammation, the immune system can target even healthy, unaffected tissues, and may involve multiple organ systems including digestive, respiratory, musculoskeletal and skin. The currently available treatments, including antihistamines, immunosuppressants and corticosteroids, primarily focus on alleviating symptoms instead of targeting the root cause of inflammation, in addition to being associated with a variety of side effects. Emerging approaches in immunology and molecular medicine focus on the development of novel therapies, aimed at correcting the underlying disease cause. These new approaches encompass a vast array of treatments - from biologics and targeted therapies against specific cytokines or small-molecules inhibitors (e.g. IL-1, IL-6, JAK and BTK inhibitors) to novel drug delivery systems and modulation of gut microbiome (GM), thus paving the way towards more precise and personalized treatment. Novel therapies will potentially allow the management of chronic immune-mediated illnesses with greater efficacy, fewer side effects and eventually better outcomes. Our broad overview tackles the most recent innovations in the field and their potential to reshape the future of care for patients suffering from autoimmune diseases, allergies and other chronic inflammatory conditions, while highlighting the need for further research to ensure the safety and efficacy of such treatments along with ethical considerations.},
}
RevDate: 2026-11-14
Immunomodulation in Craniofacial and Periodontal Regeneration.
Tissue engineering. Part A [Epub ahead of print].
Craniofacial and periodontal defects collectively impose one of the largest tissue-loss burdens in regenerative medicine. They span a broad spectrum of etiologies chronic periodontitis to acute maxillofacial trauma. The field has shifted from biomaterial and cell-based strategies that minimize host inflammation toward strategies that orchestrate it. This review synthesizes the current evidence base for immune modulation in craniofacial and periodontal regeneration and frames it around a central thesis: successful regeneration depends on the timed transition from an early inflammatory phase that clears microbes and recruits progenitors to a pro-resolution phase that supports angiogenesis, osteogenesis, cementogenesis, and periodontal ligament reattachment. In this review, we explore unique features of the oral and craniofacial niche, including scarless mucosal wound-healing phenotype, contributions of saliva and gingival crevicular fluid, and resident immune populations that maintain tolerance to a dense commensal microbiome. In addition, we examine the temporal logic of innate immunity from neutrophil and monocyte infiltration through macrophage M1-to-M2 transition, alongside adaptive contributions from regulatory T cells, T helper 17 cells, and antibody-mediated responses. Then, osteoimmunology is examined in the context of neural crest-derived craniofacial bone and the periodontal ligament as an immunomodulatory niche. Four immunomodulatory intervention classes are reviewed: scaffold-based design, controlled release of cytokines, ions, and specialized pro-resolving mediators, mesenchymal stromal cell and extracellular vesicle therapies, and direct macrophage or regulatory T cell engineering. Translational barriers and future directions pave the way for the convergence of immunology, biomaterials science, and clinical dentistry toward an emerging discipline of niche immunoengineering for the craniofacial complex.Impact StatementCraniofacial and periodontal regeneration carries a global burden exceeding one billion prevalent cases yet remains poorly served by regeneration paradigms imported from long bone or skin. This review consolidates the case that immune orchestration, rather than immune suppression, is the central lever for regenerative success in this niche. By organizing the evidence into a coherent framework of biomaterial, molecular, cellular, and immune-engineering strategies, the review offers clinicians, immunologists, and tissue engineers a shared vocabulary for designing and evaluating immune-informed regenerative therapies with realistic prospects for clinical translation.
Additional Links: PMID-43031389
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43031389,
year = {2026},
author = {Cheng, YC and Gouveia, Z and Chang, N and Wu, DT},
title = {Immunomodulation in Craniofacial and Periodontal Regeneration.},
journal = {Tissue engineering. Part A},
volume = {},
number = {},
pages = {19373341261504726},
doi = {10.1177/19373341261504726},
pmid = {43031389},
issn = {1937-335X},
abstract = {Craniofacial and periodontal defects collectively impose one of the largest tissue-loss burdens in regenerative medicine. They span a broad spectrum of etiologies chronic periodontitis to acute maxillofacial trauma. The field has shifted from biomaterial and cell-based strategies that minimize host inflammation toward strategies that orchestrate it. This review synthesizes the current evidence base for immune modulation in craniofacial and periodontal regeneration and frames it around a central thesis: successful regeneration depends on the timed transition from an early inflammatory phase that clears microbes and recruits progenitors to a pro-resolution phase that supports angiogenesis, osteogenesis, cementogenesis, and periodontal ligament reattachment. In this review, we explore unique features of the oral and craniofacial niche, including scarless mucosal wound-healing phenotype, contributions of saliva and gingival crevicular fluid, and resident immune populations that maintain tolerance to a dense commensal microbiome. In addition, we examine the temporal logic of innate immunity from neutrophil and monocyte infiltration through macrophage M1-to-M2 transition, alongside adaptive contributions from regulatory T cells, T helper 17 cells, and antibody-mediated responses. Then, osteoimmunology is examined in the context of neural crest-derived craniofacial bone and the periodontal ligament as an immunomodulatory niche. Four immunomodulatory intervention classes are reviewed: scaffold-based design, controlled release of cytokines, ions, and specialized pro-resolving mediators, mesenchymal stromal cell and extracellular vesicle therapies, and direct macrophage or regulatory T cell engineering. Translational barriers and future directions pave the way for the convergence of immunology, biomaterials science, and clinical dentistry toward an emerging discipline of niche immunoengineering for the craniofacial complex.Impact StatementCraniofacial and periodontal regeneration carries a global burden exceeding one billion prevalent cases yet remains poorly served by regeneration paradigms imported from long bone or skin. This review consolidates the case that immune orchestration, rather than immune suppression, is the central lever for regenerative success in this niche. By organizing the evidence into a coherent framework of biomaterial, molecular, cellular, and immune-engineering strategies, the review offers clinicians, immunologists, and tissue engineers a shared vocabulary for designing and evaluating immune-informed regenerative therapies with realistic prospects for clinical translation.},
}
RevDate: 2026-11-15
CmpDate: 2026-11-14
Parental Contributions to Offspring Skin Microbiota Remain Detectable After Metamorphosis.
Molecular ecology, 35(22):.
Parental care creates opportunities for microbial transmission, yet its contribution to offspring skin microbiota remains poorly understood, particularly in species undergoing metamorphosis. We investigated this role in the Neotropical poison frog Allobates femoralis using a controlled cross-fostering experiment. Across 30 trials, tadpoles were transported by their biological father, a foster father or transferred manually to a provided water bowl. We characterized bacterial communities in adults, clutch mucus, tadpoles, metamorphs and environmental samples using 16S rRNA gene sequencing, Bayesian source tracking and analyses of shared sequence variants. Source tracking estimated contributions from both biological parents and, in cross-fostered offspring, foster fathers, alongside environmental sources. Parental microbial contributions remained detectable after metamorphosis despite substantial changes in community composition, indicating that early parental contact may influence microbial assembly across developmental stages. Because foster fathers contacted clutches before transport, their contributions could reflect microbial transfer during brooding, transport or both. Some sequence variants shared between fathers and offspring belonged to genera containing documented Batrachochytrium dendrobatidis-inhibitory isolates, although neither inhibitory activity nor disease protection was tested. Our findings identify paternal care as a pathway contributing to offspring skin microbial assembly under laboratory conditions. They extend the significance of parental care beyond provisioning and relocation, while highlighting the need to establish taxon-level persistence, functional consequences and transmission dynamics in natural populations.
Additional Links: PMID-43031458
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43031458,
year = {2026},
author = {Angiolani-Larrea, FN and Bouchali, R and Loyau, A and Schmeller, DS and Ringler, E},
title = {Parental Contributions to Offspring Skin Microbiota Remain Detectable After Metamorphosis.},
journal = {Molecular ecology},
volume = {35},
number = {22},
pages = {},
pmid = {43031458},
issn = {1365-294X},
support = {310030_197921//Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung/ ; 310030_215049//Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung/ ; //AXA Research Fund/ ; ANR-21-BIRE-0002-01//Agence Nationale de la Recherche/ ; },
mesh = {Animals ; *Metamorphosis, Biological ; RNA, Ribosomal, 16S/genetics ; *Skin Microbiome ; Larva/microbiology ; *Poison Frogs/microbiology/growth & development ; Bayes Theorem ; Bacteria/classification/genetics ; Sequence Analysis, DNA ; Batrachochytrium ; *Skin/microbiology ; },
abstract = {Parental care creates opportunities for microbial transmission, yet its contribution to offspring skin microbiota remains poorly understood, particularly in species undergoing metamorphosis. We investigated this role in the Neotropical poison frog Allobates femoralis using a controlled cross-fostering experiment. Across 30 trials, tadpoles were transported by their biological father, a foster father or transferred manually to a provided water bowl. We characterized bacterial communities in adults, clutch mucus, tadpoles, metamorphs and environmental samples using 16S rRNA gene sequencing, Bayesian source tracking and analyses of shared sequence variants. Source tracking estimated contributions from both biological parents and, in cross-fostered offspring, foster fathers, alongside environmental sources. Parental microbial contributions remained detectable after metamorphosis despite substantial changes in community composition, indicating that early parental contact may influence microbial assembly across developmental stages. Because foster fathers contacted clutches before transport, their contributions could reflect microbial transfer during brooding, transport or both. Some sequence variants shared between fathers and offspring belonged to genera containing documented Batrachochytrium dendrobatidis-inhibitory isolates, although neither inhibitory activity nor disease protection was tested. Our findings identify paternal care as a pathway contributing to offspring skin microbial assembly under laboratory conditions. They extend the significance of parental care beyond provisioning and relocation, while highlighting the need to establish taxon-level persistence, functional consequences and transmission dynamics in natural populations.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
*Metamorphosis, Biological
RNA, Ribosomal, 16S/genetics
*Skin Microbiome
Larva/microbiology
*Poison Frogs/microbiology/growth & development
Bayes Theorem
Bacteria/classification/genetics
Sequence Analysis, DNA
Batrachochytrium
*Skin/microbiology
RevDate: 2026-11-14
CmpDate: 2026-11-14
Integrated microbiome and metaproteome analyses reveal microbial functions underlying traditional fermented amaranth stem fermentation.
Frontiers in microbiology, 17:1983810.
Fermented amaranth stems are a traditional Chinese fermented vegetable characterized by a distinctive pungent flavor and complex microbial ecology. This study compared samples from Anhui (AH), Jiangsu (JS), and Zhejiang (ZJ) using physicochemical analysis, volatile profiling, free amino acid (FAA) determination, 16S rRNA sequencing, and metaproteomics. Across the three regions, pH ranged from 4.08 to 4.39, total titratable acidity from 2.7 to 3.5 mL, viable counts from 7.7 to 8.6 log CFU/g, and total volatile concentrations from 99,021 to 332,864 μg/L. After removing chloroplast- and mitochondrial-derived reads, Firmicutes (approximately 56-77%) and Proteobacteria (approximately 23-40%) dominated the bacterial communities, with Lactobacillus, Lactococcus, and Pseudomonas as the major genera. Total FAA concentrations were 888.5, 778.0, and 582.0 μg/mL in AH, JS, and ZJ, respectively. Metaproteomics identified 7,158 unique protein accession records, of which 3,926 received taxonomic assignments. Functional annotation highlighted carbohydrate metabolism, energy metabolism, stress-response functions, and carbohydrate-active enzymes. These results demonstrate region-associated differences in bacterial composition, expressed functions, and flavor-related traits and provide candidate microbial-functional links for future targeted validation.
Additional Links: PMID-43031608
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43031608,
year = {2026},
author = {Meng, L and Ze, H and Hu, X and Chen, J and Li, K and Li, Q and Hu, W},
title = {Integrated microbiome and metaproteome analyses reveal microbial functions underlying traditional fermented amaranth stem fermentation.},
journal = {Frontiers in microbiology},
volume = {17},
number = {},
pages = {1983810},
pmid = {43031608},
issn = {1664-302X},
abstract = {Fermented amaranth stems are a traditional Chinese fermented vegetable characterized by a distinctive pungent flavor and complex microbial ecology. This study compared samples from Anhui (AH), Jiangsu (JS), and Zhejiang (ZJ) using physicochemical analysis, volatile profiling, free amino acid (FAA) determination, 16S rRNA sequencing, and metaproteomics. Across the three regions, pH ranged from 4.08 to 4.39, total titratable acidity from 2.7 to 3.5 mL, viable counts from 7.7 to 8.6 log CFU/g, and total volatile concentrations from 99,021 to 332,864 μg/L. After removing chloroplast- and mitochondrial-derived reads, Firmicutes (approximately 56-77%) and Proteobacteria (approximately 23-40%) dominated the bacterial communities, with Lactobacillus, Lactococcus, and Pseudomonas as the major genera. Total FAA concentrations were 888.5, 778.0, and 582.0 μg/mL in AH, JS, and ZJ, respectively. Metaproteomics identified 7,158 unique protein accession records, of which 3,926 received taxonomic assignments. Functional annotation highlighted carbohydrate metabolism, energy metabolism, stress-response functions, and carbohydrate-active enzymes. These results demonstrate region-associated differences in bacterial composition, expressed functions, and flavor-related traits and provide candidate microbial-functional links for future targeted validation.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
To oral health and beyond: integrating maternal-child oral health to prevent early childhood caries.
Frontiers in dental medicine, 7:1884801.
Early childhood caries (ECC) remains one of the most prevalent chronic diseases affecting children worldwide. Increasing evidence suggests that maternal biological, behavioral, and developmental factors during pregnancy influence infant oral microbiome establishment and early caries susceptibility before clinical disease becomes evident. Prenatal oral healthcare, maternal oral health education, and caregiver-centered interventions have therefore emerged as important components of preventive strategies. This Perspective synthesizes current evidence on maternal-infant transmission dynamics and proposes the Three-Dimensional Maternal Axis as a conceptual framework for understanding early-life influences on ECC development. Building on prior models of maternal influence on childhood caries, this framework foregrounds biological, behavioral, and developmental influences as proximal and interconnected pathways operating across pregnancy and early childhood. A critical preventive window appears to extend from pregnancy through approximately three years of age, during which enamel development, microbial colonization, feeding transitions, and oral health behaviors become established. The article further discusses the translational implications of maternal-centered prevention approaches, including integration of oral health into prenatal care, continuity of care during early childhood, and the potential role of digital health technologies in expanding access to preventive support. Particular attention is given to implementation challenges, health equity, and opportunities for interdisciplinary and cross-sector prevention models. Together, these findings support broader and earlier approaches to ECC prevention that integrate maternal-child oral health across developmental stages and caregiving contexts.
Additional Links: PMID-43031663
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43031663,
year = {2026},
author = {Castilho, GT and de Lima, CM and Pessoa, MN and Tagliaferro, EPDS and Murata, RM and Pardi, V},
title = {To oral health and beyond: integrating maternal-child oral health to prevent early childhood caries.},
journal = {Frontiers in dental medicine},
volume = {7},
number = {},
pages = {1884801},
pmid = {43031663},
issn = {2673-4915},
abstract = {Early childhood caries (ECC) remains one of the most prevalent chronic diseases affecting children worldwide. Increasing evidence suggests that maternal biological, behavioral, and developmental factors during pregnancy influence infant oral microbiome establishment and early caries susceptibility before clinical disease becomes evident. Prenatal oral healthcare, maternal oral health education, and caregiver-centered interventions have therefore emerged as important components of preventive strategies. This Perspective synthesizes current evidence on maternal-infant transmission dynamics and proposes the Three-Dimensional Maternal Axis as a conceptual framework for understanding early-life influences on ECC development. Building on prior models of maternal influence on childhood caries, this framework foregrounds biological, behavioral, and developmental influences as proximal and interconnected pathways operating across pregnancy and early childhood. A critical preventive window appears to extend from pregnancy through approximately three years of age, during which enamel development, microbial colonization, feeding transitions, and oral health behaviors become established. The article further discusses the translational implications of maternal-centered prevention approaches, including integration of oral health into prenatal care, continuity of care during early childhood, and the potential role of digital health technologies in expanding access to preventive support. Particular attention is given to implementation challenges, health equity, and opportunities for interdisciplinary and cross-sector prevention models. Together, these findings support broader and earlier approaches to ECC prevention that integrate maternal-child oral health across developmental stages and caregiving contexts.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
Effects of pepper-mung bean intercropping on pepper productivity, nutrient accumulation, and rhizosphere microbial communities under continuous cropping.
Frontiers in plant science, 17:1987577.
Continuous monocropping can impair sustainable pepper (Capsicum annuum L.) production by disrupting soil nutrient availability, microbial communities, and biological functioning. Legume-based intercropping offers a potential strategy to alleviate these constraints, but its effects in continuously cropped pepper systems remain poorly understood. Here, a field experiment was conducted in a long-term continuously cropped pepper field to evaluate the effects of mung bean intercropping on pepper growth and yield, nutrient accumulation, rhizosphere soil properties, and microbial communities. Compared with pepper monocropping (MP), pepper-mung bean intercropping (IP) significantly increased average fruit weight and pepper yield, but did not affect plant height, stem diameter, or fruit number per plant. IP altered the accumulation and distribution of N, P, and K among pepper organs, particularly in reproductive tissues. In the rhizosphere, IP increased available N, P, and K and urease, dehydrogenase, and catalase activities, while total N, P, and K remained unchanged. Amplicon sequencing revealed significant differences in bacterial and fungal community composition between MP and IP. At the fungal genus level, Bisifusarium and Neocosmospora were enriched under MP, whereas Conocybe was enriched under IP. IP also increased the relative abundances of several bacterial taxa, particularly Vicinamibacterales, Vicinamibacteraceae, KD4-96, and Rokubacteriales. Several IP-enriched taxa were positively correlated with rhizosphere nutrient availability, soil enzyme activities, and pepper yield-related traits. Overall, mung bean intercropping was associated with improved rhizosphere nutrient availability and enzyme activities, together with substantial restructuring of bacterial and fungal communities, and may therefore contribute to improved pepper productivity under continuous cropping.
Additional Links: PMID-43031798
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43031798,
year = {2026},
author = {Zhang, S and Chang, P and Wang, J and Li, T and Wang, Y and Han, M and Zhang, L and Duan, Q and Hua, F and Zhang, Z},
title = {Effects of pepper-mung bean intercropping on pepper productivity, nutrient accumulation, and rhizosphere microbial communities under continuous cropping.},
journal = {Frontiers in plant science},
volume = {17},
number = {},
pages = {1987577},
pmid = {43031798},
issn = {1664-462X},
abstract = {Continuous monocropping can impair sustainable pepper (Capsicum annuum L.) production by disrupting soil nutrient availability, microbial communities, and biological functioning. Legume-based intercropping offers a potential strategy to alleviate these constraints, but its effects in continuously cropped pepper systems remain poorly understood. Here, a field experiment was conducted in a long-term continuously cropped pepper field to evaluate the effects of mung bean intercropping on pepper growth and yield, nutrient accumulation, rhizosphere soil properties, and microbial communities. Compared with pepper monocropping (MP), pepper-mung bean intercropping (IP) significantly increased average fruit weight and pepper yield, but did not affect plant height, stem diameter, or fruit number per plant. IP altered the accumulation and distribution of N, P, and K among pepper organs, particularly in reproductive tissues. In the rhizosphere, IP increased available N, P, and K and urease, dehydrogenase, and catalase activities, while total N, P, and K remained unchanged. Amplicon sequencing revealed significant differences in bacterial and fungal community composition between MP and IP. At the fungal genus level, Bisifusarium and Neocosmospora were enriched under MP, whereas Conocybe was enriched under IP. IP also increased the relative abundances of several bacterial taxa, particularly Vicinamibacterales, Vicinamibacteraceae, KD4-96, and Rokubacteriales. Several IP-enriched taxa were positively correlated with rhizosphere nutrient availability, soil enzyme activities, and pepper yield-related traits. Overall, mung bean intercropping was associated with improved rhizosphere nutrient availability and enzyme activities, together with substantial restructuring of bacterial and fungal communities, and may therefore contribute to improved pepper productivity under continuous cropping.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
Signal weighting as an organizing principle of adaptive systems.
PNAS nexus, 5(11):pgag333.
Current biological frameworks centered on replication, variation, and selection provide powerful explanations for evolutionary change but do not fully explain how adaptive systems determine relevance in context or maintain coordinated behavior across interacting components. Across diverse domains-including immune recognition, host-microbiome interactions, neural systems, and ecological regulation-adaptive behavior depends on the integration, prioritization, and modulation of signals through feedback. Here, we propose signal weighting as a conceptual framework for understanding how adaptive systems assign, update, and stabilize relevance over time. Signal weighting describes the context-dependent modulation of signal influence through processes that filter, amplify, attenuate, and recursively adjust responses based on prior interactions and system state. Importantly, adaptive systems rarely function in isolation. When signal-weighting processes become coupled across interfaces between interacting systems, their dynamics can stabilize coordinated behaviors that extend beyond individual components, contributing to the emergence of higher-order adaptive units. This logic is evident in immune pattern recognition, where signals are selectively reinforced or attenuated to maintain functional balance, and in host-microbiome systems, where immune and microbial processes reciprocally shape one another through continuous feedback across shared interfaces. In this view, adaptive organization emerges not only through selection acting on variation but also through the recursive stabilization of interactions that remain coherent under perturbation. By identifying shared weighting architectures across biological scales and substrates, signal weighting provides a conceptual bridge across fragmented adaptive literatures and offers a general organizational framework for understanding how coordinated complexity emerges, stabilizes, and persists in living systems.
Additional Links: PMID-43031864
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43031864,
year = {2026},
author = {Sutherland, DB and Lemaitre, B},
title = {Signal weighting as an organizing principle of adaptive systems.},
journal = {PNAS nexus},
volume = {5},
number = {11},
pages = {pgag333},
pmid = {43031864},
issn = {2752-6542},
abstract = {Current biological frameworks centered on replication, variation, and selection provide powerful explanations for evolutionary change but do not fully explain how adaptive systems determine relevance in context or maintain coordinated behavior across interacting components. Across diverse domains-including immune recognition, host-microbiome interactions, neural systems, and ecological regulation-adaptive behavior depends on the integration, prioritization, and modulation of signals through feedback. Here, we propose signal weighting as a conceptual framework for understanding how adaptive systems assign, update, and stabilize relevance over time. Signal weighting describes the context-dependent modulation of signal influence through processes that filter, amplify, attenuate, and recursively adjust responses based on prior interactions and system state. Importantly, adaptive systems rarely function in isolation. When signal-weighting processes become coupled across interfaces between interacting systems, their dynamics can stabilize coordinated behaviors that extend beyond individual components, contributing to the emergence of higher-order adaptive units. This logic is evident in immune pattern recognition, where signals are selectively reinforced or attenuated to maintain functional balance, and in host-microbiome systems, where immune and microbial processes reciprocally shape one another through continuous feedback across shared interfaces. In this view, adaptive organization emerges not only through selection acting on variation but also through the recursive stabilization of interactions that remain coherent under perturbation. By identifying shared weighting architectures across biological scales and substrates, signal weighting provides a conceptual bridge across fragmented adaptive literatures and offers a general organizational framework for understanding how coordinated complexity emerges, stabilizes, and persists in living systems.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
Substrate-mediated oxidative stress alleviation and rhizosphere microbiome modulation enable submerged macrophyte restoration in high-turbidity water.
Frontiers in plant science, 17:1961849.
INTRODUCTION: Ecological restoration of submerged macrophytes in highly turbid waters is severely hampered by light attenuation, which imposes significant oxidative stress on plants and disrupts their physiological homeostasis. While suspended planting technology offers a solution by optimizing light exposure, the critical role of planting substrates in modulating plant stress tolerance and rhizosphere resilience remains largely unexplored-a knowledge gap that this study addresses for the first time. This study is novel in systematically linking substrate physical properties to plant redox regulation and rhizosphere microbiome assembly under turbid-water stress, providing an integrated plant-microbe perspective previously unaddressed.
METHODS: In this study, we cultivated Vallisneria spinulosa Yan using four suspended substrates (plastic mesh, palm mat, linen cloth, and bamboo woven strips) in outdoor flume experiments, aiming to evaluate their effects on plant physiology, water remediation, and associated microbial networks.
RESULTS: Our results demonstrated that the linen cloth substrate most effectively alleviated oxidative damage, as evidenced by significantly enhanced root development, biomass accumulation, and leaf photosynthetic pigment content, alongside a marked reduction in physiological oxidative stress markers. Functionally, all treatments achieved over 90% turbidity removal; however, the linen cloth group exhibited superior purification efficiency, with the highest total nitrogen and total phosphorus removal loads (2.32 × 10[-4] and 2.70 × 10[-4] g·m[-2]·d[-1], respectively). Critically, microbial community analysis revealed that the linen cloth substrate fostered a more complex and interconnected rhizosphere network, with a notable enrichment of a denitrifying bacterial family (Comamonadaceae), indicating a synergistic enhancement of plant-microbe mutualism under stress.
DISCUSSION: Collectively, our findings identify linen cloth as the optimal substrate for suspended planting, not merely as a physical support, but as a catalyst for reinforcing the plant's antioxidant defense system and orchestrating a beneficial rhizosphere microbiome, thereby providing a robust theoretical framework for applying this redox-based ecological engineering strategy in turbid water restoration.
Additional Links: PMID-43031911
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43031911,
year = {2026},
author = {Lu, T and Huang, Y and Liu, Z and Wu, Y and Wu, S and Fan, C},
title = {Substrate-mediated oxidative stress alleviation and rhizosphere microbiome modulation enable submerged macrophyte restoration in high-turbidity water.},
journal = {Frontiers in plant science},
volume = {17},
number = {},
pages = {1961849},
pmid = {43031911},
issn = {1664-462X},
abstract = {INTRODUCTION: Ecological restoration of submerged macrophytes in highly turbid waters is severely hampered by light attenuation, which imposes significant oxidative stress on plants and disrupts their physiological homeostasis. While suspended planting technology offers a solution by optimizing light exposure, the critical role of planting substrates in modulating plant stress tolerance and rhizosphere resilience remains largely unexplored-a knowledge gap that this study addresses for the first time. This study is novel in systematically linking substrate physical properties to plant redox regulation and rhizosphere microbiome assembly under turbid-water stress, providing an integrated plant-microbe perspective previously unaddressed.
METHODS: In this study, we cultivated Vallisneria spinulosa Yan using four suspended substrates (plastic mesh, palm mat, linen cloth, and bamboo woven strips) in outdoor flume experiments, aiming to evaluate their effects on plant physiology, water remediation, and associated microbial networks.
RESULTS: Our results demonstrated that the linen cloth substrate most effectively alleviated oxidative damage, as evidenced by significantly enhanced root development, biomass accumulation, and leaf photosynthetic pigment content, alongside a marked reduction in physiological oxidative stress markers. Functionally, all treatments achieved over 90% turbidity removal; however, the linen cloth group exhibited superior purification efficiency, with the highest total nitrogen and total phosphorus removal loads (2.32 × 10[-4] and 2.70 × 10[-4] g·m[-2]·d[-1], respectively). Critically, microbial community analysis revealed that the linen cloth substrate fostered a more complex and interconnected rhizosphere network, with a notable enrichment of a denitrifying bacterial family (Comamonadaceae), indicating a synergistic enhancement of plant-microbe mutualism under stress.
DISCUSSION: Collectively, our findings identify linen cloth as the optimal substrate for suspended planting, not merely as a physical support, but as a catalyst for reinforcing the plant's antioxidant defense system and orchestrating a beneficial rhizosphere microbiome, thereby providing a robust theoretical framework for applying this redox-based ecological engineering strategy in turbid water restoration.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
Nutritional intervention trial of yeast mannans derived from baker's yeast enriches Bacteroides and Parabacteroides with concurrent reduction of Klebsiella pneumoniae.
Frontiers in microbiology, 17:1958679.
INTRODUCTION: Supplementation with a yeast cell wall fraction rich in mannans is well tolerated in adults without gastrointestinal disease; however, limited research has examined its selective utilization by the gut microbiota and associated health benefits. The aim of this analysis was to investigate the specific effects of yeast mannans on the composition and metabolic function of the gut microbiota.
METHODS: Fecal samples from an open-label study of adults consuming 15 g of yeast mannans per day were profiled for fecal microbiota composition using whole metagenome sequencing, and fecal and urine metabolomics were analyzed by direct infusion and liquid chromatography-tandem mass spectrometry (DI-MS/MS and LC-MS/MS).
RESULTS: Differential abundance testing identified 46 species whose relative abundances increased with the yeast mannan intervention, primarily in the genera Bacteroides and Parabacteroides. Thomasclavelia spiroformis showed the largest fold increase. Four species decreased in relative abundance, with a greater-than-2-fold decrease in Klebsiella pneumoniae, with 45% of participants showing no detection following the yeast mannan intervention. Minor metabolomic changes were noted, including increased urinary excretion of N-acetylalanine, alanine, and caproic acid, and decreases in fecal concentrations of ether-linked phosphatidylcholines C36:4 and C40:1.
DISCUSSION: Yeast mannan supplementation selectively enriched several Bacteroides and Parabacteroides, saccharolytic commensals that may outcompete Klebsiella pneumoniae, an opportunistic pathobiont capable of causing extraintestinal infections.
Additional Links: PMID-43032102
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43032102,
year = {2026},
author = {Moreno, ML and Taft, DH and Tompkins, TA and Dahl, WJ},
title = {Nutritional intervention trial of yeast mannans derived from baker's yeast enriches Bacteroides and Parabacteroides with concurrent reduction of Klebsiella pneumoniae.},
journal = {Frontiers in microbiology},
volume = {17},
number = {},
pages = {1958679},
pmid = {43032102},
issn = {1664-302X},
abstract = {INTRODUCTION: Supplementation with a yeast cell wall fraction rich in mannans is well tolerated in adults without gastrointestinal disease; however, limited research has examined its selective utilization by the gut microbiota and associated health benefits. The aim of this analysis was to investigate the specific effects of yeast mannans on the composition and metabolic function of the gut microbiota.
METHODS: Fecal samples from an open-label study of adults consuming 15 g of yeast mannans per day were profiled for fecal microbiota composition using whole metagenome sequencing, and fecal and urine metabolomics were analyzed by direct infusion and liquid chromatography-tandem mass spectrometry (DI-MS/MS and LC-MS/MS).
RESULTS: Differential abundance testing identified 46 species whose relative abundances increased with the yeast mannan intervention, primarily in the genera Bacteroides and Parabacteroides. Thomasclavelia spiroformis showed the largest fold increase. Four species decreased in relative abundance, with a greater-than-2-fold decrease in Klebsiella pneumoniae, with 45% of participants showing no detection following the yeast mannan intervention. Minor metabolomic changes were noted, including increased urinary excretion of N-acetylalanine, alanine, and caproic acid, and decreases in fecal concentrations of ether-linked phosphatidylcholines C36:4 and C40:1.
DISCUSSION: Yeast mannan supplementation selectively enriched several Bacteroides and Parabacteroides, saccharolytic commensals that may outcompete Klebsiella pneumoniae, an opportunistic pathobiont capable of causing extraintestinal infections.},
}
RevDate: 2026-11-15
CmpDate: 2026-11-14
Multi-omics integration reveals oral microbiota-metabolite-immune interactions in recurrent aphthous ulceration.
Frontiers in microbiology, 17:1889297.
Recurrent aphthous ulceration (RAU) is a chronic inflammatory disease of the oral mucosa, but its underlying mechanisms remain unclear. In this study, integrated oral microbiome, serum metabolomics, and immune analyses were performed in 16 RAU patients and 16 healthy controls. 16S rRNA sequencing revealed suggestive compositional shifts in the oral microbiota of RAU patients, with nominal trends toward enrichment of Fusobacterium, Moraxella, and Granulicatella and depletion of Treponema and Lancefieldella. PICRUSt2 analysis indicated functional shifts associated with amino acid metabolism and inflammatory signaling. Untargeted metabolomics identified extensive metabolic remodeling, including altered gamma-glutamylcysteine, eicosapentaenoic acid (EPA), crocetin, pristanic acid, and cysteinyl-containing dipeptides, suggesting disturbances in oxidative stress regulation and inflammatory lipid metabolism. KEGG analysis further demonstrated enrichment of pathways related to cysteine and methionine metabolism, purine metabolism, taurine and hypotaurine metabolism, and primary bile acid biosynthesis. Immune profiling showed significant alterations in CD4[+] T lymphocyte subsets, accompanied by elevated IL-1, IL-6, and TNF-α levels. Integrated correlation analysis revealed strong associations among differential microbial taxa, metabolites, and inflammatory cytokines. Collectively, these findings suggest that coordinated alterations in the oral microbiota, serum metabolites, and immune responses are associated with RAU, providing new insights into the biological features of RAU and potential therapeutic targets for further investigation.
Additional Links: PMID-43032261
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43032261,
year = {2026},
author = {Shao, C and Wang, H and Li, J and Guo, H and Gong, X and Liu, R and He, H and Shao, M},
title = {Multi-omics integration reveals oral microbiota-metabolite-immune interactions in recurrent aphthous ulceration.},
journal = {Frontiers in microbiology},
volume = {17},
number = {},
pages = {1889297},
pmid = {43032261},
issn = {1664-302X},
abstract = {Recurrent aphthous ulceration (RAU) is a chronic inflammatory disease of the oral mucosa, but its underlying mechanisms remain unclear. In this study, integrated oral microbiome, serum metabolomics, and immune analyses were performed in 16 RAU patients and 16 healthy controls. 16S rRNA sequencing revealed suggestive compositional shifts in the oral microbiota of RAU patients, with nominal trends toward enrichment of Fusobacterium, Moraxella, and Granulicatella and depletion of Treponema and Lancefieldella. PICRUSt2 analysis indicated functional shifts associated with amino acid metabolism and inflammatory signaling. Untargeted metabolomics identified extensive metabolic remodeling, including altered gamma-glutamylcysteine, eicosapentaenoic acid (EPA), crocetin, pristanic acid, and cysteinyl-containing dipeptides, suggesting disturbances in oxidative stress regulation and inflammatory lipid metabolism. KEGG analysis further demonstrated enrichment of pathways related to cysteine and methionine metabolism, purine metabolism, taurine and hypotaurine metabolism, and primary bile acid biosynthesis. Immune profiling showed significant alterations in CD4[+] T lymphocyte subsets, accompanied by elevated IL-1, IL-6, and TNF-α levels. Integrated correlation analysis revealed strong associations among differential microbial taxa, metabolites, and inflammatory cytokines. Collectively, these findings suggest that coordinated alterations in the oral microbiota, serum metabolites, and immune responses are associated with RAU, providing new insights into the biological features of RAU and potential therapeutic targets for further investigation.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
The integrated bioenergetic-interoceptive model of schizophrenia-spectrum disorders.
Frontiers in psychiatry, 17:1911221.
Schizophrenia has traditionally been conceptualized as a heterogeneous neurodevelopmental disorder involving neurotransmitter dysregulation, synaptic dysfunction, and large-scale brain network abnormalities. However, a growing body of convergent evidence indicates that schizophrenia is embedded in broader, system-level physiological dysregulation involving metabolic, immune, endocrine, gastrointestinal, autonomic, and interoceptive alterations. This article proposes an integrated bioenergetic-interoceptive model of schizophrenia-spectrum disorders, in which the disorder is understood as a disturbance of predictive allostatic regulation under energetic constraint. According to the model, reduced metabolic flexibility, altered cerebral bioenergetics, cumulative allostatic load, microbiome-gut-brain axis dysregulation, and disturbed interoceptive timing converge on late-maturing, energetically demanding association networks that support salience attribution, self-referential processing, cognitive control, social cognition, and embodied self-experience. Within this framework, the mismatch between energy demand and available capacity constitutes a functionally proximal energetic constraint on adaptive brain-body regulation, whereas impaired metabolic flexibility represents one possible dynamic mechanism underlying this constraint. Gut-immune-metabolite signaling is interpreted as a modulatory input system that may alter the reliability and metabolic cost of interoceptive inference. Gastric, cardiac, respiratory, and vagal rhythms may constitute candidate timing mechanisms through which bodily signals contribute to the temporal organization of the embodied self. The model further posits that neotenous association cortical systems and large-scale networks-including the default mode, salience, frontoparietal, cingulo-insular, and self-referential systems-are particularly vulnerable to convergent metabolic, inflammatory, autonomic, and interoceptive stressors. The model reframes schizophrenia as a multisystem disturbance of predictive brain-body regulation and delineates testable directions for future multimodal biomarker research and for adjunctive interventions targeting bioenergetic, inflammatory, autonomic, gut-brain, and interoceptive mechanisms.
Additional Links: PMID-43032295
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43032295,
year = {2026},
author = {Szendi, I and Treuer, T},
title = {The integrated bioenergetic-interoceptive model of schizophrenia-spectrum disorders.},
journal = {Frontiers in psychiatry},
volume = {17},
number = {},
pages = {1911221},
pmid = {43032295},
issn = {1664-0640},
abstract = {Schizophrenia has traditionally been conceptualized as a heterogeneous neurodevelopmental disorder involving neurotransmitter dysregulation, synaptic dysfunction, and large-scale brain network abnormalities. However, a growing body of convergent evidence indicates that schizophrenia is embedded in broader, system-level physiological dysregulation involving metabolic, immune, endocrine, gastrointestinal, autonomic, and interoceptive alterations. This article proposes an integrated bioenergetic-interoceptive model of schizophrenia-spectrum disorders, in which the disorder is understood as a disturbance of predictive allostatic regulation under energetic constraint. According to the model, reduced metabolic flexibility, altered cerebral bioenergetics, cumulative allostatic load, microbiome-gut-brain axis dysregulation, and disturbed interoceptive timing converge on late-maturing, energetically demanding association networks that support salience attribution, self-referential processing, cognitive control, social cognition, and embodied self-experience. Within this framework, the mismatch between energy demand and available capacity constitutes a functionally proximal energetic constraint on adaptive brain-body regulation, whereas impaired metabolic flexibility represents one possible dynamic mechanism underlying this constraint. Gut-immune-metabolite signaling is interpreted as a modulatory input system that may alter the reliability and metabolic cost of interoceptive inference. Gastric, cardiac, respiratory, and vagal rhythms may constitute candidate timing mechanisms through which bodily signals contribute to the temporal organization of the embodied self. The model further posits that neotenous association cortical systems and large-scale networks-including the default mode, salience, frontoparietal, cingulo-insular, and self-referential systems-are particularly vulnerable to convergent metabolic, inflammatory, autonomic, and interoceptive stressors. The model reframes schizophrenia as a multisystem disturbance of predictive brain-body regulation and delineates testable directions for future multimodal biomarker research and for adjunctive interventions targeting bioenergetic, inflammatory, autonomic, gut-brain, and interoceptive mechanisms.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
Microbial metabolites in chemotherapy-induced cognitive impairment: from mechanistic associations to pharmacological target validation.
Frontiers in pharmacology, 17:1968616.
Chemotherapy-induced cognitive impairment (CICI) encompasses heterogeneous changes in memory, attention, executive function and processing speed. Microbial metabolites offer experimentally tractable candidates because their exposure, dose-response relationships and host-target engagement can be measured. This review evaluates short-chain fatty acids (SCFAs), microbial indoles and host kynurenine metabolism, and microbially modified bile acids, while considering microbial inflammatory products as distinct modifiers of the intestinal-brain environment. Evidence is assessed against five criteria: CICI specificity, temporal sequence, selective causal manipulation, host-target engagement and oncological compatibility. Clinical microbiome associations and probiotic intervention findings support further investigation, but do not establish mediation by an individual metabolite. Selected chemotherapy models provide cognitive and molecular intervention evidence, although its strength varies by agent, metabolic pathway and behavioral endpoint. Changes in metabolite concentrations may reflect altered diet, epithelial absorption, host metabolism or clearance as well as microbial production. Translation therefore requires regimen-specific longitudinal sampling, compartment- appropriate exposure measurements, selective pathway perturbation and domain-specific cognitive assessment with controls for sickness and motor impairment. Cognitive protection must also be evaluated alongside chemotherapy exposure, tumor control and infectious safety. This framework distinguishes biomarkers of treatment-associated injury from causal mediators and identifies the evidence needed to develop metabolite-guided pharmacological interventions.
Additional Links: PMID-43032353
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43032353,
year = {2026},
author = {Tian, Y and Li, W and Zhou, J and Yu, J},
title = {Microbial metabolites in chemotherapy-induced cognitive impairment: from mechanistic associations to pharmacological target validation.},
journal = {Frontiers in pharmacology},
volume = {17},
number = {},
pages = {1968616},
pmid = {43032353},
issn = {1663-9812},
abstract = {Chemotherapy-induced cognitive impairment (CICI) encompasses heterogeneous changes in memory, attention, executive function and processing speed. Microbial metabolites offer experimentally tractable candidates because their exposure, dose-response relationships and host-target engagement can be measured. This review evaluates short-chain fatty acids (SCFAs), microbial indoles and host kynurenine metabolism, and microbially modified bile acids, while considering microbial inflammatory products as distinct modifiers of the intestinal-brain environment. Evidence is assessed against five criteria: CICI specificity, temporal sequence, selective causal manipulation, host-target engagement and oncological compatibility. Clinical microbiome associations and probiotic intervention findings support further investigation, but do not establish mediation by an individual metabolite. Selected chemotherapy models provide cognitive and molecular intervention evidence, although its strength varies by agent, metabolic pathway and behavioral endpoint. Changes in metabolite concentrations may reflect altered diet, epithelial absorption, host metabolism or clearance as well as microbial production. Translation therefore requires regimen-specific longitudinal sampling, compartment- appropriate exposure measurements, selective pathway perturbation and domain-specific cognitive assessment with controls for sickness and motor impairment. Cognitive protection must also be evaluated alongside chemotherapy exposure, tumor control and infectious safety. This framework distinguishes biomarkers of treatment-associated injury from causal mediators and identifies the evidence needed to develop metabolite-guided pharmacological interventions.},
}
RevDate: 2026-11-13
ROOMIE1 controls rhizobiome assembly in Lotus japonicus and shows a genomic signature distinct from climate-associated loci.
The New phytologist [Epub ahead of print].
How plant genomes accommodate selective pressures across spatial and temporal scales remains poorly understood. Here, we address this by comparing the population-genomic signatures of root microbiome- and climate-associated loci in a natural Lotus japonicus population. We inoculated 155 L. japonicus accessions with a synthetic community of 107 bacterial isolates and performed genome-wide association analyses of rhizosphere microbiome traits. We then carried out functional validation, testing effects of mutations and natural allelic variation, and compared population-genomic characteristics of microbiome-associated and climate-associated loci. We identified 355 significant quantitative trait loci associated with rhizosphere microbiome variation. Microbiome-associated loci showed heterogeneous genomic signatures. One subset displayed strong regional differentiation and near fixation of specific haplotypes, whereas another showed low differentiation, and maintenance of multiple haplotypes within populations. The latter pattern was exemplified by ROOT MICROBIOME ESTABLISHMENT 1 (ROOMIE1). Disruption of ROOMIE1 reproducibly altered rhizosphere microbiome composition in both synthetic communities and native soil, whereas natural ROOMIE1 haplotypes were associated with microbiome differences among closely related accessions. Our findings reveal that microbiome-associated loci can display population-genomic signatures that sharply contrast with those at climate-associated loci, with ROOMIE1 representing a host gene that controls rhizosphere microbiome composition and shows standing haplotype variation at a local scale.
Additional Links: PMID-43023737
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43023737,
year = {2026},
author = {Quilbé, J and Mouritzen, TW and Akyol, TY and Mustamin, Y and Bamba, M and Schierup, MH and Sato, S and Andersen, SU},
title = {ROOMIE1 controls rhizobiome assembly in Lotus japonicus and shows a genomic signature distinct from climate-associated loci.},
journal = {The New phytologist},
volume = {},
number = {},
pages = {},
doi = {10.1111/nph.71756},
pmid = {43023737},
issn = {1469-8137},
support = {NNF19SA0059362//Novo Nordisk Fonden (Novo Nordisk Foundation)/ ; },
abstract = {How plant genomes accommodate selective pressures across spatial and temporal scales remains poorly understood. Here, we address this by comparing the population-genomic signatures of root microbiome- and climate-associated loci in a natural Lotus japonicus population. We inoculated 155 L. japonicus accessions with a synthetic community of 107 bacterial isolates and performed genome-wide association analyses of rhizosphere microbiome traits. We then carried out functional validation, testing effects of mutations and natural allelic variation, and compared population-genomic characteristics of microbiome-associated and climate-associated loci. We identified 355 significant quantitative trait loci associated with rhizosphere microbiome variation. Microbiome-associated loci showed heterogeneous genomic signatures. One subset displayed strong regional differentiation and near fixation of specific haplotypes, whereas another showed low differentiation, and maintenance of multiple haplotypes within populations. The latter pattern was exemplified by ROOT MICROBIOME ESTABLISHMENT 1 (ROOMIE1). Disruption of ROOMIE1 reproducibly altered rhizosphere microbiome composition in both synthetic communities and native soil, whereas natural ROOMIE1 haplotypes were associated with microbiome differences among closely related accessions. Our findings reveal that microbiome-associated loci can display population-genomic signatures that sharply contrast with those at climate-associated loci, with ROOMIE1 representing a host gene that controls rhizosphere microbiome composition and shows standing haplotype variation at a local scale.},
}
RevDate: 2026-11-13
H2-O deficiency is associated with altered intestinal bacterial communities and differential IgG binding.
mSphere [Epub ahead of print].
The non-classical major histocompatibility complex class II (MHCII) molecule H2-O regulates peptide loading by inhibiting H2-M, thereby restricting the repertoire of high-affinity peptides presented to CD4[+] T cells. H2-O deficiency enhances protective immunoglobulin G (IgG) responses against pathogens, including retroviruses and Staphylococcus aureus, and promotes the generation of IgG specific for the commensal bacterium Staphylococcus xylosus. Whether these expanded antibody responses influence intestinal microbial communities is unknown. Here, using gnotobiotic mouse models, we demonstrate that H2-O shapes the gut bacterial composition to a limited but significant extent. H2-O deficiency was associated with increased serum IgG reactivity against commensal microbial antigens (Ags). Sequencing antibody-coated bacteria revealed distinct populations between H2-O-deficient and H2-O-sufficient mice within the IgG-coated, but not IgA-coated, fractions. Together, these findings identify an association between H2-O genotype and microbiome composition and reveal differential IgG, but not IgA, binding to intestinal bacterial communities. These results expand current understanding of how Ag presentation pathways influence host-microbiome interactions and suggest a potential relationship between regulation of the MHCII peptidome, IgG responses, and commensal ecology.IMPORTANCEOur findings demonstrate that the absence of H2-O not only promotes protective IgG responses against retroviruses and Staphylococcus aureus but also is associated with altered intestinal IgG binding patterns and differences in gut microbiome composition.
Additional Links: PMID-43023739
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43023739,
year = {2026},
author = {Lietuvninkas, HB and Cullum, E and Denzin, L and Golovkina, T},
title = {H2-O deficiency is associated with altered intestinal bacterial communities and differential IgG binding.},
journal = {mSphere},
volume = {},
number = {},
pages = {e0069226},
doi = {10.1128/msphere.00692-26},
pmid = {43023739},
issn = {2379-5042},
abstract = {The non-classical major histocompatibility complex class II (MHCII) molecule H2-O regulates peptide loading by inhibiting H2-M, thereby restricting the repertoire of high-affinity peptides presented to CD4[+] T cells. H2-O deficiency enhances protective immunoglobulin G (IgG) responses against pathogens, including retroviruses and Staphylococcus aureus, and promotes the generation of IgG specific for the commensal bacterium Staphylococcus xylosus. Whether these expanded antibody responses influence intestinal microbial communities is unknown. Here, using gnotobiotic mouse models, we demonstrate that H2-O shapes the gut bacterial composition to a limited but significant extent. H2-O deficiency was associated with increased serum IgG reactivity against commensal microbial antigens (Ags). Sequencing antibody-coated bacteria revealed distinct populations between H2-O-deficient and H2-O-sufficient mice within the IgG-coated, but not IgA-coated, fractions. Together, these findings identify an association between H2-O genotype and microbiome composition and reveal differential IgG, but not IgA, binding to intestinal bacterial communities. These results expand current understanding of how Ag presentation pathways influence host-microbiome interactions and suggest a potential relationship between regulation of the MHCII peptidome, IgG responses, and commensal ecology.IMPORTANCEOur findings demonstrate that the absence of H2-O not only promotes protective IgG responses against retroviruses and Staphylococcus aureus but also is associated with altered intestinal IgG binding patterns and differences in gut microbiome composition.},
}
RevDate: 2026-11-13
The Gut-Heart-Muscle Hypothesis in Heart Failure: Emerging Associations, Mechanistic Uncertainty, and the Potential Role of Exercise.
Additional Links: PMID-43023958
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43023958,
year = {2026},
author = {Yuzefpolskaya, M and Bertoni, AG and Colombo, PC and Demmer, RT},
title = {The Gut-Heart-Muscle Hypothesis in Heart Failure: Emerging Associations, Mechanistic Uncertainty, and the Potential Role of Exercise.},
journal = {JACC. Heart failure},
volume = {},
number = {},
pages = {103501},
doi = {10.1016/j.jchf.2026.103501},
pmid = {43023958},
issn = {2213-1787},
}
RevDate: 2026-11-14
CmpDate: 2026-11-13
Inflammaging and Cellular Senescence in Postmenopausal Depression: Linking Estrogen Deficiency, Immune Dysregulation, and Brain Aging.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 40(22):.
Postmenopausal depression is clinically heterogeneous and cannot be explained by estrogen deficiency alone. We propose a conceptual, testable neuroimmune-aging model in which endocrine decline may interact with inflammaging, cellular senescence, and brain vulnerability in a subset of women. The evidentiary base is uneven: direct studies of senescence in well-phenotyped postmenopausal depression are lacking; clinical endocrine data come mainly from perimenopausal depression; molecular-senescence findings come from late-life depression or general major depressive disorder; and most cellular and brain mechanisms are supported by aging or preclinical models. Reduced estrogen signaling may weaken immune homeostasis, whereas peripheral cytokines or senescence-associated secretory phenotype factors could influence vascular and neural interfaces, glia, neurotransmitter metabolism, stress signaling, mitochondrial function, and neuroplasticity. These pathways are candidate mediators, not established causal mechanisms. Clinically established care remains diagnosis-based antidepressant treatment, evidence-based management of vasomotor and sleep symptoms, and individualized menopausal hormone therapy for appropriate candidates. Anti-inflammatory, microbiome-based, and senescence-targeted strategies remain investigational; no senolytic or senomorphic is approved for depression or menopause-related mood symptoms. Prospective studies integrating menopausal staging, prespecified confounders, senescence biomarkers, neuroimaging, and mood outcomes are needed to test this model.
Additional Links: PMID-43023986
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43023986,
year = {2026},
author = {Zhang, L and Yao, Y and Cai, X},
title = {Inflammaging and Cellular Senescence in Postmenopausal Depression: Linking Estrogen Deficiency, Immune Dysregulation, and Brain Aging.},
journal = {FASEB journal : official publication of the Federation of American Societies for Experimental Biology},
volume = {40},
number = {22},
pages = {},
pmid = {43023986},
issn = {1530-6860},
support = {2025ZR012//Zhejiang Province Traditional Chinese Medicine Science and Technology Project/ ; },
mesh = {Humans ; Female ; *Estrogens/deficiency ; *Cellular Senescence ; *Brain/metabolism/pathology ; *Aging/immunology ; *Postmenopause ; *Depression/metabolism/immunology ; Animals ; *Inflammation/immunology ; },
abstract = {Postmenopausal depression is clinically heterogeneous and cannot be explained by estrogen deficiency alone. We propose a conceptual, testable neuroimmune-aging model in which endocrine decline may interact with inflammaging, cellular senescence, and brain vulnerability in a subset of women. The evidentiary base is uneven: direct studies of senescence in well-phenotyped postmenopausal depression are lacking; clinical endocrine data come mainly from perimenopausal depression; molecular-senescence findings come from late-life depression or general major depressive disorder; and most cellular and brain mechanisms are supported by aging or preclinical models. Reduced estrogen signaling may weaken immune homeostasis, whereas peripheral cytokines or senescence-associated secretory phenotype factors could influence vascular and neural interfaces, glia, neurotransmitter metabolism, stress signaling, mitochondrial function, and neuroplasticity. These pathways are candidate mediators, not established causal mechanisms. Clinically established care remains diagnosis-based antidepressant treatment, evidence-based management of vasomotor and sleep symptoms, and individualized menopausal hormone therapy for appropriate candidates. Anti-inflammatory, microbiome-based, and senescence-targeted strategies remain investigational; no senolytic or senomorphic is approved for depression or menopause-related mood symptoms. Prospective studies integrating menopausal staging, prespecified confounders, senescence biomarkers, neuroimaging, and mood outcomes are needed to test this model.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
Female
*Estrogens/deficiency
*Cellular Senescence
*Brain/metabolism/pathology
*Aging/immunology
*Postmenopause
*Depression/metabolism/immunology
Animals
*Inflammation/immunology
RevDate: 2026-11-13
CmpDate: 2026-11-13
Microbiome Flexibility and Metabolomic Buffering in Octocorals During Environmental Acclimation.
Microbial ecology, 89(1):.
Octocorals are keystone reef species and sources of valuable bioactive compounds, yet the microbial dynamics underlying their acclimation to cultivation remain poorly characterized. We examined whether transplanted corals would show differential recovery trajectories between bacterial community and metabolome, and explored the potential role of microbial functional redundancy in shaping holobiont resilience. To address this, we analyzed a 19‑week multi‑omics time series dataset (16S rRNA sequencing, amino‑acid and lipid profiling) from transplanted octocorals, Lobophytum sp. and Sclerophytum sp., benchmarked against wild reef baselines. Bacterial communities diverged initially, converged by week 12, and re‑diverged by week 19, whereas metabolomes consistently converged toward wild norms despite species-specific variations. Integration of microbial and metabolomic data further revealed that microbe-metabolite associations were restructured across environments, consistent with environment-driven reorganization of holobiont interactions. These findings characterize the temporal dynamics of octocoral bacterial communities during acclimation and identify metabolomic stability as a complementary indicator of holobiont resilience, with implications for monitoring and optimizing octocoral cultivation.
Additional Links: PMID-43023992
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43023992,
year = {2026},
author = {Lin, YC and Wu, CY and Wang, MC and Cheng, HY and Meng, YZ and Chang, HJ and Hung, JH and Wang, YC and Lin, TH and Tseng, YC and Hsu, CC and Chang, CW and Yang, SH},
title = {Microbiome Flexibility and Metabolomic Buffering in Octocorals During Environmental Acclimation.},
journal = {Microbial ecology},
volume = {89},
number = {1},
pages = {},
pmid = {43023992},
issn = {1432-184X},
support = {NSTC 112-2311-B-002-017-MY3//National Science and Technology Council/ ; NTU-114V1034-3//Ministry of Education/ ; NTUCCP- 114L892606//National Taiwan University/ ; },
mesh = {Animals ; *Anthozoa/microbiology/physiology/metabolism ; *Acclimatization ; *Microbiota ; *Bacteria/classification/genetics/isolation & purification/metabolism ; *Metabolome ; RNA, Ribosomal, 16S/genetics ; Multiomics ; Metabolomics ; Symbiosis ; },
abstract = {Octocorals are keystone reef species and sources of valuable bioactive compounds, yet the microbial dynamics underlying their acclimation to cultivation remain poorly characterized. We examined whether transplanted corals would show differential recovery trajectories between bacterial community and metabolome, and explored the potential role of microbial functional redundancy in shaping holobiont resilience. To address this, we analyzed a 19‑week multi‑omics time series dataset (16S rRNA sequencing, amino‑acid and lipid profiling) from transplanted octocorals, Lobophytum sp. and Sclerophytum sp., benchmarked against wild reef baselines. Bacterial communities diverged initially, converged by week 12, and re‑diverged by week 19, whereas metabolomes consistently converged toward wild norms despite species-specific variations. Integration of microbial and metabolomic data further revealed that microbe-metabolite associations were restructured across environments, consistent with environment-driven reorganization of holobiont interactions. These findings characterize the temporal dynamics of octocoral bacterial communities during acclimation and identify metabolomic stability as a complementary indicator of holobiont resilience, with implications for monitoring and optimizing octocoral cultivation.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
*Anthozoa/microbiology/physiology/metabolism
*Acclimatization
*Microbiota
*Bacteria/classification/genetics/isolation & purification/metabolism
*Metabolome
RNA, Ribosomal, 16S/genetics
Multiomics
Metabolomics
Symbiosis
RevDate: 2026-11-13
Environmental Microbiomes as Sources of Postbiotic Therapeutics: A One Health Perspective on Translational Applications.
Probiotics and antimicrobial proteins [Epub ahead of print].
Environmental microbiomes are reservoirs of specialized microorganisms with implications for ecosystem functionality, host health, and therapeutic discovery. Soil, marine, plant-associated, wastewater, freshwater, and extreme-environment microbiomes contain communities capable of producing bioactive metabolites and functional biomolecules. Postbiotics-non-viable microorganisms and their functional components that confer health benefits-offer potential advantages in stability, safety, scalability, and pharmaceutical development. This review examines environmental microbiomes as sources of postbiotic therapeutics within a One Health framework. A critical integrative translational review synthesized literature on environmental microbiomes, postbiotic diversity, molecular mechanisms, therapeutic applications, technological advances, and barriers to clinical translation. Evidence was organized across ecological sources, postbiotic classes, human-health applications, discovery platforms, pharmaceutical development, and translational challenges. Environmental microbiomes represent chemically and functionally diverse reservoirs of postbiotic candidates shaped by ecological adaptation, microbial competition, and environmental selection. Major classes-including short-chain fatty acids, bacteriocins, extracellular vesicles, indole and tryptophan metabolites, exopolysaccharides, and microbial/lytic enzymes-act through receptor signaling, immune modulation, barrier protection, antimicrobial activity, metabolic regulation, intercellular communication, and enzymatic target modification. Metagenomics, metabolomics, artificial intelligence, synthetic biology, organoid and microfluidic models, advanced delivery systems, and biomanufacturing increasingly enable discovery and development. However, reproducibility, microbiome variability, manufacturing scalability, regulatory standardization, cost, and equitable translation remain barriers. Environmental microbiomes provide important reservoirs for postbiotic discovery. Integrating ecological microbiology with multi-omics, computational innovation, pharmaceutical engineering, and human-relevant validation could accelerate development of defined, reproducible, and scalable postbiotic therapeutics. Preserving microbial ecosystem diversity is relevant to environmental sustainability and future microbiome-derived therapeutic innovation within One Health medicine.
Additional Links: PMID-43024025
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43024025,
year = {2026},
author = {Chigozie, VU and Oghonyon, EI and Enyi, EO},
title = {Environmental Microbiomes as Sources of Postbiotic Therapeutics: A One Health Perspective on Translational Applications.},
journal = {Probiotics and antimicrobial proteins},
volume = {},
number = {},
pages = {},
pmid = {43024025},
issn = {1867-1314},
abstract = {Environmental microbiomes are reservoirs of specialized microorganisms with implications for ecosystem functionality, host health, and therapeutic discovery. Soil, marine, plant-associated, wastewater, freshwater, and extreme-environment microbiomes contain communities capable of producing bioactive metabolites and functional biomolecules. Postbiotics-non-viable microorganisms and their functional components that confer health benefits-offer potential advantages in stability, safety, scalability, and pharmaceutical development. This review examines environmental microbiomes as sources of postbiotic therapeutics within a One Health framework. A critical integrative translational review synthesized literature on environmental microbiomes, postbiotic diversity, molecular mechanisms, therapeutic applications, technological advances, and barriers to clinical translation. Evidence was organized across ecological sources, postbiotic classes, human-health applications, discovery platforms, pharmaceutical development, and translational challenges. Environmental microbiomes represent chemically and functionally diverse reservoirs of postbiotic candidates shaped by ecological adaptation, microbial competition, and environmental selection. Major classes-including short-chain fatty acids, bacteriocins, extracellular vesicles, indole and tryptophan metabolites, exopolysaccharides, and microbial/lytic enzymes-act through receptor signaling, immune modulation, barrier protection, antimicrobial activity, metabolic regulation, intercellular communication, and enzymatic target modification. Metagenomics, metabolomics, artificial intelligence, synthetic biology, organoid and microfluidic models, advanced delivery systems, and biomanufacturing increasingly enable discovery and development. However, reproducibility, microbiome variability, manufacturing scalability, regulatory standardization, cost, and equitable translation remain barriers. Environmental microbiomes provide important reservoirs for postbiotic discovery. Integrating ecological microbiology with multi-omics, computational innovation, pharmaceutical engineering, and human-relevant validation could accelerate development of defined, reproducible, and scalable postbiotic therapeutics. Preserving microbial ecosystem diversity is relevant to environmental sustainability and future microbiome-derived therapeutic innovation within One Health medicine.},
}
RevDate: 2026-11-13
The Application of Engineered Probiotics in the Prophylaxis and Control of Salmonella Infections.
Probiotics and antimicrobial proteins [Epub ahead of print].
Salmonella is a major zoonotic pathogen responsible for human and animal infections, posing significant challenges to public health and disease control. Its pathogenicity relies on a suite of molecular mechanisms mediating bacterial adhesion, invasion, intracellular persistence, immune evasion, and host-microbe crosstalk. Conventional probiotics mitigate Salmonella infection through competitive exclusion, secretion of antimicrobial metabolites, intestinal barrier reinforcement, microbiota remodelling and host immunomodulation. However, their efficacy varies depending on strain, host, dose, formulation, delivery route, infection model, and intervention timing. Genetically engineered probiotics and complementary non-genetic functional enhancement strategies offer opportunities to introduce or tailor defined antimicrobial, biosensing, colonisation or ecological functions. This narrative review summarizes recent progress in genetically engineered probiotics, non-genetic functional enhancement of probiotics, and attenuated pathogen strains for Salmonella control. Genetically engineered probiotics are equipped with programmable regulatory and antibacterial modules, while non-genetic probiotic approaches include probiotic-nanomaterial biohybrids, metabolically adapted strains and microbiome-directed substrate interventions. Preclinical studies show these microbial systems can provide programmable, targeted, context-dependent functions to reduce Salmonella colonisation, though their performance is also highly context-dependent. Future studies should focus on improving functional stability, standardizing efficacy and biosafety evaluation, clarifying ecological and environmental risks, and addressing manufacturing, formulation, quality-control, and regulatory requirements for translational development.
Additional Links: PMID-43024026
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43024026,
year = {2026},
author = {Zhu, Z and Xu, F and Yin, D and Shao, Y},
title = {The Application of Engineered Probiotics in the Prophylaxis and Control of Salmonella Infections.},
journal = {Probiotics and antimicrobial proteins},
volume = {},
number = {},
pages = {},
pmid = {43024026},
issn = {1867-1314},
support = {KJCX20261009//Beijing Academy of Agricuture and Forestry Sciences/ ; 32202679//National Natural Science Foundation of China/ ; XMS202616//Beijing Academy of Agricultural and Forestry Sciences/ ; },
abstract = {Salmonella is a major zoonotic pathogen responsible for human and animal infections, posing significant challenges to public health and disease control. Its pathogenicity relies on a suite of molecular mechanisms mediating bacterial adhesion, invasion, intracellular persistence, immune evasion, and host-microbe crosstalk. Conventional probiotics mitigate Salmonella infection through competitive exclusion, secretion of antimicrobial metabolites, intestinal barrier reinforcement, microbiota remodelling and host immunomodulation. However, their efficacy varies depending on strain, host, dose, formulation, delivery route, infection model, and intervention timing. Genetically engineered probiotics and complementary non-genetic functional enhancement strategies offer opportunities to introduce or tailor defined antimicrobial, biosensing, colonisation or ecological functions. This narrative review summarizes recent progress in genetically engineered probiotics, non-genetic functional enhancement of probiotics, and attenuated pathogen strains for Salmonella control. Genetically engineered probiotics are equipped with programmable regulatory and antibacterial modules, while non-genetic probiotic approaches include probiotic-nanomaterial biohybrids, metabolically adapted strains and microbiome-directed substrate interventions. Preclinical studies show these microbial systems can provide programmable, targeted, context-dependent functions to reduce Salmonella colonisation, though their performance is also highly context-dependent. Future studies should focus on improving functional stability, standardizing efficacy and biosafety evaluation, clarifying ecological and environmental risks, and addressing manufacturing, formulation, quality-control, and regulatory requirements for translational development.},
}
RevDate: 2026-11-13
CmpDate: 2026-11-13
Characterizing Gut Diversity During Aging.
Methods in molecular biology (Clifton, N.J.), 3105:189-200.
Microbiome Protocols and Analyses are commonly reported with 16S sequencing in young animals. Our protocol aims to establish a standardized method for shotgun sequencing to improve the resolution of differentially expressed bacteria in aging mice, which otherwise have low alpha and beta diversity.
Additional Links: PMID-43024207
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43024207,
year = {2027},
author = {Vaddi, P and Lynch, DB and Hill, CM},
title = {Characterizing Gut Diversity During Aging.},
journal = {Methods in molecular biology (Clifton, N.J.)},
volume = {3105},
number = {},
pages = {189-200},
pmid = {43024207},
issn = {1940-6029},
mesh = {Animals ; *Aging ; Mice ; RNA, Ribosomal, 16S/genetics ; *Gastrointestinal Microbiome/genetics ; Shotgun Sequencing ; *Bacteria/genetics/classification ; Biodiversity ; },
abstract = {Microbiome Protocols and Analyses are commonly reported with 16S sequencing in young animals. Our protocol aims to establish a standardized method for shotgun sequencing to improve the resolution of differentially expressed bacteria in aging mice, which otherwise have low alpha and beta diversity.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
*Aging
Mice
RNA, Ribosomal, 16S/genetics
*Gastrointestinal Microbiome/genetics
Shotgun Sequencing
*Bacteria/genetics/classification
Biodiversity
RevDate: 2026-11-13
After COVID-19 Vaccination, Why Do Some People Run a Fever?.
JAMA pii:2856877 [Epub ahead of print].
Additional Links: PMID-43024340
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43024340,
year = {2026},
author = {Rubin, R},
title = {After COVID-19 Vaccination, Why Do Some People Run a Fever?.},
journal = {JAMA},
volume = {},
number = {},
pages = {},
doi = {10.1001/jama.2026.22638},
pmid = {43024340},
issn = {1538-3598},
}
RevDate: 2026-11-13
CD11c+ dermal dendritic cells are abundant HIV target cells in the foreskin and are increased in men with HIV-associated penile anaerobes.
Cell reports, 45(11):118330 pii:S2211-1247(26)01409-9 [Epub ahead of print].
HIV-associated penile anaerobes are associated with reduced epithelial barrier proteins and increased foreskin T cell density, but their relationships with myeloid populations remain unexplored. We analyzed inner foreskin tissues and penile microbiome data from 116 HIV-negative Ugandan men undergoing voluntary medical male circumcision. Quantitative immunofluorescence showed 48.6% of cells expressing the HIV entry receptors, CD4 and CCR5, co-express CD11c. Men with a high abundance of bacteria associated with HIV seroconversion and immune cells (BASIC species) had a greater density of foreskin dermal CD11c+ dendritic cell 2 (DC2) populations. Integration with previously published foreskin cytokine data revealed that the density of foreskin CD207-negative DC2 cells was positively correlated with concentrations of IL-1α, IL-1β, IL-8, CCL4, MMP-9, and resistin. These cross-sectional findings suggest that BASIC species are associated with a broader foreskin immune phenotype marked by increased densities of HIV-susceptible dermal dendritic cells, alongside increased T cells and epithelial disruption.
Additional Links: PMID-43024505
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43024505,
year = {2026},
author = {Buchanan, LB and Khan, Y and Rojas-Vargas, J and Shao, Z and Biribawa, VM and Ssemunywa, HR and Namuniina, A and Okech, B and Tobian, AAR and Park, DE and Liu, CM and Kaul, R and Galiwango, RM and Prodger, JL},
title = {CD11c+ dermal dendritic cells are abundant HIV target cells in the foreskin and are increased in men with HIV-associated penile anaerobes.},
journal = {Cell reports},
volume = {45},
number = {11},
pages = {118330},
doi = {10.1016/j.celrep.2026.118330},
pmid = {43024505},
issn = {2211-1247},
abstract = {HIV-associated penile anaerobes are associated with reduced epithelial barrier proteins and increased foreskin T cell density, but their relationships with myeloid populations remain unexplored. We analyzed inner foreskin tissues and penile microbiome data from 116 HIV-negative Ugandan men undergoing voluntary medical male circumcision. Quantitative immunofluorescence showed 48.6% of cells expressing the HIV entry receptors, CD4 and CCR5, co-express CD11c. Men with a high abundance of bacteria associated with HIV seroconversion and immune cells (BASIC species) had a greater density of foreskin dermal CD11c+ dendritic cell 2 (DC2) populations. Integration with previously published foreskin cytokine data revealed that the density of foreskin CD207-negative DC2 cells was positively correlated with concentrations of IL-1α, IL-1β, IL-8, CCL4, MMP-9, and resistin. These cross-sectional findings suggest that BASIC species are associated with a broader foreskin immune phenotype marked by increased densities of HIV-susceptible dermal dendritic cells, alongside increased T cells and epithelial disruption.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-13
Dysregulated microbiota-gut-brain axis induced by intermittent access to palatable food is associated with binge-like eating regardless of obesity development.
Gut microbes, 18(1):2756714.
Recurrent consumption of energy dense palatable foods contributes to the rising prevalence of obesity and can also promote loss-of-control eating in a subset of individuals. Obesity is commonly associated with peripheral inflammation, impaired sensitivity to appetite-regulating hormones, and alterations in gut microbiota composition, all of which may exacerbate binge-eating behaviors. However, emerging evidence suggests that repeated exposure to palatable foods alone can induce maladaptive eating patterns even prior to the development of obesity. In this study, intermittent access to palatable food (e.g., cheesecake) induced binge-like eating behavior in non-obese female rats, accompanied by hypothalamic microglial reactivity and altered leptin signaling pathway. Additionally, even sporadic exposure to palatable food was sufficient to alter gut microbiota composition, increasing microbial diversity and promoting taxa adapted to high fat and sugar availability, including potential pathobionts (e.g., Escherichia, Streptococcus, and Clostridium spp.) as well as carbohydrate-fermenting bacteria such as Bifidobacterium and Roseburia. Notably, increased microbial diversity was associated with both hyperphagic behavior and reduced hypothalamic leptin pathway responsiveness. Overall, these findings suggest that gut microbiota imbalance and central neuroimmune adaptations occurred in the absence of significant weight gain. This highlights the potential value of early interventions which may represent promising candidate strategies for future investigation.
Additional Links: PMID-43024513
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43024513,
year = {2026},
author = {Aeschlimann, L and Nassirnia, S and Bouzourene, N and Clavien, C and Bangerter, M and Gilardi, F and Thomas, A and Greub, G and Boutrel, B and Bertelli, C and Rossetti, C},
title = {Dysregulated microbiota-gut-brain axis induced by intermittent access to palatable food is associated with binge-like eating regardless of obesity development.},
journal = {Gut microbes},
volume = {18},
number = {1},
pages = {2756714},
doi = {10.1080/19490976.2026.2756714},
pmid = {43024513},
issn = {1949-0984},
mesh = {Animals ; Female ; *Obesity/microbiology/metabolism/physiopathology ; Rats ; Leptin/metabolism ; *Gastrointestinal Microbiome ; *Bulimia/microbiology/metabolism/physiopathology ; *Brain-Gut Axis/physiology ; Rats, Sprague-Dawley ; Hypothalamus/metabolism ; Bacteria/classification/isolation & purification/genetics ; Brain ; },
abstract = {Recurrent consumption of energy dense palatable foods contributes to the rising prevalence of obesity and can also promote loss-of-control eating in a subset of individuals. Obesity is commonly associated with peripheral inflammation, impaired sensitivity to appetite-regulating hormones, and alterations in gut microbiota composition, all of which may exacerbate binge-eating behaviors. However, emerging evidence suggests that repeated exposure to palatable foods alone can induce maladaptive eating patterns even prior to the development of obesity. In this study, intermittent access to palatable food (e.g., cheesecake) induced binge-like eating behavior in non-obese female rats, accompanied by hypothalamic microglial reactivity and altered leptin signaling pathway. Additionally, even sporadic exposure to palatable food was sufficient to alter gut microbiota composition, increasing microbial diversity and promoting taxa adapted to high fat and sugar availability, including potential pathobionts (e.g., Escherichia, Streptococcus, and Clostridium spp.) as well as carbohydrate-fermenting bacteria such as Bifidobacterium and Roseburia. Notably, increased microbial diversity was associated with both hyperphagic behavior and reduced hypothalamic leptin pathway responsiveness. Overall, these findings suggest that gut microbiota imbalance and central neuroimmune adaptations occurred in the absence of significant weight gain. This highlights the potential value of early interventions which may represent promising candidate strategies for future investigation.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
Female
*Obesity/microbiology/metabolism/physiopathology
Rats
Leptin/metabolism
*Gastrointestinal Microbiome
*Bulimia/microbiology/metabolism/physiopathology
*Brain-Gut Axis/physiology
Rats, Sprague-Dawley
Hypothalamus/metabolism
Bacteria/classification/isolation & purification/genetics
Brain
RevDate: 2026-11-13
Root-inspired selective biofilm control: Design principles for programmable interfaces.
Microbiological research, 315:128823 pii:S0944-5013(26)00387-3 [Epub ahead of print].
Most antifouling technologies delay attachment, kill colonizers, or remove biomass. Plant roots instead preserve water and nutrient exchange while regulating dense microbial communities through zonation, hydrated mucilage, patterned metabolite release, immunity, competition, and selective recruitment. This critical review develops a root-inspired framework for selective biofilm control: a bounded, functionally defined community that remains below application-specific limits for coverage, harmful activity, and asset impairment, and can be reset when those limits are exceeded. We distinguish established rhizosphere biology and materials evidence from proposed engineering translations. We examine renewable hydrated layers, spatial chemical fields, conditional sensing and response, and context-dependent priority effects, integrating them with biofilm matrix, mechanics, dispersal, and polymicrobial tolerance. We propose that programmable interfaces combine a low-fouling base, renewable outer layer, local cues, and feedback based on measured performance. The framework is a design hypothesis rather than a validated integrated technology. Translation requires local-field measurements, causal controls, realistic mixed-community ageing tests, repeated reset cycles, and application-specific safety assessment. Sterile exclusion remains preferable where any viable colonization is unacceptable.
Additional Links: PMID-43025162
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43025162,
year = {2026},
author = {Amin, A and Zaman, W and Ullah, A},
title = {Root-inspired selective biofilm control: Design principles for programmable interfaces.},
journal = {Microbiological research},
volume = {315},
number = {},
pages = {128823},
doi = {10.1016/j.micres.2026.128823},
pmid = {43025162},
issn = {1618-0623},
abstract = {Most antifouling technologies delay attachment, kill colonizers, or remove biomass. Plant roots instead preserve water and nutrient exchange while regulating dense microbial communities through zonation, hydrated mucilage, patterned metabolite release, immunity, competition, and selective recruitment. This critical review develops a root-inspired framework for selective biofilm control: a bounded, functionally defined community that remains below application-specific limits for coverage, harmful activity, and asset impairment, and can be reset when those limits are exceeded. We distinguish established rhizosphere biology and materials evidence from proposed engineering translations. We examine renewable hydrated layers, spatial chemical fields, conditional sensing and response, and context-dependent priority effects, integrating them with biofilm matrix, mechanics, dispersal, and polymicrobial tolerance. We propose that programmable interfaces combine a low-fouling base, renewable outer layer, local cues, and feedback based on measured performance. The framework is a design hypothesis rather than a validated integrated technology. Translation requires local-field measurements, causal controls, realistic mixed-community ageing tests, repeated reset cycles, and application-specific safety assessment. Sterile exclusion remains preferable where any viable colonization is unacceptable.},
}
RevDate: 2026-11-13
Longitudinal dynamics of the oral microbiota during allogeneic hematopoietic stem cell transplantation: an exploratory study with complementary gut microbiota analysis.
Journal of oral biosciences, 68(6):100836 pii:S1349-0079(26)00104-0 [Epub ahead of print].
OBJECTIVES: The oral microbiota undergoes substantial ecological disruption during allogeneic hematopoietic stem cell transplantation (allo-HSCT), potentially contributing to systemic infections. Although allo-HSCT-associated gut microbiota dysbiosis has been extensively investigated, longitudinal changes in oral microbiota and their relationship with bloodstream infections (BSIs) remain incompletely understood. We therefore aimed to characterize longitudinal changes in oral and gut microbiota and examine their association with BSIs.
METHODS: We prospectively analyzed the oral and gut microbiota of 16 adult allo-HSCT recipients using 16S rRNA gene sequencing. Salivary and fecal samples were collected before transplantation, on the day of transplantation, during neutropenia, at engraftment, and after engraftment.
RESULTS: Six patients developed 11 BSI episodes, with the first episode in each patient occurring at a median of 8 days after transplantation. Staphylococcus haemolyticus was the most common pathogen (7/11 episodes), followed by Enterococcus faecium (2/11 episodes). The oral microbiota underwent marked longitudinal alterations throughout the transplantation period, accompanied by similar changes in the gut microbiota. Differences in microbiota trajectories were observed between patients with and without BSIs despite comparable cumulative antibiotic exposure. Oral-associated genera, including Streptococcus, Fusobacterium, Veillonella, Actinomyces, and Lautropia, were detected in fecal samples, suggesting possible oral-to-gut translocation.
CONCLUSIONS: The oral and gut microbiota underwent substantial longitudinal alterations during allo-HSCT. Differences in microbiota dynamics between patients with and without BSIs were not explained solely by antibiotic exposure. These exploratory findings provide insights into the timing of oral and gut microbiota alterations during allo-HSCT and highlight potential relationships between oral and gut microbial changes and BSIs.
Additional Links: PMID-43025194
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43025194,
year = {2026},
author = {Ohbayashi, Y and Imataki, O and Takeuchi, A and Sakaji, M and Ishida, T and Uchida, S and Uemura, M and Nakayama-Imaohji, H and Tada, A and Kuwahara, T and Miyake, M},
title = {Longitudinal dynamics of the oral microbiota during allogeneic hematopoietic stem cell transplantation: an exploratory study with complementary gut microbiota analysis.},
journal = {Journal of oral biosciences},
volume = {68},
number = {6},
pages = {100836},
doi = {10.1016/j.job.2026.100836},
pmid = {43025194},
issn = {1880-3865},
abstract = {OBJECTIVES: The oral microbiota undergoes substantial ecological disruption during allogeneic hematopoietic stem cell transplantation (allo-HSCT), potentially contributing to systemic infections. Although allo-HSCT-associated gut microbiota dysbiosis has been extensively investigated, longitudinal changes in oral microbiota and their relationship with bloodstream infections (BSIs) remain incompletely understood. We therefore aimed to characterize longitudinal changes in oral and gut microbiota and examine their association with BSIs.
METHODS: We prospectively analyzed the oral and gut microbiota of 16 adult allo-HSCT recipients using 16S rRNA gene sequencing. Salivary and fecal samples were collected before transplantation, on the day of transplantation, during neutropenia, at engraftment, and after engraftment.
RESULTS: Six patients developed 11 BSI episodes, with the first episode in each patient occurring at a median of 8 days after transplantation. Staphylococcus haemolyticus was the most common pathogen (7/11 episodes), followed by Enterococcus faecium (2/11 episodes). The oral microbiota underwent marked longitudinal alterations throughout the transplantation period, accompanied by similar changes in the gut microbiota. Differences in microbiota trajectories were observed between patients with and without BSIs despite comparable cumulative antibiotic exposure. Oral-associated genera, including Streptococcus, Fusobacterium, Veillonella, Actinomyces, and Lautropia, were detected in fecal samples, suggesting possible oral-to-gut translocation.
CONCLUSIONS: The oral and gut microbiota underwent substantial longitudinal alterations during allo-HSCT. Differences in microbiota dynamics between patients with and without BSIs were not explained solely by antibiotic exposure. These exploratory findings provide insights into the timing of oral and gut microbiota alterations during allo-HSCT and highlight potential relationships between oral and gut microbial changes and BSIs.},
}
RevDate: 2026-11-13
Dietary shifts across human evolution reveal a progressive loss of gut microbial diversity and functions.
Nutrition research (New York, N.Y.), 155:214-232 pii:S0271-5317(26)00129-6 [Epub ahead of print].
This narrative review summarizes the evolutionary, archaeological, and metagenomic evidence to illustrate how significant dietary shifts, from Paleolithic hunter-gatherer lifestyles to Neolithic agricultural practices and ultimately to modern industrial diets, have gradually transformed the human gut microbiome. The objective is to position diet as a dominant influence on gut microbial evolution, and to demonstrate that the contemporary Western diet signifies a profound divergence from the nutritional context to which our microbiota has coevolved over thousands of years. The available data uncovers three main conclusions. First, hunter-gatherer communities exhibit remarkably elevated α-diversity, a predominance of Prevotella and Treponema, and an abundance of cellulose-degrading Ruminococcus, which together facilitate substantial short-chain fatty acid synthesis. Second, comparative studies reveal a notable shift from Prevotella to Bacteroides in industrialized societies, along with a substantial decline in microbial diversity and a deterioration of carbohydrate-metabolizing pathways. Third, preindustrial gut microbiota were fundamentally different from Westernized ones, emphasizing that both dietary processing and food type influenced the evolution of human gut microbiota. Collectively, the modern industrial diet has created an evolutionary discord, leading to the gradual decline of ancient microbial lineages and their metabolic capabilities. This functional deterioration, especially in fiber fermentation and short-chain fatty acid production, is mechanistically associated with the increase of chronic inflammatory and metabolic disorders. These observations establish a historical reference point for gut microbiota composition, highlighting that dietary rewilding and targeted microbial restoration are empirically supported methods for mitigating contemporary dysbiosis.
Additional Links: PMID-43025213
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43025213,
year = {2026},
author = {Dey, P},
title = {Dietary shifts across human evolution reveal a progressive loss of gut microbial diversity and functions.},
journal = {Nutrition research (New York, N.Y.)},
volume = {155},
number = {},
pages = {214-232},
doi = {10.1016/j.nutres.2026.10.009},
pmid = {43025213},
issn = {1879-0739},
abstract = {This narrative review summarizes the evolutionary, archaeological, and metagenomic evidence to illustrate how significant dietary shifts, from Paleolithic hunter-gatherer lifestyles to Neolithic agricultural practices and ultimately to modern industrial diets, have gradually transformed the human gut microbiome. The objective is to position diet as a dominant influence on gut microbial evolution, and to demonstrate that the contemporary Western diet signifies a profound divergence from the nutritional context to which our microbiota has coevolved over thousands of years. The available data uncovers three main conclusions. First, hunter-gatherer communities exhibit remarkably elevated α-diversity, a predominance of Prevotella and Treponema, and an abundance of cellulose-degrading Ruminococcus, which together facilitate substantial short-chain fatty acid synthesis. Second, comparative studies reveal a notable shift from Prevotella to Bacteroides in industrialized societies, along with a substantial decline in microbial diversity and a deterioration of carbohydrate-metabolizing pathways. Third, preindustrial gut microbiota were fundamentally different from Westernized ones, emphasizing that both dietary processing and food type influenced the evolution of human gut microbiota. Collectively, the modern industrial diet has created an evolutionary discord, leading to the gradual decline of ancient microbial lineages and their metabolic capabilities. This functional deterioration, especially in fiber fermentation and short-chain fatty acid production, is mechanistically associated with the increase of chronic inflammatory and metabolic disorders. These observations establish a historical reference point for gut microbiota composition, highlighting that dietary rewilding and targeted microbial restoration are empirically supported methods for mitigating contemporary dysbiosis.},
}
RevDate: 2026-11-13
Hidden depths: Divergent microbiome trajectories as indicators of growth performance in long-term coral transplantation.
Marine environmental research, 223:108553 pii:S0141-1136(26)00722-1 [Epub ahead of print].
Growing evidence highlights the coral microbiome as a critical regulator of host acclimation to new environments and a promising source of information for evaluating transplantation performance. In this 16-month study, we conducted long-term repeated monitoring (10 sampling events) of Acropora hyacinthus at two depths to examine coral performance and bacterial dynamics. Corals transplanted in shallow-water transplantation sites showed significantly lower survival and impaired growth rates compared to those in deep-water transplantation sites. Microbial community analyses revealed that deep-water transplants maintained resilient, U-shaped alpha and beta diversity trajectories, whereas shallow-water transplants experienced a continuous decline in diversity, alongside a positive correlation between microbial diversity and coral growth. This trend was consistent with the stronger determinism exhibited by stressed shallow-water corals over time, suggesting that growth performance may be associated with a moderate balance between deterministic and stochastic assembly processes. Random Forest modeling identified core bacterial taxa that exhibited stronger associations with growth rate than diversity-based metrics and assembly processes, highlighting their potential as candidate biomarkers. Together, these findings suggest that selecting well-matched transplantation sites and incorporating microbiome-based monitoring may help inform early-stage restoration strategies and improve cost-effectiveness. However, more refined transplantation designs and broader spatiotemporal replication are needed to confirm these associations and disentangle transplantation effects from potential confounders.
Additional Links: PMID-43025279
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43025279,
year = {2026},
author = {Zhu, W and Liu, X and Qiu, Z and Zhang, J and Zhao, H and Rinkevich, B and Yang, P and Wang, A and Li, X},
title = {Hidden depths: Divergent microbiome trajectories as indicators of growth performance in long-term coral transplantation.},
journal = {Marine environmental research},
volume = {223},
number = {},
pages = {108553},
doi = {10.1016/j.marenvres.2026.108553},
pmid = {43025279},
issn = {1879-0291},
abstract = {Growing evidence highlights the coral microbiome as a critical regulator of host acclimation to new environments and a promising source of information for evaluating transplantation performance. In this 16-month study, we conducted long-term repeated monitoring (10 sampling events) of Acropora hyacinthus at two depths to examine coral performance and bacterial dynamics. Corals transplanted in shallow-water transplantation sites showed significantly lower survival and impaired growth rates compared to those in deep-water transplantation sites. Microbial community analyses revealed that deep-water transplants maintained resilient, U-shaped alpha and beta diversity trajectories, whereas shallow-water transplants experienced a continuous decline in diversity, alongside a positive correlation between microbial diversity and coral growth. This trend was consistent with the stronger determinism exhibited by stressed shallow-water corals over time, suggesting that growth performance may be associated with a moderate balance between deterministic and stochastic assembly processes. Random Forest modeling identified core bacterial taxa that exhibited stronger associations with growth rate than diversity-based metrics and assembly processes, highlighting their potential as candidate biomarkers. Together, these findings suggest that selecting well-matched transplantation sites and incorporating microbiome-based monitoring may help inform early-stage restoration strategies and improve cost-effectiveness. However, more refined transplantation designs and broader spatiotemporal replication are needed to confirm these associations and disentangle transplantation effects from potential confounders.},
}
RevDate: 2026-11-13
Chronic polystyrene nanoplastics exposure reprograms gene expression, alternative splicing, and disrupts host-microbiome-metabolic networks to promote atherosclerosis in LDLr[-]/[-] mice.
Journal of hazardous materials, 519:144190 pii:S0304-3894(26)03171-7 [Epub ahead of print].
Micro- and nanoplastics have been detected in human blood and carotid atheromas, yet their mechanistic contribution to atherogenesis is poorly defined, and chronic exposure studies of nanoplastics are limited. This multi-omics study investigates chronic (12-week) oral exposure to 80 nm polystyrene nanoplastics in LDLr[-]/[-] mice, integrating aortic plaque quantification, hepatic transcriptomics with alternative splicing profiling, gut microbiome 16S sequencing, and liver untargeted metabolomics into a unified host-microbiome-metabolite network. Nanoplastics increased aortic lipid deposition, suppressed hepatic detoxification and anti-atherogenic lipid pathways at the transcriptional and post-transcriptional levels including alternative splicing events. Exposure induced gut dysbiosis, reduced SCFA-producing commensals and enriched pro-atherogenic pathobionts, shifts co-occurring directionally with hepatic transcriptional modules. Hepatic genes (down-regulated Fbp1, Ccn1 and Cyp2c29; upregulated Chka) and gut genera (depleted Bacteroides; enriched Faecalibaculum and Streptococcus) were confirmed by RT-qPCR and genus-specific qPCR. Untargeted metabolomics showed elevated aromatic and branched-chain amino acids such as tryptophan and methionine, and depletion of glutathione precursor γ-glutamylcysteine and the antioxidant taurine, implicating oxidative stress and amino-acid dysregulation. Concordance with human MASLD (GSE135251) and atherosclerotic plaque (GSE100927) transcriptomes and gut signatures matching human atherosclerotic microbiome profiles suggest plausibility for human relevance. This research implicates nanoplastics as a cardiovascular risk factor involving splicing reprogramming and gut-liver crosstalk.
Additional Links: PMID-43025328
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43025328,
year = {2026},
author = {Khan, A and Vasquez, DEC and Si, Y and Vidar, WS and Wu, K and Chiu, N and Jia, Z},
title = {Chronic polystyrene nanoplastics exposure reprograms gene expression, alternative splicing, and disrupts host-microbiome-metabolic networks to promote atherosclerosis in LDLr[-]/[-] mice.},
journal = {Journal of hazardous materials},
volume = {519},
number = {},
pages = {144190},
doi = {10.1016/j.jhazmat.2026.144190},
pmid = {43025328},
issn = {1873-3336},
abstract = {Micro- and nanoplastics have been detected in human blood and carotid atheromas, yet their mechanistic contribution to atherogenesis is poorly defined, and chronic exposure studies of nanoplastics are limited. This multi-omics study investigates chronic (12-week) oral exposure to 80 nm polystyrene nanoplastics in LDLr[-]/[-] mice, integrating aortic plaque quantification, hepatic transcriptomics with alternative splicing profiling, gut microbiome 16S sequencing, and liver untargeted metabolomics into a unified host-microbiome-metabolite network. Nanoplastics increased aortic lipid deposition, suppressed hepatic detoxification and anti-atherogenic lipid pathways at the transcriptional and post-transcriptional levels including alternative splicing events. Exposure induced gut dysbiosis, reduced SCFA-producing commensals and enriched pro-atherogenic pathobionts, shifts co-occurring directionally with hepatic transcriptional modules. Hepatic genes (down-regulated Fbp1, Ccn1 and Cyp2c29; upregulated Chka) and gut genera (depleted Bacteroides; enriched Faecalibaculum and Streptococcus) were confirmed by RT-qPCR and genus-specific qPCR. Untargeted metabolomics showed elevated aromatic and branched-chain amino acids such as tryptophan and methionine, and depletion of glutathione precursor γ-glutamylcysteine and the antioxidant taurine, implicating oxidative stress and amino-acid dysregulation. Concordance with human MASLD (GSE135251) and atherosclerotic plaque (GSE100927) transcriptomes and gut signatures matching human atherosclerotic microbiome profiles suggest plausibility for human relevance. This research implicates nanoplastics as a cardiovascular risk factor involving splicing reprogramming and gut-liver crosstalk.},
}
RevDate: 2026-11-13
The OMM[12] model after ten years: what did we learn about the gut microbiome from a defined microbial community?.
Current opinion in microbiology, 94:102849 pii:S1369-5274(26)00143-8 [Epub ahead of print].
Over the past decade, the Oligo-Mouse-Microbiota (OMM[12]) has emerged as a cornerstone model for mechanistic studies of the gut microbiome. As a rationally designed, defined microbial community, OMM[12] reduces the complexity of the native microbiota while preserving key ecological and functional traits of the murine gut ecosystem. Comprising twelve culturable, genome-sequenced, and phenotypically characterized strains of murine origin, the model enables reproducible and stable colonization across hosts and experimental settings. Initially developed to study colonization resistance, OMM[12] has since been widely applied across diverse fields, including microbial ecology, immunology, and computational biology, providing fundamental insights into host-microbe and microbe-microbe interactions. Its broad adoption has been supported by the development of a rich experimental and computational toolbox, including strain-resolved sequencing, metabolomics, and metabolic modeling approaches. Here, we review a decade of OMM[12] research, highlighting its design principles, methodological advances, and key scientific discoveries, and we additionally provide an overview of available resources, including a newly established website (daisybio.ls.tum.de/omm12/) that consolidates tools, protocols, and datasets to facilitate community use. Together, this review underscores the continued importance of OMM[12] as a versatile platform for causal and quantitative microbiome research.
Additional Links: PMID-43025334
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43025334,
year = {2026},
author = {Niedermeier, LS and Burrichter, AG and Matchado, MS and Stecher, B},
title = {The OMM[12] model after ten years: what did we learn about the gut microbiome from a defined microbial community?.},
journal = {Current opinion in microbiology},
volume = {94},
number = {},
pages = {102849},
doi = {10.1016/j.mib.2026.102849},
pmid = {43025334},
issn = {1879-0364},
abstract = {Over the past decade, the Oligo-Mouse-Microbiota (OMM[12]) has emerged as a cornerstone model for mechanistic studies of the gut microbiome. As a rationally designed, defined microbial community, OMM[12] reduces the complexity of the native microbiota while preserving key ecological and functional traits of the murine gut ecosystem. Comprising twelve culturable, genome-sequenced, and phenotypically characterized strains of murine origin, the model enables reproducible and stable colonization across hosts and experimental settings. Initially developed to study colonization resistance, OMM[12] has since been widely applied across diverse fields, including microbial ecology, immunology, and computational biology, providing fundamental insights into host-microbe and microbe-microbe interactions. Its broad adoption has been supported by the development of a rich experimental and computational toolbox, including strain-resolved sequencing, metabolomics, and metabolic modeling approaches. Here, we review a decade of OMM[12] research, highlighting its design principles, methodological advances, and key scientific discoveries, and we additionally provide an overview of available resources, including a newly established website (daisybio.ls.tum.de/omm12/) that consolidates tools, protocols, and datasets to facilitate community use. Together, this review underscores the continued importance of OMM[12] as a versatile platform for causal and quantitative microbiome research.},
}
RevDate: 2026-11-13
[Adjunctive enteral nutrition in Crohn's disease during biologic therapy: More than a supportive measure? A narrative review].
Zeitschrift fur Gastroenterologie [Epub ahead of print].
OBJECTIVE: This narrative review aimed to critically evaluate evidence for combining enteral nutrition (EN) with biologic therapy in adults with Crohn's disease (CD).
METHODS: PubMed, Embase and the Cochrane Library were searched on EN combined with biologics, incl. infliximab, adalimumab, vedolizumab, and ustekinumab. Studies published from 01/2018-06/2026 and current clinical guidelines were considered. The evidence was evaluated regarding clinical effectiveness and methodological limitations.
RESULTS: Current evidence suggests that adding enteral nutrition to biologic therapy may relatively increase clinical and endoscopic remission rates by up to 50 % compared with biologic monotherapy. The potential benefit may be due to enhanced mucosal healing, alterations in the intestinal microbiome, and improved pharmacokinetics. Higher rates of transmural healing and lower relapse, treatment escalation, and surgery rates have also been reported. While exclusive EN has a broader evidence base, partial EN may offer advantages in clinical practice because of its greater feasibility and acceptability. Evidence is limited by selection bias, heterogeneous treatment protocols and lack of blinding.
CONCLUSION: Combining EN with biologics is a promising therapeutic approach for adults with CD. Prospective RCTs are needed to establish efficacy, safety and optimal use of exclusive and partial EN.
Additional Links: PMID-43025458
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43025458,
year = {2026},
author = {Peters, S and Tessmer, L and Dignass, A and Stein, J},
title = {[Adjunctive enteral nutrition in Crohn's disease during biologic therapy: More than a supportive measure? A narrative review].},
journal = {Zeitschrift fur Gastroenterologie},
volume = {},
number = {},
pages = {},
doi = {10.1055/a-2992-6044},
pmid = {43025458},
issn = {1439-7803},
abstract = {OBJECTIVE: This narrative review aimed to critically evaluate evidence for combining enteral nutrition (EN) with biologic therapy in adults with Crohn's disease (CD).
METHODS: PubMed, Embase and the Cochrane Library were searched on EN combined with biologics, incl. infliximab, adalimumab, vedolizumab, and ustekinumab. Studies published from 01/2018-06/2026 and current clinical guidelines were considered. The evidence was evaluated regarding clinical effectiveness and methodological limitations.
RESULTS: Current evidence suggests that adding enteral nutrition to biologic therapy may relatively increase clinical and endoscopic remission rates by up to 50 % compared with biologic monotherapy. The potential benefit may be due to enhanced mucosal healing, alterations in the intestinal microbiome, and improved pharmacokinetics. Higher rates of transmural healing and lower relapse, treatment escalation, and surgery rates have also been reported. While exclusive EN has a broader evidence base, partial EN may offer advantages in clinical practice because of its greater feasibility and acceptability. Evidence is limited by selection bias, heterogeneous treatment protocols and lack of blinding.
CONCLUSION: Combining EN with biologics is a promising therapeutic approach for adults with CD. Prospective RCTs are needed to establish efficacy, safety and optimal use of exclusive and partial EN.},
}
RevDate: 2026-11-13
Black spot Shell syndrome in the marble crab Metacarcinus edwardsii from northern Chilean Patagonia: Prevalence and associated bacterial assemblages.
Journal of invertebrate pathology pii:S0022-2011(26)00267-3 [Epub ahead of print].
Black spot shell syndrome is a polymicrobial shell disease of crustaceans that can impair host fitness and reduce fishery value, yet it has not previously been documented in the marble crab, Metacarcinus edwardsii, in Chile. This study characterised the prevalence of black spot shell syndrome and the associated culturable bacterial assemblage in M. edwardsii from northern Chilean Patagonia. In August 2023, 2518 crabs were sampled across three fishing grounds in the Aysén Region and examined for lesion presence, lesion coverage and host traits, while bacteria from unaffected and affected carapaces were cultured and identified by 16S rRNA gene sequencing. Overall prevalence was 13.7%; occurrence differed among sites, increased with carapace width and was not associated with sex. Among affected crabs, lesion coverage also varied among sites and showed no association with sex or carapace width. Forty-three bacterial isolates representing seven genera were recovered, with members of the Pseudomonas fluorescens species complex predominating across lesion stages. Several Pseudomonas isolates exhibited chitinolytic and proteolytic activities consistent with a potential role in cuticle degradation. However, these findings do not establish Pseudomonas as the primary aetiological agent of the syndrome. These findings provide the first epidemiological and microbiological baseline evidence of black spot shell syndrome in M. edwardsii in Chile and highlight the need for continued surveillance, culture-independent microbiome profiling and targeted pathogenicity studies.
Additional Links: PMID-43025481
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43025481,
year = {2026},
author = {Bórquez, A and Poveda, SL and Hamamé, M and Lobos, J and Pardo, LM},
title = {Black spot Shell syndrome in the marble crab Metacarcinus edwardsii from northern Chilean Patagonia: Prevalence and associated bacterial assemblages.},
journal = {Journal of invertebrate pathology},
volume = {},
number = {},
pages = {108791},
doi = {10.1016/j.jip.2026.108791},
pmid = {43025481},
issn = {1096-0805},
abstract = {Black spot shell syndrome is a polymicrobial shell disease of crustaceans that can impair host fitness and reduce fishery value, yet it has not previously been documented in the marble crab, Metacarcinus edwardsii, in Chile. This study characterised the prevalence of black spot shell syndrome and the associated culturable bacterial assemblage in M. edwardsii from northern Chilean Patagonia. In August 2023, 2518 crabs were sampled across three fishing grounds in the Aysén Region and examined for lesion presence, lesion coverage and host traits, while bacteria from unaffected and affected carapaces were cultured and identified by 16S rRNA gene sequencing. Overall prevalence was 13.7%; occurrence differed among sites, increased with carapace width and was not associated with sex. Among affected crabs, lesion coverage also varied among sites and showed no association with sex or carapace width. Forty-three bacterial isolates representing seven genera were recovered, with members of the Pseudomonas fluorescens species complex predominating across lesion stages. Several Pseudomonas isolates exhibited chitinolytic and proteolytic activities consistent with a potential role in cuticle degradation. However, these findings do not establish Pseudomonas as the primary aetiological agent of the syndrome. These findings provide the first epidemiological and microbiological baseline evidence of black spot shell syndrome in M. edwardsii in Chile and highlight the need for continued surveillance, culture-independent microbiome profiling and targeted pathogenicity studies.},
}
RevDate: 2026-11-13
An oral delivery platform for protein drugs: PDA/PEGylated engineered probiotics responsively release TLR5 agonists to prevent radiation enteritis.
Journal of controlled release : official journal of the Controlled Release Society pii:S0168-3659(26)00950-8 [Epub ahead of print].
Oral protein delivery is hindered by gastrointestinal degradation and poor mucosal bioavailability. Engineered probiotics offer a promising strategy for oral protein delivery, but their therapeutic efficacy is often limited by insufficient payload expression and low secretion efficiency. Here, we present a living oral platform that integrates high-yield protein biosynthesis with on-demand intestinal release. By gene manipulation and FLAG tagging, we dramatically upregulate constitutive expression of GP532 in probiotic Escherichia coli Nissle 1917 (EcN), while installing an arabinose-inducible autolytic switch for efficient intracellular payload release. A dual-layer coating of polydopamine (PDA) and polyethylene glycol (PEG) confers acid resistance and mucus penetration, while allowing arabinose to permeate and blocking digestive enzymes. Upon single oral gavage in a murine model of radiation enteritis, our formulation achieves therapeutic efficacy fully equivalent to systemic injection of GP532 in mitigating intestinal injury. Critically, unlike injectable biologics, this living platform promotes the restoration of gut microbial community structure and beneficial taxa, a unique benefit unattainable by parenteral administration, while the engineered strain is completely cleared within 24 h. By synergizing genetic circuit engineering, surface chemical modification, and in situ luminal release, this work establishes a single-dose, orally effective alternative to injectable protein therapy, offering a transformative strategy for the prevention of radiation enteritis with the added benefit of microbiome maintenance.
Additional Links: PMID-43025506
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43025506,
year = {2026},
author = {Song, Y and Li, Z and Wang, M and Hong, J and Zhang, Y and Zuo, J and Peng, H and Yuan, B and Jin, Y},
title = {An oral delivery platform for protein drugs: PDA/PEGylated engineered probiotics responsively release TLR5 agonists to prevent radiation enteritis.},
journal = {Journal of controlled release : official journal of the Controlled Release Society},
volume = {},
number = {},
pages = {115546},
doi = {10.1016/j.jconrel.2026.115546},
pmid = {43025506},
issn = {1873-4995},
abstract = {Oral protein delivery is hindered by gastrointestinal degradation and poor mucosal bioavailability. Engineered probiotics offer a promising strategy for oral protein delivery, but their therapeutic efficacy is often limited by insufficient payload expression and low secretion efficiency. Here, we present a living oral platform that integrates high-yield protein biosynthesis with on-demand intestinal release. By gene manipulation and FLAG tagging, we dramatically upregulate constitutive expression of GP532 in probiotic Escherichia coli Nissle 1917 (EcN), while installing an arabinose-inducible autolytic switch for efficient intracellular payload release. A dual-layer coating of polydopamine (PDA) and polyethylene glycol (PEG) confers acid resistance and mucus penetration, while allowing arabinose to permeate and blocking digestive enzymes. Upon single oral gavage in a murine model of radiation enteritis, our formulation achieves therapeutic efficacy fully equivalent to systemic injection of GP532 in mitigating intestinal injury. Critically, unlike injectable biologics, this living platform promotes the restoration of gut microbial community structure and beneficial taxa, a unique benefit unattainable by parenteral administration, while the engineered strain is completely cleared within 24 h. By synergizing genetic circuit engineering, surface chemical modification, and in situ luminal release, this work establishes a single-dose, orally effective alternative to injectable protein therapy, offering a transformative strategy for the prevention of radiation enteritis with the added benefit of microbiome maintenance.},
}
RevDate: 2026-11-13
Chronic ethanol feeding drives gut microbiome remodeling and influences cholestatic liver injury in mice.
The American journal of pathology pii:S0002-9440(26)00322-6 [Epub ahead of print].
Alcohol-associated liver disease (ALD) is a major cause of liver-related mortality worldwide and encompasses steatosis, cirrhosis, and alcohol-associated hepatitis (AH). AH is frequently accompanied by cholestasis, characterized by impaired bile flow and disrupted bile acid homeostasis. Although gut microbiome (GM) dysbiosis has been linked to ALD progression and cholestatic injury, its functional role in alcohol-associated cholestasis remains unclear. Mice were subjected to chronic ethanol-feeding (EF) or pair-feeding (PF) for 4 weeks. Fecal samples collected at 10 days and 4 weeks underwent shotgun metagenomic sequencing. To assess the functional impact of microbiome alterations, cecal contents from male mice after 4 weeks of EF or PF were used for fecal microbiota transplantation (FMT). Recipient mice received antibiotics during acclimatization, followed by 10 days of EF and FMT every other day. Forty-eight hours before sacrifice, mice were challenged with α-naphthylisothiocyanate (ANIT; 25 mg/kg) to induce cholestatic liver injury. Liver injury, cholestasis, and inflammation were evaluated biochemically and histologically. EF induced progressive GM remodeling, whereas PF did not. Unexpectedly, FMT from PF donors aggravated ANIT-promoted liver injury, cholestasis, and hepatic inflammation in EF recipients of both sexes. In contrast, FMT from EF donors did not significantly alter injury compared with non-FMT controls. These findings suggest that GM derived from PF and chronic EF mice differentially influence susceptibility to cholestatic liver injury in EF recipients.
Additional Links: PMID-43025638
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43025638,
year = {2026},
author = {Copes, J and Godeaux, E and Yan, S},
title = {Chronic ethanol feeding drives gut microbiome remodeling and influences cholestatic liver injury in mice.},
journal = {The American journal of pathology},
volume = {},
number = {},
pages = {},
doi = {10.1016/j.ajpath.2026.10.012},
pmid = {43025638},
issn = {1525-2191},
abstract = {Alcohol-associated liver disease (ALD) is a major cause of liver-related mortality worldwide and encompasses steatosis, cirrhosis, and alcohol-associated hepatitis (AH). AH is frequently accompanied by cholestasis, characterized by impaired bile flow and disrupted bile acid homeostasis. Although gut microbiome (GM) dysbiosis has been linked to ALD progression and cholestatic injury, its functional role in alcohol-associated cholestasis remains unclear. Mice were subjected to chronic ethanol-feeding (EF) or pair-feeding (PF) for 4 weeks. Fecal samples collected at 10 days and 4 weeks underwent shotgun metagenomic sequencing. To assess the functional impact of microbiome alterations, cecal contents from male mice after 4 weeks of EF or PF were used for fecal microbiota transplantation (FMT). Recipient mice received antibiotics during acclimatization, followed by 10 days of EF and FMT every other day. Forty-eight hours before sacrifice, mice were challenged with α-naphthylisothiocyanate (ANIT; 25 mg/kg) to induce cholestatic liver injury. Liver injury, cholestasis, and inflammation were evaluated biochemically and histologically. EF induced progressive GM remodeling, whereas PF did not. Unexpectedly, FMT from PF donors aggravated ANIT-promoted liver injury, cholestasis, and hepatic inflammation in EF recipients of both sexes. In contrast, FMT from EF donors did not significantly alter injury compared with non-FMT controls. These findings suggest that GM derived from PF and chronic EF mice differentially influence susceptibility to cholestatic liver injury in EF recipients.},
}
RevDate: 2026-11-13
Translocation of the environmental bacterium Aquitalea magnusonii promotes systemic inflammation and liver fibrosis in chronic liver disease.
Journal of hepatology pii:S0168-8278(26)03047-3 [Epub ahead of print].
BACKGROUND & AIMS: Impaired mucosal barrier integrity facilitates translocation of the gut microbiome into the circulation and the liver, thereby exacerbating the severity of chronic liver diseases (CLD). This study aimed to investigate the pathogenic role of non-commensal environmental bacteria, specifically Aquitalea magnusonii in CLD progression by assessing its ability to cross the intestinal barrier and induce systemic inflammation and liver fibrosis.
METHODS: Using an integrated translational framework, patient blood analyses were combined with multi-omics profiling, human intestinal epithelial models, peripheral blood mononuclear cells (PBMC), hepatic stellate cells (HSC), monocytes, and alcoholic (ALD) and metabolic dysfunction-associated (MASLD) models to evaluate the translocation, virulence, inflammatory and fibrotic potential of A. magnusonii in CLD.
RESULTS: Non-commensal environmental bacteria, including Aquitalea spp. were detected in multiple organs in both ALD and MASLD models. Detection of Aquitalea DNA in patient samples and other non-commensal environmental bacteria in tap water suggested potential aquatic reservoirs. A. magnusonii produced 12 acute-on-chronic liver failure (ACLF) associated metabolites and its outer membrane vesicles (OMV) were enriched in virulence-related proteins, supporting roles in adhesion, invasion, and immune activation. In addition, gavage with A. magnusonii led to a substantial dysbiotic shift in the gut microbiome. Mechanistically, the cell-free supernatant of A. magnusonii culture activated TLR2- and TLR4-dependent pro-inflammatory signaling pathways. Exposure to A. magnusonii or its pathogen-associated molecular patterns (PAMPs) significantly increased inflammation and fibrosis in vitro and in vivo.
CONCLUSION: Non-commensal environmental bacteria, in the example of A. magnusonii, can translocate across the intestinal barrier and promote liver inflammation and fibrogenesis via metabolite production, virulence-associated OMV, and innate immune activation.
IMPACT AND IMPLICATIONS: This study highlights an underrecognized role of non-commensal environmental bacteria in chronic liver disease. Beyond gut commensals, detection of non-commensal environmental microbes such as Aquitalea was associated with markers of more advanced liver disease, while experimental studies of A. magnusonii support biological plausibility for a potential contributory role. These findings highlight the importance of considering environmental reservoirs and non-commensal pathogens in microbial contributions to CLD pathogenesis.
Additional Links: PMID-43025758
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43025758,
year = {2026},
author = {Tyc, O and Arif, S and Uschner, FE and Jung, N and Gu, W and Ortiz, C and Klein, S and Zarei, S and Torres, S and Landvogt, N and Pedersen, KJ and Kew, C and Chen, W and Rooney, M and Arif, H and Castelli, F and Pons, N and Windbergs, M and Bruns, T and von Bergen, M and Garbeva, P and Zweers, H and Đikic, I and Ehrlich, D and Junot, C and Lelouvier, B and Trebicka, J and Schierwagen, R},
title = {Translocation of the environmental bacterium Aquitalea magnusonii promotes systemic inflammation and liver fibrosis in chronic liver disease.},
journal = {Journal of hepatology},
volume = {},
number = {},
pages = {},
doi = {10.1016/j.jhep.2026.10.036},
pmid = {43025758},
issn = {1600-0641},
abstract = {BACKGROUND & AIMS: Impaired mucosal barrier integrity facilitates translocation of the gut microbiome into the circulation and the liver, thereby exacerbating the severity of chronic liver diseases (CLD). This study aimed to investigate the pathogenic role of non-commensal environmental bacteria, specifically Aquitalea magnusonii in CLD progression by assessing its ability to cross the intestinal barrier and induce systemic inflammation and liver fibrosis.
METHODS: Using an integrated translational framework, patient blood analyses were combined with multi-omics profiling, human intestinal epithelial models, peripheral blood mononuclear cells (PBMC), hepatic stellate cells (HSC), monocytes, and alcoholic (ALD) and metabolic dysfunction-associated (MASLD) models to evaluate the translocation, virulence, inflammatory and fibrotic potential of A. magnusonii in CLD.
RESULTS: Non-commensal environmental bacteria, including Aquitalea spp. were detected in multiple organs in both ALD and MASLD models. Detection of Aquitalea DNA in patient samples and other non-commensal environmental bacteria in tap water suggested potential aquatic reservoirs. A. magnusonii produced 12 acute-on-chronic liver failure (ACLF) associated metabolites and its outer membrane vesicles (OMV) were enriched in virulence-related proteins, supporting roles in adhesion, invasion, and immune activation. In addition, gavage with A. magnusonii led to a substantial dysbiotic shift in the gut microbiome. Mechanistically, the cell-free supernatant of A. magnusonii culture activated TLR2- and TLR4-dependent pro-inflammatory signaling pathways. Exposure to A. magnusonii or its pathogen-associated molecular patterns (PAMPs) significantly increased inflammation and fibrosis in vitro and in vivo.
CONCLUSION: Non-commensal environmental bacteria, in the example of A. magnusonii, can translocate across the intestinal barrier and promote liver inflammation and fibrogenesis via metabolite production, virulence-associated OMV, and innate immune activation.
IMPACT AND IMPLICATIONS: This study highlights an underrecognized role of non-commensal environmental bacteria in chronic liver disease. Beyond gut commensals, detection of non-commensal environmental microbes such as Aquitalea was associated with markers of more advanced liver disease, while experimental studies of A. magnusonii support biological plausibility for a potential contributory role. These findings highlight the importance of considering environmental reservoirs and non-commensal pathogens in microbial contributions to CLD pathogenesis.},
}
RevDate: 2026-11-13
The farm effect on asthma and allergies - Thirty years of research.
The Journal of allergy and clinical immunology pii:S0091-6749(26)00803-1 [Epub ahead of print].
The 'farm effect' describes a strong asthma- and allergy-protective signal by farm exposure, which is surprisingly consistent across the globe. Representing a more traditional lifestyle, the farm environment appears to be a reminiscent of the environmental exposure humankind experienced since the neolithic. The farm environment is characterized by a high microbial load and diversity, which seem essential for adequate immune maturation. The aim of this review article is to delineate how research into the farm effect evolved from classical epidemiology over biomarker research, microbiome sequencing, and multi-omics analyses to emerging prevention strategies. We explore how the farm effect and the various versions of the hygiene hypothesis are closely intertwined with each simultaneously contributing the development of the other. We follow the development of our understanding of the mechanisms underpinning the farm effect, focusing on the two most consistent exposures, namely microbial exposure in animal sheds and consumption of unprocessed cow's milk. The decades of research into the farm effect represent true translational work: Moving from observation to intervention, with the advent of new therapeutic interventions on the horizon, now is the time to look back at how it all started, how our understanding has evolved over time and what this might mean for the future.
Additional Links: PMID-43025765
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43025765,
year = {2026},
author = {Murphy, SM and Ege, MJ},
title = {The farm effect on asthma and allergies - Thirty years of research.},
journal = {The Journal of allergy and clinical immunology},
volume = {},
number = {},
pages = {},
doi = {10.1016/j.jaci.2026.10.027},
pmid = {43025765},
issn = {1097-6825},
abstract = {The 'farm effect' describes a strong asthma- and allergy-protective signal by farm exposure, which is surprisingly consistent across the globe. Representing a more traditional lifestyle, the farm environment appears to be a reminiscent of the environmental exposure humankind experienced since the neolithic. The farm environment is characterized by a high microbial load and diversity, which seem essential for adequate immune maturation. The aim of this review article is to delineate how research into the farm effect evolved from classical epidemiology over biomarker research, microbiome sequencing, and multi-omics analyses to emerging prevention strategies. We explore how the farm effect and the various versions of the hygiene hypothesis are closely intertwined with each simultaneously contributing the development of the other. We follow the development of our understanding of the mechanisms underpinning the farm effect, focusing on the two most consistent exposures, namely microbial exposure in animal sheds and consumption of unprocessed cow's milk. The decades of research into the farm effect represent true translational work: Moving from observation to intervention, with the advent of new therapeutic interventions on the horizon, now is the time to look back at how it all started, how our understanding has evolved over time and what this might mean for the future.},
}
RevDate: 2026-11-13
Altered IgA-associated gut microbiota and serum IgA are associated with disease severity in alcohol-associated liver disease.
Gut pii:gutjnl-2026-339201 [Epub ahead of print].
Additional Links: PMID-43025989
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43025989,
year = {2026},
author = {Schöler, D and Hsu, CL and Miwa, T and Brol, MJ and Freund, L and Lang, S and Fouts, DE and , and Stärkel, P and Schnabl, B},
title = {Altered IgA-associated gut microbiota and serum IgA are associated with disease severity in alcohol-associated liver disease.},
journal = {Gut},
volume = {},
number = {},
pages = {},
doi = {10.1136/gutjnl-2026-339201},
pmid = {43025989},
issn = {1468-3288},
}
RevDate: 2026-11-13
How to train your microbe: editing environmental bacteria.
Trends in microbiology pii:S0966-842X(26)00285-4 [Epub ahead of print].
Genome editing is an essential tool in microbiology, enabling researchers to assess gene function, link genotype to phenotype, and design microbes with specific features. Most tools have been developed in model bacteria, and adapting them to environmental species remains time- and resource-intensive. This review provides a framework for engineering environmental bacteria, including assessment of genetic tractability, considerations for overcoming challenges in recalcitrant systems, and an overview of techniques with guidance on tool selection. We discuss the emerging field of microbiome editing, where genome modifications can be delivered to bacteria within complex microbial communities and hosts, opening new possibilities for mechanistic studies across diverse environments. These advances promise to shift functional microbiology from reductionist, isolate-based approaches toward contextually informed, mechanistic investigations.
Additional Links: PMID-43026054
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43026054,
year = {2026},
author = {Flaig, ML and Hardwick, MMJ and Burmølle, M and Alker, ATP},
title = {How to train your microbe: editing environmental bacteria.},
journal = {Trends in microbiology},
volume = {},
number = {},
pages = {},
doi = {10.1016/j.tim.2026.10.007},
pmid = {43026054},
issn = {1878-4380},
abstract = {Genome editing is an essential tool in microbiology, enabling researchers to assess gene function, link genotype to phenotype, and design microbes with specific features. Most tools have been developed in model bacteria, and adapting them to environmental species remains time- and resource-intensive. This review provides a framework for engineering environmental bacteria, including assessment of genetic tractability, considerations for overcoming challenges in recalcitrant systems, and an overview of techniques with guidance on tool selection. We discuss the emerging field of microbiome editing, where genome modifications can be delivered to bacteria within complex microbial communities and hosts, opening new possibilities for mechanistic studies across diverse environments. These advances promise to shift functional microbiology from reductionist, isolate-based approaches toward contextually informed, mechanistic investigations.},
}
RevDate: 2026-11-13
Microbial medicine in clinical pediatrics: evolving approaches to diagnosis and management.
Current problems in pediatric and adolescent health care pii:S1538-5442(26)00090-8 [Epub ahead of print].
Our increasing understanding of the microbiome has revealed its critical role in immunity, metabolism, infectious disease susceptibility, and overall human health. Advances in the detection of microbial species using new sequencing technologies has led to the emergence of a new frontier in medicine. Integrating the microbiome with diagnostics and therapeutics has introduced the field of 'microbial medicine', representing a major translational advance in pediatric healthcare. The early-life microbiome is particularly important serving as a critical developmental window during which rapidly altering microbial communities can contribute to immune tolerance and confer disease risk. Factors that can shape the early-life microbial landscape include delivery mode, breastfeeding, diet, antibiotic exposure and geography. Disruptions in the microbiome have been linked to numerous pediatric diseases including necrotizing enterocolitis, inflammatory bowel disease, neonatal sepsis, allergic diseases, metabolic syndrome, neurodevelopmental disorders and psychiatric conditions. While early microbiome research has been largely correlational, growing mechanistic insights into host-microbe interactions have paved the way for the development of microbiome-targeted therapeutics. Promising approaches include prebiotics, probiotics, fecal microbiota transplantation, liver biotherapeutic products, genetically engineered microbes and microbiome-derived metabolites. Studies are however lacking in the pediatric population and therefore there is a growing need for a coordinated effort to increase access to microbiome-based therapeutics in children. Significant challenges include a lack of age-specific reference standards, understanding long-term safety, and standardizing available treatments. In this review we discuss the emergence of microbial medicine in pediatric care. We examine the current evidence evaluating the development of the microbiome, the factors that shape early-life microbial colonization and the use of microbial therapeutics in clinical practice. We highlight the challenges and opportunities associated with translating these discoveries into pediatric practice and suggest research priorities and infrastructure development required to establish microbial medicine as a mainstay in pediatric practice.
Additional Links: PMID-43026137
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43026137,
year = {2026},
author = {Rich, S and Fawad, JA and Baldassano, RN and Zackular, JP and Pai, N},
title = {Microbial medicine in clinical pediatrics: evolving approaches to diagnosis and management.},
journal = {Current problems in pediatric and adolescent health care},
volume = {},
number = {},
pages = {102003},
doi = {10.1016/j.cppeds.2026.102003},
pmid = {43026137},
issn = {1538-3199},
abstract = {Our increasing understanding of the microbiome has revealed its critical role in immunity, metabolism, infectious disease susceptibility, and overall human health. Advances in the detection of microbial species using new sequencing technologies has led to the emergence of a new frontier in medicine. Integrating the microbiome with diagnostics and therapeutics has introduced the field of 'microbial medicine', representing a major translational advance in pediatric healthcare. The early-life microbiome is particularly important serving as a critical developmental window during which rapidly altering microbial communities can contribute to immune tolerance and confer disease risk. Factors that can shape the early-life microbial landscape include delivery mode, breastfeeding, diet, antibiotic exposure and geography. Disruptions in the microbiome have been linked to numerous pediatric diseases including necrotizing enterocolitis, inflammatory bowel disease, neonatal sepsis, allergic diseases, metabolic syndrome, neurodevelopmental disorders and psychiatric conditions. While early microbiome research has been largely correlational, growing mechanistic insights into host-microbe interactions have paved the way for the development of microbiome-targeted therapeutics. Promising approaches include prebiotics, probiotics, fecal microbiota transplantation, liver biotherapeutic products, genetically engineered microbes and microbiome-derived metabolites. Studies are however lacking in the pediatric population and therefore there is a growing need for a coordinated effort to increase access to microbiome-based therapeutics in children. Significant challenges include a lack of age-specific reference standards, understanding long-term safety, and standardizing available treatments. In this review we discuss the emergence of microbial medicine in pediatric care. We examine the current evidence evaluating the development of the microbiome, the factors that shape early-life microbial colonization and the use of microbial therapeutics in clinical practice. We highlight the challenges and opportunities associated with translating these discoveries into pediatric practice and suggest research priorities and infrastructure development required to establish microbial medicine as a mainstay in pediatric practice.},
}
RevDate: 2026-11-13
CmpDate: 2026-11-13
From penicillin to precision: reframing AMR in dentistry through time - past lessons, present risks, and future solutions.
British dental journal, 241(9):689-697.
Antimicrobial resistance (AMR) is a public health global threat projected to cause 10 million deaths annually by 2050 and a major health protection issue. Dentistry contributes approximately 10% of antibiotic prescriptions worldwide, often for conditions where antibiotics offer limited benefit. This article reframes AMR in dentistry through a historical, current, and future lens, integrating risk assessment principles, empirical prescribing trends, and precision strategies. We trace the trajectory from the penicillin era to modern stewardship challenges, examine the dental AMR burden and prescribing patterns using English Surveillance Programme for Antimicrobial Utilisation and Resistance 2023-2024 data, and explore innovative solutions including rapid diagnostics, microbiome restoration, and non-antibiotic therapies. Drawing on evolutionary insights from ancient microbiomes, we argue that AMR is not merely a clinical phenomenon, but a microbial ecological imbalance driven by industrialisation and antibiotic overuse. Future health protection strategies involving interdisciplinary working must combine stewardship with precision dentistry and microbial ecosystem restoration in a one-world setting to mitigate AMR risk while preserving microbial and host resilience. Public health plays an important role working with a range of other stakeholders/agencies in a multidisciplinary approach.
Additional Links: PMID-43026253
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43026253,
year = {2026},
author = {Edwards, LA and Edwards, JA and Dailey, Y},
title = {From penicillin to precision: reframing AMR in dentistry through time - past lessons, present risks, and future solutions.},
journal = {British dental journal},
volume = {241},
number = {9},
pages = {689-697},
doi = {10.1038/s41415-026-0173-y},
pmid = {43026253},
issn = {1476-5373},
mesh = {Humans ; *Anti-Bacterial Agents/therapeutic use ; *Penicillins/therapeutic use ; *Dentistry/trends ; *Antimicrobial Stewardship ; Risk Assessment ; Drug Resistance, Bacterial ; },
abstract = {Antimicrobial resistance (AMR) is a public health global threat projected to cause 10 million deaths annually by 2050 and a major health protection issue. Dentistry contributes approximately 10% of antibiotic prescriptions worldwide, often for conditions where antibiotics offer limited benefit. This article reframes AMR in dentistry through a historical, current, and future lens, integrating risk assessment principles, empirical prescribing trends, and precision strategies. We trace the trajectory from the penicillin era to modern stewardship challenges, examine the dental AMR burden and prescribing patterns using English Surveillance Programme for Antimicrobial Utilisation and Resistance 2023-2024 data, and explore innovative solutions including rapid diagnostics, microbiome restoration, and non-antibiotic therapies. Drawing on evolutionary insights from ancient microbiomes, we argue that AMR is not merely a clinical phenomenon, but a microbial ecological imbalance driven by industrialisation and antibiotic overuse. Future health protection strategies involving interdisciplinary working must combine stewardship with precision dentistry and microbial ecosystem restoration in a one-world setting to mitigate AMR risk while preserving microbial and host resilience. Public health plays an important role working with a range of other stakeholders/agencies in a multidisciplinary approach.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Anti-Bacterial Agents/therapeutic use
*Penicillins/therapeutic use
*Dentistry/trends
*Antimicrobial Stewardship
Risk Assessment
Drug Resistance, Bacterial
RevDate: 2026-11-14
CmpDate: 2026-11-13
Integrating whole-genome sequencing and metagenomics improves phenotype prediction of fat deposition traits in pigs.
Genetics, selection, evolution : GSE, 58(1):.
BACKGROUND: Fat deposition is a key economic trait affecting production efficiency and carcass quality in pigs and is influenced by both genetic and environmental factors. Although increasing evidence indicates that the gut microbiome contributes to host phenotypic variation, current genomic evaluation and prediction models largely rely on host genotype information and rarely account for microbiome effects. This study aimed to quantify the contribution of the gut microbiome to fat deposition traits and to evaluate whether incorporating microbiome information could improve phenotypic prediction in pigs.
RESULTS: We collected phenotypic characteristics of six fat deposition traits including the shoulder backfat thickness, the 6th-7th rib backfat thickness, the last rib backfat thickness, waist backfat thickness, the 3rd-4th last rib backfat thickness, and the average backfat thickness from 478 Duroc × Landrace × Yorkshire pigs. Using whole-genome resequencing and metagenomic sequencing, we identified 21 million single nucleotide variants and quantified the abundances of 20,336 gut microbial species across 478 pigs. Distinct fecal microbial community structures were observed between pigs with high- and low-fat deposition, and 27 bacterial species were identified as potential biomarkers associated with fat deposition. Microbiability estimates for the six backfat thickness traits ranged from 0.17 to 0.44, indicating that the gut microbiome accounted for a considerable proportion of phenotypic variance beyond host genetic contributions. In contrast, the interaction effects between the host genome and gut microbiome accounted for only a negligible proportion of phenotypic variance across the six traits. Incorporating overall microbiome information into genomic prediction models resulted in mean phenotypic predictive abilities ranging from 0.082 to 0.292, representing increases in predictive ability of 0.023 to 0.084 across traits and reductions in the mean squared error of prediction of 0.001 to 0.009 compared with the additive genetic model.
CONCLUSIONS: Our findings demonstrate that the gut microbiome makes a substantial contribution to variation in fat deposition traits in pigs. Integrating host whole-genome resequencing and gut metagenomic information yielded modest absolute gains in phenotypic predictive ability, suggesting that the gut microbiome may provide complementary information for prediction models of complex traits in pigs.
Additional Links: PMID-43026532
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43026532,
year = {2026},
author = {Liu, Y and Lin, M and Luo, J and Yang, J and Yao, Z and Lin, D and Qiu, H and Zhang, Z and Huang, S and Zheng, E and Cai, G and Wu, Z and Liu, L and Wu, JJ},
title = {Integrating whole-genome sequencing and metagenomics improves phenotype prediction of fat deposition traits in pigs.},
journal = {Genetics, selection, evolution : GSE},
volume = {58},
number = {1},
pages = {},
pmid = {43026532},
issn = {1297-9686},
support = {2025B0202080002//Natural Science Foundation of Guangdong Province project/ ; 2025-XPY-01-002//Guangdong Provincial Special Finance Project for Seed Industry Revitalization Action/ ; NYQN2025004//Guangdong Special Support Program/ ; 2019BT02N630//Local Innovative and Research Teams Project of Guangdong Province/ ; 32502844//National Natural Science Foundation of China/ ; GZB20230230//the Postdoctoral Fellowship Program of CPSF/ ; GZB20250817//the Postdoctoral Fellowship Program of CPSF/ ; },
mesh = {Animals ; *Metagenomics/methods ; Phenotype ; *Whole Genome Sequencing/methods ; Swine/genetics ; *Gastrointestinal Microbiome/genetics ; Polymorphism, Single Nucleotide ; *Adipose Tissue ; Genotype ; },
abstract = {BACKGROUND: Fat deposition is a key economic trait affecting production efficiency and carcass quality in pigs and is influenced by both genetic and environmental factors. Although increasing evidence indicates that the gut microbiome contributes to host phenotypic variation, current genomic evaluation and prediction models largely rely on host genotype information and rarely account for microbiome effects. This study aimed to quantify the contribution of the gut microbiome to fat deposition traits and to evaluate whether incorporating microbiome information could improve phenotypic prediction in pigs.
RESULTS: We collected phenotypic characteristics of six fat deposition traits including the shoulder backfat thickness, the 6th-7th rib backfat thickness, the last rib backfat thickness, waist backfat thickness, the 3rd-4th last rib backfat thickness, and the average backfat thickness from 478 Duroc × Landrace × Yorkshire pigs. Using whole-genome resequencing and metagenomic sequencing, we identified 21 million single nucleotide variants and quantified the abundances of 20,336 gut microbial species across 478 pigs. Distinct fecal microbial community structures were observed between pigs with high- and low-fat deposition, and 27 bacterial species were identified as potential biomarkers associated with fat deposition. Microbiability estimates for the six backfat thickness traits ranged from 0.17 to 0.44, indicating that the gut microbiome accounted for a considerable proportion of phenotypic variance beyond host genetic contributions. In contrast, the interaction effects between the host genome and gut microbiome accounted for only a negligible proportion of phenotypic variance across the six traits. Incorporating overall microbiome information into genomic prediction models resulted in mean phenotypic predictive abilities ranging from 0.082 to 0.292, representing increases in predictive ability of 0.023 to 0.084 across traits and reductions in the mean squared error of prediction of 0.001 to 0.009 compared with the additive genetic model.
CONCLUSIONS: Our findings demonstrate that the gut microbiome makes a substantial contribution to variation in fat deposition traits in pigs. Integrating host whole-genome resequencing and gut metagenomic information yielded modest absolute gains in phenotypic predictive ability, suggesting that the gut microbiome may provide complementary information for prediction models of complex traits in pigs.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
*Metagenomics/methods
Phenotype
*Whole Genome Sequencing/methods
Swine/genetics
*Gastrointestinal Microbiome/genetics
Polymorphism, Single Nucleotide
*Adipose Tissue
Genotype
RevDate: 2026-11-13
CmpDate: 2026-11-13
Traversing the canopy: phenology-driven changes and within-canopy transport shape the phyllosphere microbiome in a temperate floodplain hardwood forest.
Environmental microbiome, 21(1):.
Phyllosphere microbiomes are subject to microbial import from various sources and undergo substantial changes during phenological changes of plants. However, especially for forest canopies, these processes are still poorly understood. We disentangled the controls of phenology-driven changes versus tree species identity on the phyllosphere microbiome in a temperate floodplain forest and assessed the role of transport processes in shaping distribution patterns within the canopy. Leveraging the infrastructure of the Leipzig canopy crane (Central Germany), we followed bacterial community composition and rainwater-mediated bacterial transport for oak (Quercus robur L.), ash (Fraxinus excelsior L.) and linden (Tilia cordata MILL) across early (May), mid (July) and late (October) phenological stages. These stages explained 23% of phyllosphere bacterial community variation, followed by tree species identity (13%) and canopy position (2%). Phyllosphere bacterial community assembly was mostly driven by dispersal limitation at the early phenological stage while communities became more homogeneous and functionally redundant during mid and late phenological stages, along with a strong decline of plant pathogens and increasing potential for microbially mediated biocontrol mechanisms. Throughfall-mediated transport of bacteria increased substantially from March to May, indicating the strong influence of wash-off effects from the emerging foliage. Our findings demonstrate that in temperate forests, phenology-driven effects on the phyllosphere microbiome exceed tree species' specific effects. Extent and selectivity of throughfall-mediated mobilization of microbes adds another layer of complexity to the spatial heterogeneity of microbial communities in tree crowns.
Additional Links: PMID-43026595
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43026595,
year = {2026},
author = {Loganathachetti, DS and Michalzik, B and Sandoval, MM and Zerhusen, P and Richter, R and Engelmann, RA and Künne, T and Wirth, C and Küsel, K and Herrmann, M},
title = {Traversing the canopy: phenology-driven changes and within-canopy transport shape the phyllosphere microbiome in a temperate floodplain hardwood forest.},
journal = {Environmental microbiome},
volume = {21},
number = {1},
pages = {},
pmid = {43026595},
issn = {2524-6372},
abstract = {Phyllosphere microbiomes are subject to microbial import from various sources and undergo substantial changes during phenological changes of plants. However, especially for forest canopies, these processes are still poorly understood. We disentangled the controls of phenology-driven changes versus tree species identity on the phyllosphere microbiome in a temperate floodplain forest and assessed the role of transport processes in shaping distribution patterns within the canopy. Leveraging the infrastructure of the Leipzig canopy crane (Central Germany), we followed bacterial community composition and rainwater-mediated bacterial transport for oak (Quercus robur L.), ash (Fraxinus excelsior L.) and linden (Tilia cordata MILL) across early (May), mid (July) and late (October) phenological stages. These stages explained 23% of phyllosphere bacterial community variation, followed by tree species identity (13%) and canopy position (2%). Phyllosphere bacterial community assembly was mostly driven by dispersal limitation at the early phenological stage while communities became more homogeneous and functionally redundant during mid and late phenological stages, along with a strong decline of plant pathogens and increasing potential for microbially mediated biocontrol mechanisms. Throughfall-mediated transport of bacteria increased substantially from March to May, indicating the strong influence of wash-off effects from the emerging foliage. Our findings demonstrate that in temperate forests, phenology-driven effects on the phyllosphere microbiome exceed tree species' specific effects. Extent and selectivity of throughfall-mediated mobilization of microbes adds another layer of complexity to the spatial heterogeneity of microbial communities in tree crowns.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
ILA-producing Lacticaseibacillus paracasei NCU-21 exerts anti-acute myeloid leukemia effects by inhibiting the PI3K-AKT pathway.
Genome biology, 27(1):.
BACKGROUND: Cytarabine (Ara-C) remains the cornerstone of induction therapy for acute myeloid leukemia (AML). However, its overall clinical efficacy is suboptimal, and the regimen is frequently accompanied by severe disruption of intestinal homeostasis. Consequently, identifying novel adjunctive therapies to improve treatment outcomes represents a critical clinical need.
RESULTS: Gut microbiome profiling in AML mouse models reveals that Ara-C treatment significantly depletes Lactobacillus abundance. Through a probiotic intervention model, we demonstrate that administration of Lacticaseibacillus paracasei NCU-21 reduces leukemic burden, as well as size and weight of the spleen (p < 0.05). Mechanistically, L. paracasei NCU-21 restores microbial homeostasis, upregulates tight junction proteins (p < 0.05), and suppresses the lipopolysaccharide (LPS)-Toll-like receptor 4 (TLR4) pathway (p < 0.01), thereby attenuating systemic pro-inflammatory cytokine levels. Subsequent metabolomics confirms that indole-3-lactic acid (ILA) is the primary functional metabolite of L. paracasei NCU-21. In vivo administration of ILA recapitulates the anti-AML effects of the probiotic, and in vitro assays confirm that ILA directly induces AML cell apoptosis (p < 0.001) by suppressing the PI3K-AKT pathway.
CONCLUSIONS: This work demonstrates that L. paracasei NCU-21 mitigates AML progression via the production of ILA, supporting its potential as an adjunct therapy.
Additional Links: PMID-43026600
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43026600,
year = {2026},
author = {Kong, L and Zhang, X and Ding, L and Liu, L and Wang, J and Zhang, Z and Tu, H and Li, J and Chen, T},
title = {ILA-producing Lacticaseibacillus paracasei NCU-21 exerts anti-acute myeloid leukemia effects by inhibiting the PI3K-AKT pathway.},
journal = {Genome biology},
volume = {27},
number = {1},
pages = {},
pmid = {43026600},
issn = {1474-760X},
support = {81760033//National Natural Science Foundation of China/ ; 20223BBG71006//Key Research and Development Program of Jiangxi Province/ ; },
mesh = {Animals ; *Leukemia, Myeloid, Acute/metabolism/therapy/drug therapy/microbiology/pathology ; *Proto-Oncogene Proteins c-akt/metabolism ; *Phosphatidylinositol 3-Kinases/metabolism ; Signal Transduction/drug effects ; Mice ; *Lacticaseibacillus paracasei/metabolism ; *Probiotics/therapeutic use/pharmacology ; Humans ; Gastrointestinal Microbiome/drug effects ; Cytarabine/pharmacology/therapeutic use ; },
abstract = {BACKGROUND: Cytarabine (Ara-C) remains the cornerstone of induction therapy for acute myeloid leukemia (AML). However, its overall clinical efficacy is suboptimal, and the regimen is frequently accompanied by severe disruption of intestinal homeostasis. Consequently, identifying novel adjunctive therapies to improve treatment outcomes represents a critical clinical need.
RESULTS: Gut microbiome profiling in AML mouse models reveals that Ara-C treatment significantly depletes Lactobacillus abundance. Through a probiotic intervention model, we demonstrate that administration of Lacticaseibacillus paracasei NCU-21 reduces leukemic burden, as well as size and weight of the spleen (p < 0.05). Mechanistically, L. paracasei NCU-21 restores microbial homeostasis, upregulates tight junction proteins (p < 0.05), and suppresses the lipopolysaccharide (LPS)-Toll-like receptor 4 (TLR4) pathway (p < 0.01), thereby attenuating systemic pro-inflammatory cytokine levels. Subsequent metabolomics confirms that indole-3-lactic acid (ILA) is the primary functional metabolite of L. paracasei NCU-21. In vivo administration of ILA recapitulates the anti-AML effects of the probiotic, and in vitro assays confirm that ILA directly induces AML cell apoptosis (p < 0.001) by suppressing the PI3K-AKT pathway.
CONCLUSIONS: This work demonstrates that L. paracasei NCU-21 mitigates AML progression via the production of ILA, supporting its potential as an adjunct therapy.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
*Leukemia, Myeloid, Acute/metabolism/therapy/drug therapy/microbiology/pathology
*Proto-Oncogene Proteins c-akt/metabolism
*Phosphatidylinositol 3-Kinases/metabolism
Signal Transduction/drug effects
Mice
*Lacticaseibacillus paracasei/metabolism
*Probiotics/therapeutic use/pharmacology
Humans
Gastrointestinal Microbiome/drug effects
Cytarabine/pharmacology/therapeutic use
RevDate: 2026-11-13
CmpDate: 2026-11-14
A specialized microbiome enriched in nitrification and halogen cycling potential resolved from multi-omics investigation of a Caribbean suboxic and acidic marine sinkhole.
Microbiome, 14(1):.
BACKGROUND: The Luymes Sinkholes, located on the Luymes Bank northwest of Saba, represent a unique marine environment characterized by distinct biogeochemical gradients. Most noticeable is an acidic (pH ≈ 6.25) and suboxic (O2 < 60 µmol/kg) submerged 'lake' at ~ 220 m depth exhibiting extreme deviations from standard oceanographic patterns, including elevated inorganic carbon, nitrate, and phosphate, and a lower temperature (20.3 ºC vs 26.4 ºC). To determine how the microbiome within the submerged acid lake adapted to these unique conditions, we collected 59 coupled samples of size-filtered (0.22 µm) planktonic microbes for shotgun metagenomics and solid-phase extracted dissolved organic matter for untargeted metabolomics from 21 stations at depths ranging from 2 to 600 m during a 10-day research cruise in December 2019.
RESULTS: We identified a distinct microbial community within the submerged acid lake different from the non-acidic sinkholes, with increased abundances of Nitrospinota, Thermoproteota, Planctomycetota, and Actinobacteriota. We also found three enriched classes of dissolved compounds within the submerged acid lake: (1) large, (2) low-polarity, and (3) halogenated metabolites, including iodides and halobenzoic acids. Correlations between microbial taxa and metabolite classes show potential links between nitrifying archaea and halogenated compound cycling. We further supported these findings using the functional annotation of metagenome-assembled genomes (MAGs) and protein clusters showing enrichment of nitrification and halogen cycling genes, suggesting the presence of specialized degradation and biosynthetic pathways, directly connecting microbial metabolism to the observed geochemical conditions.
CONCLUSION: These findings demonstrate that the submerged acid lake contains specific microbially driven biogeochemical processes under acidified and low-oxygen conditions, providing a natural model for future extreme ocean acidification scenarios. With this multi‑omics approach, we were able to connect the microbial metabolism with this unique environment, thereby expanding our understanding of how both are interconnected. Video Abstract.
Additional Links: PMID-43026629
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43026629,
year = {2026},
author = {Boer, MD and Peets, P and van Eijnatten, AL and Nelson, CE and do Canto Brum de Menezes Pena, MM and Karancz, S and Humphreys, MP and van Duyl, FC and Meesters, EH and Snoek, BL and Melkonian, C and Haas, AF and Dutilh, BE},
title = {A specialized microbiome enriched in nitrification and halogen cycling potential resolved from multi-omics investigation of a Caribbean suboxic and acidic marine sinkhole.},
journal = {Microbiome},
volume = {14},
number = {1},
pages = {},
pmid = {43026629},
issn = {2049-2618},
mesh = {*Nitrification ; *Microbiota ; Multiomics ; Metagenomics/methods ; *Bacteria/classification/metabolism/genetics/isolation & purification ; *Halogens/metabolism ; *Lakes/microbiology/chemistry ; Metabolomics ; Hydrogen-Ion Concentration ; },
abstract = {BACKGROUND: The Luymes Sinkholes, located on the Luymes Bank northwest of Saba, represent a unique marine environment characterized by distinct biogeochemical gradients. Most noticeable is an acidic (pH ≈ 6.25) and suboxic (O2 < 60 µmol/kg) submerged 'lake' at ~ 220 m depth exhibiting extreme deviations from standard oceanographic patterns, including elevated inorganic carbon, nitrate, and phosphate, and a lower temperature (20.3 ºC vs 26.4 ºC). To determine how the microbiome within the submerged acid lake adapted to these unique conditions, we collected 59 coupled samples of size-filtered (0.22 µm) planktonic microbes for shotgun metagenomics and solid-phase extracted dissolved organic matter for untargeted metabolomics from 21 stations at depths ranging from 2 to 600 m during a 10-day research cruise in December 2019.
RESULTS: We identified a distinct microbial community within the submerged acid lake different from the non-acidic sinkholes, with increased abundances of Nitrospinota, Thermoproteota, Planctomycetota, and Actinobacteriota. We also found three enriched classes of dissolved compounds within the submerged acid lake: (1) large, (2) low-polarity, and (3) halogenated metabolites, including iodides and halobenzoic acids. Correlations between microbial taxa and metabolite classes show potential links between nitrifying archaea and halogenated compound cycling. We further supported these findings using the functional annotation of metagenome-assembled genomes (MAGs) and protein clusters showing enrichment of nitrification and halogen cycling genes, suggesting the presence of specialized degradation and biosynthetic pathways, directly connecting microbial metabolism to the observed geochemical conditions.
CONCLUSION: These findings demonstrate that the submerged acid lake contains specific microbially driven biogeochemical processes under acidified and low-oxygen conditions, providing a natural model for future extreme ocean acidification scenarios. With this multi‑omics approach, we were able to connect the microbial metabolism with this unique environment, thereby expanding our understanding of how both are interconnected. Video Abstract.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Nitrification
*Microbiota
Multiomics
Metagenomics/methods
*Bacteria/classification/metabolism/genetics/isolation & purification
*Halogens/metabolism
*Lakes/microbiology/chemistry
Metabolomics
Hydrogen-Ion Concentration
RevDate: 2026-11-14
Correction: Baseline gut microbiome and metabolome profiles predict weight loss after a structured lifestyle intervention.
Microbiome, 14(1):.
Additional Links: PMID-43026637
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43026637,
year = {2026},
author = {Seethaler, B and Basrai, M and Delzenne, NM and Walter, J and Nguyen, NK and Bischoff, SC},
title = {Correction: Baseline gut microbiome and metabolome profiles predict weight loss after a structured lifestyle intervention.},
journal = {Microbiome},
volume = {14},
number = {1},
pages = {},
pmid = {43026637},
issn = {2049-2618},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
Fecal Microbiota Transplantation in Colorectal Cancer: From Immune Regulation to Immunotherapy.
Cancers, 18(21):.
The gut microbiome influences colorectal cancer (CRC) progression and responses to immune checkpoint inhibitors (ICIs), with immunotherapy resistance remaining a major challenge in microsatellite-stable/mismatch repair-proficient (MSS/pMMR) CRC. This review examines the mechanisms and translational potential of fecal microbiota transplantation (FMT) in CRC immunotherapy, focusing on the interplay among microbial functions, metabolic alterations, and immune microenvironment remodeling. Current evidence suggests that FMT may influence antitumor immunity beyond restoring microbial diversity by transferring functionally relevant microbial communities, metabolic profiles, and immunomodulatory signals. These changes may affect antigen presentation, inflammatory signaling, T-cell activity, and myeloid-cell states, thereby shaping the tumor immune microenvironment and potentially modulating responses to PD-1/PD-L1 blockade. However, the clinical efficacy of FMT in CRC, the determinants of successful microbial engraftment, and the mechanisms linking donor-derived microbial functions to therapeutic outcomes remain incompletely understood. Integrating defined microbial consortia, metabolite-based interventions, and multi-omics-guided patient stratification may help advance FMT toward mechanism-driven precision microbiome therapy and inform strategies to improve CRC immunotherapy outcomes.
Additional Links: PMID-43026748
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43026748,
year = {2026},
author = {Yang, X and Ge, X and Gong, S and Zhu, T and Ni, C and Ma, R and Tao, Q},
title = {Fecal Microbiota Transplantation in Colorectal Cancer: From Immune Regulation to Immunotherapy.},
journal = {Cancers},
volume = {18},
number = {21},
pages = {},
pmid = {43026748},
issn = {2072-6694},
support = {2026-YRDFHI-141//Shanghai YRD Foundation for Innovation in Health Industry/ ; },
abstract = {The gut microbiome influences colorectal cancer (CRC) progression and responses to immune checkpoint inhibitors (ICIs), with immunotherapy resistance remaining a major challenge in microsatellite-stable/mismatch repair-proficient (MSS/pMMR) CRC. This review examines the mechanisms and translational potential of fecal microbiota transplantation (FMT) in CRC immunotherapy, focusing on the interplay among microbial functions, metabolic alterations, and immune microenvironment remodeling. Current evidence suggests that FMT may influence antitumor immunity beyond restoring microbial diversity by transferring functionally relevant microbial communities, metabolic profiles, and immunomodulatory signals. These changes may affect antigen presentation, inflammatory signaling, T-cell activity, and myeloid-cell states, thereby shaping the tumor immune microenvironment and potentially modulating responses to PD-1/PD-L1 blockade. However, the clinical efficacy of FMT in CRC, the determinants of successful microbial engraftment, and the mechanisms linking donor-derived microbial functions to therapeutic outcomes remain incompletely understood. Integrating defined microbial consortia, metabolite-based interventions, and multi-omics-guided patient stratification may help advance FMT toward mechanism-driven precision microbiome therapy and inform strategies to improve CRC immunotherapy outcomes.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
Immune and Circulating Biomarkers in Hepatocellular Carcinoma: Prognostic and Predictive Relevance for Immunotherapy.
Cancers, 18(21):.
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality. Immune checkpoint inhibitor (ICI)-based combinations have become the standard first-line systemic therapy, yet objective response rates remain modest (20-36%), and no HCC-specific immune biomarker has been validated to guide selection among standard ICI-based regimens. This review examines the prognostic and exploratory treatment-response associations of potential immune biomarkers in HCC, including markers within the tumor microenvironment (TME) and peripheral blood. A narrative review was conducted evaluating PD-L1 and soluble PD-L1, tumor mutational burden (TMB), tumor-infiltrating lymphocytes (TILs), including machine learning-based assessment, gene expression profiles and tumor-intrinsic pathway alterations, long non-coding RNAs, inflammatory markers (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, alpha-fetoprotein), gut microbiota, and liquid biopsy analytes (circulating tumor DNA, circulating tumor cells, cell-free DNA). PD-L1 expression shows prognostic associations and inconsistent associations with ICI outcomes; inter-assay heterogeneity further limits its use, and routine PD-L1 testing is not recommended by current guidelines. TMB is generally low in HCC, with inconsistent associations with ICI response. High CD8[+] TIL density is associated with improved survival after resection and favorable outcomes in exploratory ICI-treated cohorts, without validated treatment-selective utility. Inflammatory gene signatures and WNT/β-catenin pathway activation are associated with ICI outcomes. Gut microbiome features have shown exploratory associations with anti-PD-1 outcomes, with limited consistency across small datasets. Liquid biopsy markers, particularly ctDNA, show promise for recurrence prediction and treatment monitoring but lack assay standardization. Multiple immune biomarkers demonstrate prognostic value in HCC, and pre-existing immunity characterized by high CD8[+] T-cell infiltration and inflammatory gene signatures is associated with improved ICI-based therapy outcomes in exploratory studies. However, these exploratory markers have not been validated for routine selection among HCC regimens. Future directions include prospective validation of composite biomarker panels, standardization of assessment methodologies, and integration of artificial intelligence for TME characterization.
Additional Links: PMID-43026751
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43026751,
year = {2026},
author = {Sidhom, F and Karabiber, E and ElBeblawy, R and Babagiray, A and Yacoub, T and El-Rayes, B and Akce, M},
title = {Immune and Circulating Biomarkers in Hepatocellular Carcinoma: Prognostic and Predictive Relevance for Immunotherapy.},
journal = {Cancers},
volume = {18},
number = {21},
pages = {},
pmid = {43026751},
issn = {2072-6694},
abstract = {Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality. Immune checkpoint inhibitor (ICI)-based combinations have become the standard first-line systemic therapy, yet objective response rates remain modest (20-36%), and no HCC-specific immune biomarker has been validated to guide selection among standard ICI-based regimens. This review examines the prognostic and exploratory treatment-response associations of potential immune biomarkers in HCC, including markers within the tumor microenvironment (TME) and peripheral blood. A narrative review was conducted evaluating PD-L1 and soluble PD-L1, tumor mutational burden (TMB), tumor-infiltrating lymphocytes (TILs), including machine learning-based assessment, gene expression profiles and tumor-intrinsic pathway alterations, long non-coding RNAs, inflammatory markers (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, alpha-fetoprotein), gut microbiota, and liquid biopsy analytes (circulating tumor DNA, circulating tumor cells, cell-free DNA). PD-L1 expression shows prognostic associations and inconsistent associations with ICI outcomes; inter-assay heterogeneity further limits its use, and routine PD-L1 testing is not recommended by current guidelines. TMB is generally low in HCC, with inconsistent associations with ICI response. High CD8[+] TIL density is associated with improved survival after resection and favorable outcomes in exploratory ICI-treated cohorts, without validated treatment-selective utility. Inflammatory gene signatures and WNT/β-catenin pathway activation are associated with ICI outcomes. Gut microbiome features have shown exploratory associations with anti-PD-1 outcomes, with limited consistency across small datasets. Liquid biopsy markers, particularly ctDNA, show promise for recurrence prediction and treatment monitoring but lack assay standardization. Multiple immune biomarkers demonstrate prognostic value in HCC, and pre-existing immunity characterized by high CD8[+] T-cell infiltration and inflammatory gene signatures is associated with improved ICI-based therapy outcomes in exploratory studies. However, these exploratory markers have not been validated for routine selection among HCC regimens. Future directions include prospective validation of composite biomarker panels, standardization of assessment methodologies, and integration of artificial intelligence for TME characterization.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
The Changing Global Epidemiology of Early-Onset Colorectal Cancer: Incidence Trends, Modifiable Risk Factors, and Future Burden Projections.
Cancers, 18(21):.
Early-onset colorectal cancer (EOCRC), defined as colorectal cancer diagnosed before age 50, has become an increasing global public health concern. Incidence rates have risen among younger adults in many countries, despite stable or declining rates in older populations. This review examines global EOCRC epidemiology, potentially modifiable risk factors, and projected future disease burden. Evidence from international cancer databases, population-based registries, and observational studies is synthesised, considering differences by age, sex, geographic region, and tumour location. Key risk factors include obesity, metabolic dysfunction, dietary patterns, physical inactivity, alcohol consumption, tobacco use, antibiotic exposure, and gut microbiome alterations. The review also evaluates temporal trends and projections of incidence, prevalence, and mortality. Although increasing incidence may reflect changing lifestyles, metabolic health, environmental exposures, and other early-life risk factors, their relative contributions remain incompletely understood. Improved understanding of EOCRC epidemiology and future burden may help identify high-risk populations, guide targeted prevention strategies, inform public health policy, and support discussions on earlier colorectal cancer detection and screening.
Additional Links: PMID-43026775
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43026775,
year = {2026},
author = {Wrzosek, K and Koba, A and Bakalczuk, P and Oziębło, J and Michno, K and Pająk, W and Kleinrok, J and Korolczuk, A and Trojanowska, D and Forma, A},
title = {The Changing Global Epidemiology of Early-Onset Colorectal Cancer: Incidence Trends, Modifiable Risk Factors, and Future Burden Projections.},
journal = {Cancers},
volume = {18},
number = {21},
pages = {},
pmid = {43026775},
issn = {2072-6694},
abstract = {Early-onset colorectal cancer (EOCRC), defined as colorectal cancer diagnosed before age 50, has become an increasing global public health concern. Incidence rates have risen among younger adults in many countries, despite stable or declining rates in older populations. This review examines global EOCRC epidemiology, potentially modifiable risk factors, and projected future disease burden. Evidence from international cancer databases, population-based registries, and observational studies is synthesised, considering differences by age, sex, geographic region, and tumour location. Key risk factors include obesity, metabolic dysfunction, dietary patterns, physical inactivity, alcohol consumption, tobacco use, antibiotic exposure, and gut microbiome alterations. The review also evaluates temporal trends and projections of incidence, prevalence, and mortality. Although increasing incidence may reflect changing lifestyles, metabolic health, environmental exposures, and other early-life risk factors, their relative contributions remain incompletely understood. Improved understanding of EOCRC epidemiology and future burden may help identify high-risk populations, guide targeted prevention strategies, inform public health policy, and support discussions on earlier colorectal cancer detection and screening.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
Immunosenescence and Inflammaging in the Pathogenesis of Non-Melanoma Skin Cancer.
Cancers, 18(21):.
Non-melanoma skin cancer (NMSC) is the most frequently diagnosed malignancy worldwide, and its incidence rises disproportionately with age. While cumulative ultraviolet (UV) exposure is the dominant recognised risk factor, it does not fully account for the steep age-associated increase in NMSC, suggesting that additional, underrecognised mechanisms operate in older skin. This review synthesises evidence that immune senescence (the age-related remodelling of innate and adaptive immunity) is a central and partly modifiable driver of NMSC aetiopathogenesis. We first outline the classical risk factors and the epidemiological and economic burden of NMSC, and revisit the proposal to regard recurrent NMSC as a chronic disease. We then examine four interlocking, age-associated processes: the accumulation of senescent cells and their pro-inflammatory secretory phenotype ("inflammaging") in the skin microenvironment; UV-induced suppression of cutaneous immune function; age-related dysbiosis of the skin microbiome and its impact on antitumour immunity; and the systemic decline of T-cell-mediated tumour immunosurveillance. We integrate these processes into a framework in which immune senescence contributes to the progression of accumulated cutaneous damage to overt malignancy, and consider the implications for prevention (including senotherapeutics, microbiome modulation, and immune-stratified surveillance) that extend beyond UV-directed measures alone.
Additional Links: PMID-43026802
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43026802,
year = {2026},
author = {Mihalj, M and Mioč, NF and Sabljić, I and Čeprnja, ZŠ and Tokić, S and Buljan, M},
title = {Immunosenescence and Inflammaging in the Pathogenesis of Non-Melanoma Skin Cancer.},
journal = {Cancers},
volume = {18},
number = {21},
pages = {},
pmid = {43026802},
issn = {2072-6694},
support = {IP13-2024//Faculty of Medicine Osijek/ ; NPOO 581-UNIOS-83//University Josip Juraj Strossmayer of Osijek/ ; IP1-2026//Faculty of Medicine Osijek/ ; },
abstract = {Non-melanoma skin cancer (NMSC) is the most frequently diagnosed malignancy worldwide, and its incidence rises disproportionately with age. While cumulative ultraviolet (UV) exposure is the dominant recognised risk factor, it does not fully account for the steep age-associated increase in NMSC, suggesting that additional, underrecognised mechanisms operate in older skin. This review synthesises evidence that immune senescence (the age-related remodelling of innate and adaptive immunity) is a central and partly modifiable driver of NMSC aetiopathogenesis. We first outline the classical risk factors and the epidemiological and economic burden of NMSC, and revisit the proposal to regard recurrent NMSC as a chronic disease. We then examine four interlocking, age-associated processes: the accumulation of senescent cells and their pro-inflammatory secretory phenotype ("inflammaging") in the skin microenvironment; UV-induced suppression of cutaneous immune function; age-related dysbiosis of the skin microbiome and its impact on antitumour immunity; and the systemic decline of T-cell-mediated tumour immunosurveillance. We integrate these processes into a framework in which immune senescence contributes to the progression of accumulated cutaneous damage to overt malignancy, and consider the implications for prevention (including senotherapeutics, microbiome modulation, and immune-stratified surveillance) that extend beyond UV-directed measures alone.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
Artificial Intelligence for Colorectal Cancer Diagnosis: A Comprehensive Survey of Modalities, Frameworks, and Clinical Tasks.
Cancers, 18(21):.
The diagnosis of colorectal cancer encompasses nine complementary modalities: stool-based screening, blood-based biomarkers, cross-sectional imaging, endoscopic evaluation, histopathology, liquid biopsy, molecular and genetic profiling, microbiome analysis, and nanotechnology-based diagnostics. This narrative review synthesizes 160 references spanning seven task-specific artificial intelligence domains, including computer-aided detection, optical diagnosis, invasion depth prediction, computational pathology and radiogenomics, metastasis forecasting, neoadjuvant treatment response prediction, and surgical workflow analysis. We propose a conceptual multimodal pipeline comprising data ingestion, preprocessing and harmonization, feature representation, multimodal fusion, forecasting, explainability, and validation. A structured evidence grading framework classifies each clinical task by evidence level, consistency, and clinical readiness. We further catalog public datasets, challenge benchmarks, and five reporting standards: TRIPOD-AI, CONSORT-AI, SPIRIT-AI, DECIDE-AI, and CLAIM. Computer-aided detection and optical diagnosis demonstrate the highest maturity with Level 1 evidence from randomized controlled trials, while computational pathology, radiogenomics, and metastasis prediction remain at Level 2 with retrospective validation (internal or external). Microbiome screening, nanotechnology diagnostics, and surgical phase recognition are exploratory. The principal barriers to clinical adoption are domain shift, data scarcity, calibration, prospective validation, and workflow integration. We conclude that clinically useful artificial intelligence requires robust external validation, uncertainty quantification, explainable outputs, standardized reporting, and a structured translational pathway from retrospective evidence through regulatory clearance to post-deployment monitoring.
Additional Links: PMID-43026843
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43026843,
year = {2026},
author = {El-Mosalamy, B and Balaha, HM and El-Moursi, S and Gondim, D and Lweesy, K and Yousaf, J and Ghazal, M and El-Baz, A},
title = {Artificial Intelligence for Colorectal Cancer Diagnosis: A Comprehensive Survey of Modalities, Frameworks, and Clinical Tasks.},
journal = {Cancers},
volume = {18},
number = {21},
pages = {},
pmid = {43026843},
issn = {2072-6694},
abstract = {The diagnosis of colorectal cancer encompasses nine complementary modalities: stool-based screening, blood-based biomarkers, cross-sectional imaging, endoscopic evaluation, histopathology, liquid biopsy, molecular and genetic profiling, microbiome analysis, and nanotechnology-based diagnostics. This narrative review synthesizes 160 references spanning seven task-specific artificial intelligence domains, including computer-aided detection, optical diagnosis, invasion depth prediction, computational pathology and radiogenomics, metastasis forecasting, neoadjuvant treatment response prediction, and surgical workflow analysis. We propose a conceptual multimodal pipeline comprising data ingestion, preprocessing and harmonization, feature representation, multimodal fusion, forecasting, explainability, and validation. A structured evidence grading framework classifies each clinical task by evidence level, consistency, and clinical readiness. We further catalog public datasets, challenge benchmarks, and five reporting standards: TRIPOD-AI, CONSORT-AI, SPIRIT-AI, DECIDE-AI, and CLAIM. Computer-aided detection and optical diagnosis demonstrate the highest maturity with Level 1 evidence from randomized controlled trials, while computational pathology, radiogenomics, and metastasis prediction remain at Level 2 with retrospective validation (internal or external). Microbiome screening, nanotechnology diagnostics, and surgical phase recognition are exploratory. The principal barriers to clinical adoption are domain shift, data scarcity, calibration, prospective validation, and workflow integration. We conclude that clinically useful artificial intelligence requires robust external validation, uncertainty quantification, explainable outputs, standardized reporting, and a structured translational pathway from retrospective evidence through regulatory clearance to post-deployment monitoring.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
Temporal Transcriptomic Responses of Turbinaria peltata to Repeated Marine Heatwaves and Recovery Cycles.
Biology, 15(21):.
Marine heatwaves (MHWs) are escalating threats to coral reef ecosystems, yet the host transcriptomic mechanisms underlying acclimatization to repeated thermal stress remain poorly understood. Using de novo RNA sequencing, we tracked the temporal transcriptomic responses of the scleractinian coral Turbinaria peltata across two consecutive MHW-recovery cycles. The second heatwave elicited fewer differentially expressed genes (DEGs) than the first (279 vs. 379), whereas the second recovery phase showed the largest DEG set (399). Functionally, the first heatwave triggered acute stress defense and signal suppression, while the first recovery engaged extracellular matrix remodeling and calcium-mediated tissue repair, indicating incomplete restoration. The largest DEG set during the second recovery indicates that recurrent thermal stress imposes cumulative physiological costs demanding more extensive molecular reorganization-spanning metabolic reprogramming, mTOR and Wnt signaling, and sustained oxidative-stress management. Together with prior physiological and microbiome evidence in this species, our results support a model in which repeated heat exposure progressively shifts the coral host from acute shock defense responses toward compensatory metabolism and structural repair. Recovery thus emerges as an active but increasingly costly molecular adjustment under recurrent MHW regimes. These findings identify candidate molecular markers for evaluating coral resilience under intensifying MHW regimes.
Additional Links: PMID-43026940
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43026940,
year = {2026},
author = {Zhang, Y and Sun, Y and Zhai, X and Zhou, J and Liu, L},
title = {Temporal Transcriptomic Responses of Turbinaria peltata to Repeated Marine Heatwaves and Recovery Cycles.},
journal = {Biology},
volume = {15},
number = {21},
pages = {},
pmid = {43026940},
issn = {2079-7737},
support = {2022YFD2401302//National Key R&D Project of China/ ; 060302022401//Program for Scientific Research Start-up Funds of Guangdong Ocean University/ ; },
abstract = {Marine heatwaves (MHWs) are escalating threats to coral reef ecosystems, yet the host transcriptomic mechanisms underlying acclimatization to repeated thermal stress remain poorly understood. Using de novo RNA sequencing, we tracked the temporal transcriptomic responses of the scleractinian coral Turbinaria peltata across two consecutive MHW-recovery cycles. The second heatwave elicited fewer differentially expressed genes (DEGs) than the first (279 vs. 379), whereas the second recovery phase showed the largest DEG set (399). Functionally, the first heatwave triggered acute stress defense and signal suppression, while the first recovery engaged extracellular matrix remodeling and calcium-mediated tissue repair, indicating incomplete restoration. The largest DEG set during the second recovery indicates that recurrent thermal stress imposes cumulative physiological costs demanding more extensive molecular reorganization-spanning metabolic reprogramming, mTOR and Wnt signaling, and sustained oxidative-stress management. Together with prior physiological and microbiome evidence in this species, our results support a model in which repeated heat exposure progressively shifts the coral host from acute shock defense responses toward compensatory metabolism and structural repair. Recovery thus emerges as an active but increasingly costly molecular adjustment under recurrent MHW regimes. These findings identify candidate molecular markers for evaluating coral resilience under intensifying MHW regimes.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
A Multilevel Perspective on the Skin: Skin Architecture, Microbial Communities, Intrinsic Metabolites, and Emerging AI-Enabled Applications.
Biology, 15(21):.
The skin is the largest organ of the human body and harbors a diverse microbial community that constitutes a complex ecosystem. Despite advances in next-generation sequencing (NGS) that have greatly facilitated the characterization of skin microbiota composition, a critical gap remains in understanding how intrinsic metabolites mediate host-microbe interactions and maintain microecological homeostasis. This review synthesizes current knowledge across interconnected layers of the skin ecosystem, including architecture, microbial communities, metabolites, and computational analytics. The skin's structural features create spatially heterogeneous microenvironments that dictate microbial colonization patterns, while microbial communities have evolved adaptive strategies to exploit distinct metabolic niches. Intrinsic metabolites, encompassing lipids, proteins/peptides, ions, vitamins, and carbohydrates, constitute the chemical language through which host and microbes reciprocally communicate. The complexity of these interactions poses challenges for traditional analytical approaches, yet artificial intelligence is transforming the field by enabling progressive deepening of understanding, from predicting microbial functional potential to decoding the skin microbiome as a carrier of biological information. This multilevel framework provides a foundation for future investigations and may inform the development of personalized strategies for skin health management.
Additional Links: PMID-43026972
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43026972,
year = {2026},
author = {Ma, P and Ruan, H and Zhang, H},
title = {A Multilevel Perspective on the Skin: Skin Architecture, Microbial Communities, Intrinsic Metabolites, and Emerging AI-Enabled Applications.},
journal = {Biology},
volume = {15},
number = {21},
pages = {},
pmid = {43026972},
issn = {2079-7737},
abstract = {The skin is the largest organ of the human body and harbors a diverse microbial community that constitutes a complex ecosystem. Despite advances in next-generation sequencing (NGS) that have greatly facilitated the characterization of skin microbiota composition, a critical gap remains in understanding how intrinsic metabolites mediate host-microbe interactions and maintain microecological homeostasis. This review synthesizes current knowledge across interconnected layers of the skin ecosystem, including architecture, microbial communities, metabolites, and computational analytics. The skin's structural features create spatially heterogeneous microenvironments that dictate microbial colonization patterns, while microbial communities have evolved adaptive strategies to exploit distinct metabolic niches. Intrinsic metabolites, encompassing lipids, proteins/peptides, ions, vitamins, and carbohydrates, constitute the chemical language through which host and microbes reciprocally communicate. The complexity of these interactions poses challenges for traditional analytical approaches, yet artificial intelligence is transforming the field by enabling progressive deepening of understanding, from predicting microbial functional potential to decoding the skin microbiome as a carrier of biological information. This multilevel framework provides a foundation for future investigations and may inform the development of personalized strategies for skin health management.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
DIVE: Diversity-Informed Valuation of Ecosystem Functioning.
Biology, 15(21):.
Meta-omics datasets are inherently high-dimensional, complicating their interpretation and limiting their application to ecological and ecosystem-level analyses. We present DIVE (Diversity-Informed Valuation of Ecosystem Functioning), a structured and reproducible workflow that aggregates high-dimensional meta-omics data into ecologically meaningful community-level descriptors for investigating biodiversity-ecosystem functioning (BEF) relationships. Rather than introducing new diversity metrics or statistical estimators, DIVE integrates established alpha-diversity measures with sampling-design-aware temporal association analysis into a unified framework for relating microbial community structure to ecosystem function. The workflow is demonstrated using a multi-year metatranscriptomics dataset from a full-scale activated sludge wastewater treatment plant. DIVE identified a coherent temporal pattern approximately 23 days before ecosystem-functioning measurements, with richness-, diversity-, and evenness-related descriptors showing positive associations and dominance-related descriptors showing associations in the opposite direction. These relationships are interpreted as exploratory biodiversity-function associations rather than evidence of causation or validated prediction. By formalizing the integration of established analytical approaches into a temporally explicit workflow, DIVE supports reproducible and ecologically interpretable BEF analyses of longitudinal meta-omics data and prioritization of candidate relationships for further mechanistic investigation.
Additional Links: PMID-43027058
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43027058,
year = {2026},
author = {Mahajna, A and Gacesa, R and Keesman, KJ and Euverink, GW and Jayawardhana, B},
title = {DIVE: Diversity-Informed Valuation of Ecosystem Functioning.},
journal = {Biology},
volume = {15},
number = {21},
pages = {},
pmid = {43027058},
issn = {2079-7737},
support = {//Wetsus, European Centre of Excellence for Sustainable Water Technology/ ; },
abstract = {Meta-omics datasets are inherently high-dimensional, complicating their interpretation and limiting their application to ecological and ecosystem-level analyses. We present DIVE (Diversity-Informed Valuation of Ecosystem Functioning), a structured and reproducible workflow that aggregates high-dimensional meta-omics data into ecologically meaningful community-level descriptors for investigating biodiversity-ecosystem functioning (BEF) relationships. Rather than introducing new diversity metrics or statistical estimators, DIVE integrates established alpha-diversity measures with sampling-design-aware temporal association analysis into a unified framework for relating microbial community structure to ecosystem function. The workflow is demonstrated using a multi-year metatranscriptomics dataset from a full-scale activated sludge wastewater treatment plant. DIVE identified a coherent temporal pattern approximately 23 days before ecosystem-functioning measurements, with richness-, diversity-, and evenness-related descriptors showing positive associations and dominance-related descriptors showing associations in the opposite direction. These relationships are interpreted as exploratory biodiversity-function associations rather than evidence of causation or validated prediction. By formalizing the integration of established analytical approaches into a temporally explicit workflow, DIVE supports reproducible and ecologically interpretable BEF analyses of longitudinal meta-omics data and prioritization of candidate relationships for further mechanistic investigation.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
Combined Dietary Supplementation with Bacillus subtilis DSM 29784 and a Phytogenic Blend Modulates the Microbiome-Gut-Bone Axis in Broiler Chickens.
Animals : an open access journal from MDPI, 16(21):.
The microbiome-gut-bone axis may influence skeletal physiology in fast-growing broilers. This study evaluated dietary Bacillus subtilis DSM 29784 combined with a phytogenic blend (BsP) in 560 male Ross 308 broilers assigned to control or BsP diets (eight pens/treatment; 35 birds/pen) for 42 days. One clinically normal bird per pen was sampled on days 21, 35, and 42. BsP increased final body weight and cumulative gain and reduced the overall feed conversion ratio (p < 0.05). Intestinal barrier-associated gene expression increased, several ileal inflammatory marker transcripts decreased, and mineral-handling-related gene expression and serum/femoral mineral concentrations were higher at selected ages. Cecal 16S rRNA gene profiles showed differences in diversity and taxonomic composition. PICRUSt2 identified differences in predicted microbial functional potential, not measured pathway activity or metabolite production. Femoral inflammatory and osteogenic gene expression responses varied with age. Exploratory networks summarized microbiome-gut-bone associations at days 21, 35, and 42 without establishing causality or within-bird temporal change. BsP was associated with improved growth and altered intestinal and bone-related indicators, but clinical BCO prevention was not established. Future factorial studies should include direct bone quality measurements, standardized clinical and lesion assessments, and targeted microbial metabolite measurements.
Additional Links: PMID-43027068
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43027068,
year = {2026},
author = {Saikhwan, N and Faroongsarng, D and Ruangpanit, Y and Thodsapol, A and Rassmidatta, K and Goossens, T and Vieco-Saiz, N and Prévéraud, DP and Theapparat, Y},
title = {Combined Dietary Supplementation with Bacillus subtilis DSM 29784 and a Phytogenic Blend Modulates the Microbiome-Gut-Bone Axis in Broiler Chickens.},
journal = {Animals : an open access journal from MDPI},
volume = {16},
number = {21},
pages = {},
pmid = {43027068},
issn = {2076-2615},
support = {OTR2568-007//Prince of Songkla University/ ; },
abstract = {The microbiome-gut-bone axis may influence skeletal physiology in fast-growing broilers. This study evaluated dietary Bacillus subtilis DSM 29784 combined with a phytogenic blend (BsP) in 560 male Ross 308 broilers assigned to control or BsP diets (eight pens/treatment; 35 birds/pen) for 42 days. One clinically normal bird per pen was sampled on days 21, 35, and 42. BsP increased final body weight and cumulative gain and reduced the overall feed conversion ratio (p < 0.05). Intestinal barrier-associated gene expression increased, several ileal inflammatory marker transcripts decreased, and mineral-handling-related gene expression and serum/femoral mineral concentrations were higher at selected ages. Cecal 16S rRNA gene profiles showed differences in diversity and taxonomic composition. PICRUSt2 identified differences in predicted microbial functional potential, not measured pathway activity or metabolite production. Femoral inflammatory and osteogenic gene expression responses varied with age. Exploratory networks summarized microbiome-gut-bone associations at days 21, 35, and 42 without establishing causality or within-bird temporal change. BsP was associated with improved growth and altered intestinal and bone-related indicators, but clinical BCO prevention was not established. Future factorial studies should include direct bone quality measurements, standardized clinical and lesion assessments, and targeted microbial metabolite measurements.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
Gut Microbiota Alterations and Intestinal Pathology in Healthy, Moribund, and Recently Dead Mastacembelus Armatus from a Pond Aquaculture System.
Animals : an open access journal from MDPI, 16(21):.
Spiny eel (Mastacembelus armatus) pond aquaculture suffers from recurrent nonspecific mortality, yet the associations between gut-microbiota shifts, host histological alterations, and fish physiological status, as well as the potential roles of sediment microbiota, remain unclear. In this study, we collected healthy (H), moribund (M), and recently dead (D) fish, as well as pond sediment (S), and performed histopathological examination and 16S rRNA amplicon sequencing combined with FEAST source-tracking analysis. Histology revealed severe intestinal villus atrophy, epithelial shedding, and extensive hepatic vacuolation in M fish. Results of 16S rRNA sequencing revealed a significant decrease in the alpha diversity (Chao1) of gut microbial richness in M and D groups, compared with healthy (H) (p < 0.05). Healthy guts were dominated by Proteobacteria and the keystone genus Cetobacterium (about 40% relative abundance). In M/D, Cetobacterium nearly disappeared, while Firmicutes and Fusobacteriota became predominant, with potentially opportunistic taxa (Fusobacterium, Clostridiaceae) showing markedly higher relative abundance. Beta-diversity and LEfSe analyses showed overlapping microbial communities between M and D fish, which were distinct from those of healthy (H) fish. FEAST modeling output showed that the conditionally estimated sediment-derived proportion increased from approximately 28% in healthy (H) to ~99% in M fish. Functional profiles predicted by PICRUSt2 shifted from oxidative phosphorylation toward peptidoglycan biosynthesis and peptidase-related functional potentials. Collectively, our results demonstrate strong associations between gut-microbiota disruption, intestinal barrier impairment, and fish physiological decline. We observed associations between damaged intestinal barrier status and increased sediment-attributed fractions of potentially opportunistic microbes within the gut microbiota.
Additional Links: PMID-43027085
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43027085,
year = {2026},
author = {Yu, J and Li, P and Guo, Q and Li, Q and Xu, C and Tran, NT and Chen, X and Yang, W and Sun, J and Li, S and Zhang, M},
title = {Gut Microbiota Alterations and Intestinal Pathology in Healthy, Moribund, and Recently Dead Mastacembelus Armatus from a Pond Aquaculture System.},
journal = {Animals : an open access journal from MDPI},
volume = {16},
number = {21},
pages = {},
pmid = {43027085},
issn = {2076-2615},
support = {2024A1515011613//Science Foundation of Guangdong Province/ ; 2025GXNSFAA069705//Natural Science Foundation of Guangxi Province/ ; },
abstract = {Spiny eel (Mastacembelus armatus) pond aquaculture suffers from recurrent nonspecific mortality, yet the associations between gut-microbiota shifts, host histological alterations, and fish physiological status, as well as the potential roles of sediment microbiota, remain unclear. In this study, we collected healthy (H), moribund (M), and recently dead (D) fish, as well as pond sediment (S), and performed histopathological examination and 16S rRNA amplicon sequencing combined with FEAST source-tracking analysis. Histology revealed severe intestinal villus atrophy, epithelial shedding, and extensive hepatic vacuolation in M fish. Results of 16S rRNA sequencing revealed a significant decrease in the alpha diversity (Chao1) of gut microbial richness in M and D groups, compared with healthy (H) (p < 0.05). Healthy guts were dominated by Proteobacteria and the keystone genus Cetobacterium (about 40% relative abundance). In M/D, Cetobacterium nearly disappeared, while Firmicutes and Fusobacteriota became predominant, with potentially opportunistic taxa (Fusobacterium, Clostridiaceae) showing markedly higher relative abundance. Beta-diversity and LEfSe analyses showed overlapping microbial communities between M and D fish, which were distinct from those of healthy (H) fish. FEAST modeling output showed that the conditionally estimated sediment-derived proportion increased from approximately 28% in healthy (H) to ~99% in M fish. Functional profiles predicted by PICRUSt2 shifted from oxidative phosphorylation toward peptidoglycan biosynthesis and peptidase-related functional potentials. Collectively, our results demonstrate strong associations between gut-microbiota disruption, intestinal barrier impairment, and fish physiological decline. We observed associations between damaged intestinal barrier status and increased sediment-attributed fractions of potentially opportunistic microbes within the gut microbiota.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
Indole-3-Lactic Acid Modulates Feeding Behavior and Appetite-Related Signals in Weaned Piglets.
Animals : an open access journal from MDPI, 16(21):.
Gut microbiota-derived metabolites act as important mediators linking the gut microbiome with host physiological functions and participate in the regulation of metabolic homeostasis and behavior. However, whether the tryptophan metabolite indole-3-lactic acid (ILA) regulates feeding behavior in piglets and its potential central regulatory mechanisms remain unclear. In this study, 12 weaned piglets were used as a model to investigate the effects of ILA on feeding behavior regulation. The results showed that ILA supplementation did not significantly affect growth performance (p > 0.05), although final body weight, average daily gain, and average daily feed intake were numerically higher in the ILA group than in the control group. ILA also altered feeding behavior patterns, characterized by reduced daily feeding frequency (p < 0.05) and increased feeding rate (p = 0.053). Furthermore, ILA significantly increased serum concentrations of several appetite-related gastrointestinal hormones, including glucagon-like peptide-1, peptide YY, ghrelin, and cholecystokinin, and modified serum lipid metabolism-related parameters (p < 0.05). Hypothalamic transcriptomic analysis identified 240 differentially expressed genes in the ILA group compared with the CON group, with enrichment of genes involved in neural signaling and appetite regulation. These findings suggest that ILA may influence feeding behavior in weaned piglets, accompanied by numerical increases in feed intake and growth-related parameters, as well as changes in peripheral appetite-related gastrointestinal hormones and hypothalamic transcriptional responses.
Additional Links: PMID-43027115
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43027115,
year = {2026},
author = {Chen, K and Dong, X and He, H and Huang, Y and Su, Y},
title = {Indole-3-Lactic Acid Modulates Feeding Behavior and Appetite-Related Signals in Weaned Piglets.},
journal = {Animals : an open access journal from MDPI},
volume = {16},
number = {21},
pages = {},
pmid = {43027115},
issn = {2076-2615},
abstract = {Gut microbiota-derived metabolites act as important mediators linking the gut microbiome with host physiological functions and participate in the regulation of metabolic homeostasis and behavior. However, whether the tryptophan metabolite indole-3-lactic acid (ILA) regulates feeding behavior in piglets and its potential central regulatory mechanisms remain unclear. In this study, 12 weaned piglets were used as a model to investigate the effects of ILA on feeding behavior regulation. The results showed that ILA supplementation did not significantly affect growth performance (p > 0.05), although final body weight, average daily gain, and average daily feed intake were numerically higher in the ILA group than in the control group. ILA also altered feeding behavior patterns, characterized by reduced daily feeding frequency (p < 0.05) and increased feeding rate (p = 0.053). Furthermore, ILA significantly increased serum concentrations of several appetite-related gastrointestinal hormones, including glucagon-like peptide-1, peptide YY, ghrelin, and cholecystokinin, and modified serum lipid metabolism-related parameters (p < 0.05). Hypothalamic transcriptomic analysis identified 240 differentially expressed genes in the ILA group compared with the CON group, with enrichment of genes involved in neural signaling and appetite regulation. These findings suggest that ILA may influence feeding behavior in weaned piglets, accompanied by numerical increases in feed intake and growth-related parameters, as well as changes in peripheral appetite-related gastrointestinal hormones and hypothalamic transcriptional responses.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
Diet-Associated Gut Microbiome Divergence Contributes to Phenotypic Differentiation Among Geographically Structured Populations of Rana dybowskii.
Animals : an open access journal from MDPI, 16(21):.
Geographic phenotypic variation is a widespread feature of natural populations, often driven by local environmental heterogeneity and trophic interactions. While the gut microbiome is recognized as a key mediator between environmental resources and host physiology, its role in the adaptive differentiation of amphibians remains insufficiently explored. In this study, we employed an integrative approach-combining morphological measurements, DNA metabarcoding for dietary analysis, and 16S rRNA sequencing for gut microbial profiling-to investigate three geographically structured populations (Dandong [DD], Fushun [FS], and Benxi [BX]) of the Dybowski's frog (Rana dybowskii). The results showed that the morphological characteristics (body weight, head-body length, hindlimb length, etc.) of DD were significantly higher than those of FS and BX. Dietary analysis via gut content DNA metabarcoding identified distinct food structures; notably, the DD population consumed a higher proportion of Dipteran prey (e.g., Smittia). Correspondingly, the gut microbiota showed significant population-level clustering. We identified an enrichment of specific functional bacteria in the DD population, such as Arthrobacter, which is known for its chitin-degrading capabilities, aligning with the consumption of chitin-rich insect prey. Mantel tests further confirmed a strong correlation between dietary composition, microbial community structure, and host morphological traits. These findings suggest that diet-driven gut microbiome variation is consistent with a contributing role in the phenotypic differentiation of R. dybowskii across different habitats, although causal relationships remain to be tested directly. By integrating trophic ecology with microbial landscapes, this study provides new insights into the adaptive evolution and resource management of amphibians in heterogeneous environments.
Additional Links: PMID-43027164
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43027164,
year = {2026},
author = {Kong, L and Zhu, Y and Liu, B and Wei, H and Li, Y},
title = {Diet-Associated Gut Microbiome Divergence Contributes to Phenotypic Differentiation Among Geographically Structured Populations of Rana dybowskii.},
journal = {Animals : an open access journal from MDPI},
volume = {16},
number = {21},
pages = {},
pmid = {43027164},
issn = {2076-2615},
support = {2025 and 2026//Special Project of Rana dybowskii (2025 and 2026) of the De-partment of Agriculture and Rural Affairs of Liaoning Province./ ; },
abstract = {Geographic phenotypic variation is a widespread feature of natural populations, often driven by local environmental heterogeneity and trophic interactions. While the gut microbiome is recognized as a key mediator between environmental resources and host physiology, its role in the adaptive differentiation of amphibians remains insufficiently explored. In this study, we employed an integrative approach-combining morphological measurements, DNA metabarcoding for dietary analysis, and 16S rRNA sequencing for gut microbial profiling-to investigate three geographically structured populations (Dandong [DD], Fushun [FS], and Benxi [BX]) of the Dybowski's frog (Rana dybowskii). The results showed that the morphological characteristics (body weight, head-body length, hindlimb length, etc.) of DD were significantly higher than those of FS and BX. Dietary analysis via gut content DNA metabarcoding identified distinct food structures; notably, the DD population consumed a higher proportion of Dipteran prey (e.g., Smittia). Correspondingly, the gut microbiota showed significant population-level clustering. We identified an enrichment of specific functional bacteria in the DD population, such as Arthrobacter, which is known for its chitin-degrading capabilities, aligning with the consumption of chitin-rich insect prey. Mantel tests further confirmed a strong correlation between dietary composition, microbial community structure, and host morphological traits. These findings suggest that diet-driven gut microbiome variation is consistent with a contributing role in the phenotypic differentiation of R. dybowskii across different habitats, although causal relationships remain to be tested directly. By integrating trophic ecology with microbial landscapes, this study provides new insights into the adaptive evolution and resource management of amphibians in heterogeneous environments.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
Dietary Isoacids Improve Early-Life Feed Efficiency, Reduce Abdominal Fat Deposition, and Modulate Intestinal and Metabolic Responses in Broiler Chickens.
Animals : an open access journal from MDPI, 16(21):.
This study evaluated the effects of increasing dietary inclusion levels of branched-chain volatile fatty acids, also called isoacids (ISO), on the growth performance, carcass traits, intestinal health, and breast muscle metabolomic profile of broiler chickens. A total of 700 one-day-old male Cobb 500 chicks were assigned to five corn-soybean meal-based diets with 10 replicate pens (14 birds/pen) in a completely randomized design: A Positive Control (PC) diet formulated to meet nutritional requirements was supplemented with 0.0, 0.10, 0.20, 0.40, or 0.60% of ISO (supplied as a blend of isobutyrate and 2-methylbutyrate). Data were analyzed using General Linear Models with orthogonal polynomial contrasts, PERMANOVA for microbiome beta diversity and ANOVA with FDR correction for metabolomics. Growth performance was monitored across feeding phases. At day 42, carcass traits, breast meat quality, intestinal permeability, cecal short-chain fatty acids (SCFAs), and cecal and ileal microbiota were assessed, alongside liquid chromatography coupled to high-resolution mass spectrometry (LC-HRMS) metabolomics of the Pectoralis major muscle. Dietary ISO significantly improved average daily weight gain (p < 0.0001) and feed conversion ratio (p < 0.0001) during the first 21 days (early-life), with an optimal inclusion level of 0.40%. While overall carcass and breast yields were unaffected, ISO supplementation significantly and quadratically reduced abdominal fat deposition (p < 0.0001), with an optimal inclusion range between 0.10% and 0.40%. ISO did not compromise intestinal permeability or alter microbial alpha diversity, but it significantly restructured the cecal microbiota (beta diversity; Bray-Curtis p = 0.0213) and linearly increased cecal isobutyric acid accumulation in the cecal content (p = 0.0443). Breast muscle metabolomics revealed a dose-dependent, nonlinear response; the 0.40% inclusion level maximized the relative abundance of galactolipids, whereas the highest dose (0.60% ISO) upregulated sphingomyelins, lysophospholipids, and acylcarnitines. In conclusion, a specific dietary ISO supplementation dose of 0.4% serves as an effective nutritional strategy to boost early feed efficiency and reduce abdominal adiposity. Doses exceeding this optimal level, such as 0.60%, offer no further productive benefits and may trigger cellular stress.
Additional Links: PMID-43027210
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43027210,
year = {2026},
author = {Muñoz, BX and Benavides, S and Fireman, A and Bortoluzzi, C and Martins Bueno, IJ and Alves Rodrigues, L and Netto, R and Lopes, M and Pais, V and Longhini, G and Lovon, M and Araujo, C and Araujo, L},
title = {Dietary Isoacids Improve Early-Life Feed Efficiency, Reduce Abdominal Fat Deposition, and Modulate Intestinal and Metabolic Responses in Broiler Chickens.},
journal = {Animals : an open access journal from MDPI},
volume = {16},
number = {21},
pages = {},
pmid = {43027210},
issn = {2076-2615},
abstract = {This study evaluated the effects of increasing dietary inclusion levels of branched-chain volatile fatty acids, also called isoacids (ISO), on the growth performance, carcass traits, intestinal health, and breast muscle metabolomic profile of broiler chickens. A total of 700 one-day-old male Cobb 500 chicks were assigned to five corn-soybean meal-based diets with 10 replicate pens (14 birds/pen) in a completely randomized design: A Positive Control (PC) diet formulated to meet nutritional requirements was supplemented with 0.0, 0.10, 0.20, 0.40, or 0.60% of ISO (supplied as a blend of isobutyrate and 2-methylbutyrate). Data were analyzed using General Linear Models with orthogonal polynomial contrasts, PERMANOVA for microbiome beta diversity and ANOVA with FDR correction for metabolomics. Growth performance was monitored across feeding phases. At day 42, carcass traits, breast meat quality, intestinal permeability, cecal short-chain fatty acids (SCFAs), and cecal and ileal microbiota were assessed, alongside liquid chromatography coupled to high-resolution mass spectrometry (LC-HRMS) metabolomics of the Pectoralis major muscle. Dietary ISO significantly improved average daily weight gain (p < 0.0001) and feed conversion ratio (p < 0.0001) during the first 21 days (early-life), with an optimal inclusion level of 0.40%. While overall carcass and breast yields were unaffected, ISO supplementation significantly and quadratically reduced abdominal fat deposition (p < 0.0001), with an optimal inclusion range between 0.10% and 0.40%. ISO did not compromise intestinal permeability or alter microbial alpha diversity, but it significantly restructured the cecal microbiota (beta diversity; Bray-Curtis p = 0.0213) and linearly increased cecal isobutyric acid accumulation in the cecal content (p = 0.0443). Breast muscle metabolomics revealed a dose-dependent, nonlinear response; the 0.40% inclusion level maximized the relative abundance of galactolipids, whereas the highest dose (0.60% ISO) upregulated sphingomyelins, lysophospholipids, and acylcarnitines. In conclusion, a specific dietary ISO supplementation dose of 0.4% serves as an effective nutritional strategy to boost early feed efficiency and reduce abdominal adiposity. Doses exceeding this optimal level, such as 0.60%, offer no further productive benefits and may trigger cellular stress.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
Testicular and Rumen Microbial Responses to Selenium-Enriched Malt in Heat-Exposed Simmental Bulls.
Animals : an open access journal from MDPI, 16(21):.
This study evaluated testicular and rumen microbial responses to selenium-enriched malt in heat-exposed Simmental bulls. Eighteen bulls received a basal diet alone or supplemented to provide target supplemental Se levels of 0.3 or 0.5 mg/kg dietary DM. Metagenomics included six bulls per group, host assays four per group, and RNA sequencing three per group. Compared with controls, the high-dose group had higher serum antioxidant indices and reproductive hormone concentrations, lower inflammatory markers, higher Johnsen scores, and lower TUNEL positivity. Gene-level FDR control identified 23, 1, and 4 differentially expressed genes in the low-dose versus control, high-dose versus control, and high-dose versus low-dose contrasts, respectively. Provider-reported GSEA showed negative normalized enrichment scores for steroid biosynthesis in the control-versus-low-dose and control-versus-high-dose contrasts, indicating enrichment toward the supplemented side under the provider's contrast convention. qPCR showed lower CYP11A1, CYP17A1, SCARB1, and LDLR expression at the low dose, whereas Bax, Bcl-2, and CYP17A1 protein abundance did not differ. Rumen microbial diversity and community composition differed among groups, and two post hoc selected cofactor-related pathways had lower abundance at the low dose. None of the 160 microbiome-testis or 720 microbiome-serum associations survived FDR correction. Supplementation was associated with favorable systemic and testicular histological responses and dose-specific molecular and microbial changes under heat exposure.
Additional Links: PMID-43027216
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43027216,
year = {2026},
author = {Li, N and Li, F and Zhang, M and Zhang, F and Wu, C and Hu, L and Xu, J},
title = {Testicular and Rumen Microbial Responses to Selenium-Enriched Malt in Heat-Exposed Simmental Bulls.},
journal = {Animals : an open access journal from MDPI},
volume = {16},
number = {21},
pages = {},
pmid = {43027216},
issn = {2076-2615},
support = {JXSNKYJCRC202442//Jiangxi Academy of Agricultural Sciences/ ; },
abstract = {This study evaluated testicular and rumen microbial responses to selenium-enriched malt in heat-exposed Simmental bulls. Eighteen bulls received a basal diet alone or supplemented to provide target supplemental Se levels of 0.3 or 0.5 mg/kg dietary DM. Metagenomics included six bulls per group, host assays four per group, and RNA sequencing three per group. Compared with controls, the high-dose group had higher serum antioxidant indices and reproductive hormone concentrations, lower inflammatory markers, higher Johnsen scores, and lower TUNEL positivity. Gene-level FDR control identified 23, 1, and 4 differentially expressed genes in the low-dose versus control, high-dose versus control, and high-dose versus low-dose contrasts, respectively. Provider-reported GSEA showed negative normalized enrichment scores for steroid biosynthesis in the control-versus-low-dose and control-versus-high-dose contrasts, indicating enrichment toward the supplemented side under the provider's contrast convention. qPCR showed lower CYP11A1, CYP17A1, SCARB1, and LDLR expression at the low dose, whereas Bax, Bcl-2, and CYP17A1 protein abundance did not differ. Rumen microbial diversity and community composition differed among groups, and two post hoc selected cofactor-related pathways had lower abundance at the low dose. None of the 160 microbiome-testis or 720 microbiome-serum associations survived FDR correction. Supplementation was associated with favorable systemic and testicular histological responses and dose-specific molecular and microbial changes under heat exposure.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
Gut Microbiome Assembly and Its Consequences for Disease Susceptibility in Fish.
Animals : an open access journal from MDPI, 16(21):.
The assembly of the gut microbiome in fish is a dynamic and tightly regulated process influenced by host genetics, early-life environmental exposure, diet, and aquaculture practices. Increasing evidence indicates that deliberate manipulation of this assembly through probiotics, prebiotics, synbiotics, environmental microbiome management, and husbandry interventions can significantly alter host-microbe interactions and downstream health outcomes. This review synthesizes we have summarized the current understanding about the regulatory principles of gut microbiome assembly in fish and explored the impact of manipulating the microbiome assembly process. Emphasis will be given to the early-life microbial colonization process, which is an important time point for microbiota succession and plays an important role in the development of immunity and resistance against diseases. Aquaculture systems, like recirculating aquaculture system (RAS) and flow-through system, where there is variation in microbiome exposure and water quality, further influence the process of microbiome assembly and pathogen dynamics. Several manipulative techniques, such as live feed enrichment, the seeding of microbes, and the management of water microbiomes, have been successful in inducing the growth of beneficial microbes while suppressing opportunistic pathogens. However, the risk of microbiome dysbiosis, reduction in microbial resilience, and pathogen resistance due to microbiome manipulation cannot be overlooked. Understanding these trade-offs is essential for developing sustainable and effective strategies. By integrating insights from microbiology, immunology, and aquaculture science, this review carries out a systematic PRISMA analysis, highlights the consequences of microbiome manipulation on disease susceptibility, and provides a framework for designing microbiome-informed interventions to enhance fish health and productivity in modern aquaculture systems.
Additional Links: PMID-43027232
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43027232,
year = {2026},
author = {Behera, G and Hammer, SE and Holzer, AS and Saleh, M},
title = {Gut Microbiome Assembly and Its Consequences for Disease Susceptibility in Fish.},
journal = {Animals : an open access journal from MDPI},
volume = {16},
number = {21},
pages = {},
pmid = {43027232},
issn = {2076-2615},
support = {10.55776/PIN1743725,//FWF Austrian Science Fund/ ; 101136346//EU Partnership on Animal Health and Welfare (EUP AH&W)/ ; },
abstract = {The assembly of the gut microbiome in fish is a dynamic and tightly regulated process influenced by host genetics, early-life environmental exposure, diet, and aquaculture practices. Increasing evidence indicates that deliberate manipulation of this assembly through probiotics, prebiotics, synbiotics, environmental microbiome management, and husbandry interventions can significantly alter host-microbe interactions and downstream health outcomes. This review synthesizes we have summarized the current understanding about the regulatory principles of gut microbiome assembly in fish and explored the impact of manipulating the microbiome assembly process. Emphasis will be given to the early-life microbial colonization process, which is an important time point for microbiota succession and plays an important role in the development of immunity and resistance against diseases. Aquaculture systems, like recirculating aquaculture system (RAS) and flow-through system, where there is variation in microbiome exposure and water quality, further influence the process of microbiome assembly and pathogen dynamics. Several manipulative techniques, such as live feed enrichment, the seeding of microbes, and the management of water microbiomes, have been successful in inducing the growth of beneficial microbes while suppressing opportunistic pathogens. However, the risk of microbiome dysbiosis, reduction in microbial resilience, and pathogen resistance due to microbiome manipulation cannot be overlooked. Understanding these trade-offs is essential for developing sustainable and effective strategies. By integrating insights from microbiology, immunology, and aquaculture science, this review carries out a systematic PRISMA analysis, highlights the consequences of microbiome manipulation on disease susceptibility, and provides a framework for designing microbiome-informed interventions to enhance fish health and productivity in modern aquaculture systems.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
Gut Microbiota and Microbial Metabolites in the Regulation of Chemotherapeutic Resistance.
Cells, 15(21):.
Resistance to chemotherapy continues to be a significant challenge for cancer treatment and a contributing factor to treatment failures and tumor progression. Recently, the gut microbiome has emerged as an important modulator of the response to chemotherapy. Numerous pre-clinical and clinical studies have demonstrated a direct association between gut microbiota composition and therapy effectiveness in many cancer types, such as colorectal, breast, pancreatic, gastric, and lung cancers, melanoma, and hematological cancers. Gut microbiota effectively regulate the efficiency of chemotherapeutic agents in various ways, either by biotransformation of chemotherapeutic agents or modulation of host immunity. In addition, microbial metabolites such as short-chain fatty acids, secondary bile acids, and tryptophan metabolites are also involved in the regulation of chemotherapy response through modulating apoptosis, immunity, and epithelial-mesenchymal transition. Finally, dysbiosis induced by chemotherapy and antibiotics has also been reported to reduce the effectiveness of therapy. This review will emphasize the ways in which gut microbiota can modulate chemotherapeutic response and induce chemoresistance. Understanding the interactions between chemotherapeutic drugs and the gut microbiota can help to enhance the efficiency of chemotherapy and find more appropriate personalized treatments.
Additional Links: PMID-43027332
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43027332,
year = {2026},
author = {Bhowmic, S and Roy Choudhury, P and Das, P and Banerjee, S and Chakrabarti, J and Juin, SK and Ghosh, S},
title = {Gut Microbiota and Microbial Metabolites in the Regulation of Chemotherapeutic Resistance.},
journal = {Cells},
volume = {15},
number = {21},
pages = {},
pmid = {43027332},
issn = {2073-4409},
support = {NRI-2025-1053//Department of Health Research (DHR), Government of India,/ ; },
mesh = {Humans ; *Gastrointestinal Microbiome/drug effects ; *Drug Resistance, Neoplasm ; Animals ; *Antineoplastic Agents/therapeutic use/pharmacology ; *Neoplasms/drug therapy/microbiology/metabolism ; },
abstract = {Resistance to chemotherapy continues to be a significant challenge for cancer treatment and a contributing factor to treatment failures and tumor progression. Recently, the gut microbiome has emerged as an important modulator of the response to chemotherapy. Numerous pre-clinical and clinical studies have demonstrated a direct association between gut microbiota composition and therapy effectiveness in many cancer types, such as colorectal, breast, pancreatic, gastric, and lung cancers, melanoma, and hematological cancers. Gut microbiota effectively regulate the efficiency of chemotherapeutic agents in various ways, either by biotransformation of chemotherapeutic agents or modulation of host immunity. In addition, microbial metabolites such as short-chain fatty acids, secondary bile acids, and tryptophan metabolites are also involved in the regulation of chemotherapy response through modulating apoptosis, immunity, and epithelial-mesenchymal transition. Finally, dysbiosis induced by chemotherapy and antibiotics has also been reported to reduce the effectiveness of therapy. This review will emphasize the ways in which gut microbiota can modulate chemotherapeutic response and induce chemoresistance. Understanding the interactions between chemotherapeutic drugs and the gut microbiota can help to enhance the efficiency of chemotherapy and find more appropriate personalized treatments.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Gastrointestinal Microbiome/drug effects
*Drug Resistance, Neoplasm
Animals
*Antineoplastic Agents/therapeutic use/pharmacology
*Neoplasms/drug therapy/microbiology/metabolism
RevDate: 2026-11-14
CmpDate: 2026-11-14
Distinct Polarization of Human Macrophages in Response to Infection with the Periodontitis-Associated Bacteria Fusobacterium nucleatum, Porphyromonas gingivalis, and Tannerella forsythia.
Cells, 15(21):.
Periodontal health and disease are shaped by a dynamic interaction between the subgingival microbiome and the host immune system, in which gingival macrophages contribute to tissue homeostasis, disease progression, and inflammation resolution. Here, we investigated how three periodontitis-associated bacteria, Fusobacterium nucleatum, Porphyromonas gingivalis, and Tannerella forsythia, shape the polarization of human macrophages in vitro. THP-1 monocytes were differentiated into unpolarized M0 macrophages, or polarized toward the M1 or M2 phenotype, and infected with each bacterium at different multiplicities of infection. Polarization was assessed from the surface expression of CD80 (M1) and CD209 (M2) and from pro- and anti-inflammatory cytokine production, measured by a multiplex assay. The response to P. gingivalis differed strikingly from the two other species. Porphyromonas gingivalis suppressed both M1 and M2 polarization and reduced the levels of several pro- and anti-inflammatory cytokines. In contrast, F. nucleatum and T. forsythia enhanced CD80 expression and pro-inflammatory cytokine production in M1 macrophages and modestly increased pro-inflammatory mediators in M2 macrophages. These findings point to a distinct role for P. gingivalis as a keystone pathogen that subverts the innate immune response, and for F. nucleatum and T. forsythia as periodontal pathobionts.
Additional Links: PMID-43027372
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43027372,
year = {2026},
author = {Schwarz, K and Rickert, C and Kendlbacher, FL and Miłek, O and Behm, C and Schäffer, C and Andrukhov, O},
title = {Distinct Polarization of Human Macrophages in Response to Infection with the Periodontitis-Associated Bacteria Fusobacterium nucleatum, Porphyromonas gingivalis, and Tannerella forsythia.},
journal = {Cells},
volume = {15},
number = {21},
pages = {},
pmid = {43027372},
issn = {2073-4409},
support = {P34642//FWF Austrian Science Fund/ ; },
mesh = {Humans ; *Porphyromonas gingivalis/physiology ; *Macrophages/microbiology/immunology/metabolism/pathology ; *Fusobacterium nucleatum/physiology ; *Tannerella forsythia/physiology ; *Periodontitis/microbiology/immunology ; *Cell Polarity ; Cytokines/metabolism ; THP-1 Cells ; },
abstract = {Periodontal health and disease are shaped by a dynamic interaction between the subgingival microbiome and the host immune system, in which gingival macrophages contribute to tissue homeostasis, disease progression, and inflammation resolution. Here, we investigated how three periodontitis-associated bacteria, Fusobacterium nucleatum, Porphyromonas gingivalis, and Tannerella forsythia, shape the polarization of human macrophages in vitro. THP-1 monocytes were differentiated into unpolarized M0 macrophages, or polarized toward the M1 or M2 phenotype, and infected with each bacterium at different multiplicities of infection. Polarization was assessed from the surface expression of CD80 (M1) and CD209 (M2) and from pro- and anti-inflammatory cytokine production, measured by a multiplex assay. The response to P. gingivalis differed strikingly from the two other species. Porphyromonas gingivalis suppressed both M1 and M2 polarization and reduced the levels of several pro- and anti-inflammatory cytokines. In contrast, F. nucleatum and T. forsythia enhanced CD80 expression and pro-inflammatory cytokine production in M1 macrophages and modestly increased pro-inflammatory mediators in M2 macrophages. These findings point to a distinct role for P. gingivalis as a keystone pathogen that subverts the innate immune response, and for F. nucleatum and T. forsythia as periodontal pathobionts.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Porphyromonas gingivalis/physiology
*Macrophages/microbiology/immunology/metabolism/pathology
*Fusobacterium nucleatum/physiology
*Tannerella forsythia/physiology
*Periodontitis/microbiology/immunology
*Cell Polarity
Cytokines/metabolism
THP-1 Cells
RevDate: 2026-11-14
CmpDate: 2026-11-14
Is Oxidative Stress a Shared Mechanism Linking Autism Regression, Late Diagnosis, and Sex-Disparate Diagnostic Timing?.
Cells, 15(21):.
Autism spectrum disorder (ASD) research has largely treated early regression, late decline after a period of stability, gradual increases in symptom severity, late diagnosis, and the sex difference in diagnostic timing as separate topics. These phenomena differ in definition, evidence, and plausible mechanism, and diagnostic and recognition processes may explain much of the late-diagnosis and sex-timing findings. This narrative, hypothesis-generating review asks whether a cumulative oxidative and inflammatory burden, arising from environmental chemical exposure, infection and autoimmune activity, and chronic psychosocial stress, and modified by genetic susceptibility, one-carbon metabolism, the gut microbiome, and individual buffering capacity, could contribute to some of these trajectories. We grade the evidence for each link in four tiers (human ASD data, other human data, experimental models, and our hypotheses). Most links rest on associations with ASD risk or on experimental data; no study has linked these exposures to regression or late diagnosis, and oxidative stress may be a consequence or correlate rather than a cause. We therefore define operational terms, derive predictions that could refute the model, and outline the prospective, sex-stratified evidence needed to test it.
Additional Links: PMID-43027382
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43027382,
year = {2026},
author = {Ayoub, G},
title = {Is Oxidative Stress a Shared Mechanism Linking Autism Regression, Late Diagnosis, and Sex-Disparate Diagnostic Timing?.},
journal = {Cells},
volume = {15},
number = {21},
pages = {},
pmid = {43027382},
issn = {2073-4409},
mesh = {Humans ; *Oxidative Stress ; *Delayed Diagnosis ; *Autism Spectrum Disorder/diagnosis/metabolism ; *Autistic Disorder/diagnosis ; *Sex Characteristics ; Female ; Male ; Sex Factors ; },
abstract = {Autism spectrum disorder (ASD) research has largely treated early regression, late decline after a period of stability, gradual increases in symptom severity, late diagnosis, and the sex difference in diagnostic timing as separate topics. These phenomena differ in definition, evidence, and plausible mechanism, and diagnostic and recognition processes may explain much of the late-diagnosis and sex-timing findings. This narrative, hypothesis-generating review asks whether a cumulative oxidative and inflammatory burden, arising from environmental chemical exposure, infection and autoimmune activity, and chronic psychosocial stress, and modified by genetic susceptibility, one-carbon metabolism, the gut microbiome, and individual buffering capacity, could contribute to some of these trajectories. We grade the evidence for each link in four tiers (human ASD data, other human data, experimental models, and our hypotheses). Most links rest on associations with ASD risk or on experimental data; no study has linked these exposures to regression or late diagnosis, and oxidative stress may be a consequence or correlate rather than a cause. We therefore define operational terms, derive predictions that could refute the model, and outline the prospective, sex-stratified evidence needed to test it.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Oxidative Stress
*Delayed Diagnosis
*Autism Spectrum Disorder/diagnosis/metabolism
*Autistic Disorder/diagnosis
*Sex Characteristics
Female
Male
Sex Factors
RevDate: 2026-11-14
CmpDate: 2026-11-14
Emerging Food Fortification and Precision Nutrition: Technologies for Personalized Nutrient Delivery and Health Monitoring.
Foods (Basel, Switzerland), 15(21):.
Food fortification has experienced a revolution because of the process of encapsulation techniques, controlled delivery systems, and personalized nutrition approach. The purpose of this review is to analyze the recent trends in encapsulated and personalized food fortification systems and the possibility of increasing the stability, bioavailability, targeted delivery, and personalized nature of nutrients. A review of the scientific literature was performed, covering topics such as micro- and nanoencapsulation, microfluidization, emulsified systems, omics approaches, nutrigenomics, nutrigenetics, microbiome interventions, 3D/4D food printing technology, wearable biosensors, artificial intelligence dietary analysis, and Internet of Things in foods. According to the reviewed literature, these technological approaches could help protect, distribute, and release vitamins, minerals, probiotics, and bioactive compounds, and help provide the opportunity to develop personalized nutritional approaches. Moreover, integration of omics techniques with advanced food technologies would allow taking into account genetic, metabolic, and microbiome aspects of different nutritional needs. Furthermore, emerging digital and manufacturing technologies would also provide an opportunity to create individualized fortified foods. Nevertheless, there are still issues with regulatory aspects, cost-effectiveness, consumer acceptability, and the equity and privacy of genetic and personal data. In conclusion, the application of controlled-release technology in personalized nutrition techniques holds much promise in creating specialized fortified foods, while additional research is required to establish their safety, effectiveness, affordability, and practical application.
Additional Links: PMID-43027454
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43027454,
year = {2026},
author = {Alhodieb, FS},
title = {Emerging Food Fortification and Precision Nutrition: Technologies for Personalized Nutrient Delivery and Health Monitoring.},
journal = {Foods (Basel, Switzerland)},
volume = {15},
number = {21},
pages = {},
pmid = {43027454},
issn = {2304-8158},
abstract = {Food fortification has experienced a revolution because of the process of encapsulation techniques, controlled delivery systems, and personalized nutrition approach. The purpose of this review is to analyze the recent trends in encapsulated and personalized food fortification systems and the possibility of increasing the stability, bioavailability, targeted delivery, and personalized nature of nutrients. A review of the scientific literature was performed, covering topics such as micro- and nanoencapsulation, microfluidization, emulsified systems, omics approaches, nutrigenomics, nutrigenetics, microbiome interventions, 3D/4D food printing technology, wearable biosensors, artificial intelligence dietary analysis, and Internet of Things in foods. According to the reviewed literature, these technological approaches could help protect, distribute, and release vitamins, minerals, probiotics, and bioactive compounds, and help provide the opportunity to develop personalized nutritional approaches. Moreover, integration of omics techniques with advanced food technologies would allow taking into account genetic, metabolic, and microbiome aspects of different nutritional needs. Furthermore, emerging digital and manufacturing technologies would also provide an opportunity to create individualized fortified foods. Nevertheless, there are still issues with regulatory aspects, cost-effectiveness, consumer acceptability, and the equity and privacy of genetic and personal data. In conclusion, the application of controlled-release technology in personalized nutrition techniques holds much promise in creating specialized fortified foods, while additional research is required to establish their safety, effectiveness, affordability, and practical application.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
Hen Egg-Derived Bioactive Proteins and Peptides at the Gut Interface: From Molecular Characterization and Digestion to Microbiome Interactions and Prospective Precision Nutrition.
Foods (Basel, Switzerland), 15(21):.
Hen eggs (Gallus gallus domesticus) contain bioactive proteins, peptides and lipids, but compound characterization, mechanistic cell and animal studies, and human consumption trials have developed largely in isolation. This narrative review, supported by a documented literature search, follows one pathway: egg composition, molecular characterization, processing and digestion, bioaccessibility, intestinal and microbial interaction, host signaling, and a prospective precision-nutrition outlook. Findings are classified into translational evidence categories (a heuristic classification of experimental systems, not a ranking of study quality) and summarized in a multidimensional evidence matrix. Egg white and yolk proteins, including ovotransferrin, ovomucin and lysozyme, yield characterized peptides, notably the ovotransferrin tripeptides IRW (Ile-Arg-Trp), IQW (Ile-Gln-Trp) and LKP (Leu-Lys-Pro), and ovomucin hydrolysates, whose activities in cell and animal models are compound-specific: LKP, for example, did not reproduce the effect of IRW on insulin resistance in muscle cells. In humans, one small ileostomy study (n = 5) reports higher ileal protein digestibility for cooked than raw egg, short-term trials show that whole-egg intake raises plasma choline, and an antibiotic-suppression study shows that trimethylamine-N-oxide formation after eggs plus phosphatidylcholine depends on gut microbiota. No study identified shows that IRW, IQW or LKP are generated, survive digestion or reach the circulation after ordinary egg consumption, and only six human studies address egg intake and the gut microbiome. Dose-response, delivery-system and safety data are largely missing, and precision nutrition for egg bioactives remains a research framework. Priorities are human pharmacokinetic confirmation, longer trials with shotgun metagenomics and functional readouts, and independent safety testing.
Additional Links: PMID-43027480
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43027480,
year = {2026},
author = {Abou-Emera, OK and Aladhadh, M},
title = {Hen Egg-Derived Bioactive Proteins and Peptides at the Gut Interface: From Molecular Characterization and Digestion to Microbiome Interactions and Prospective Precision Nutrition.},
journal = {Foods (Basel, Switzerland)},
volume = {15},
number = {21},
pages = {},
pmid = {43027480},
issn = {2304-8158},
support = {QU-APC-2026//Qassim University/ ; },
abstract = {Hen eggs (Gallus gallus domesticus) contain bioactive proteins, peptides and lipids, but compound characterization, mechanistic cell and animal studies, and human consumption trials have developed largely in isolation. This narrative review, supported by a documented literature search, follows one pathway: egg composition, molecular characterization, processing and digestion, bioaccessibility, intestinal and microbial interaction, host signaling, and a prospective precision-nutrition outlook. Findings are classified into translational evidence categories (a heuristic classification of experimental systems, not a ranking of study quality) and summarized in a multidimensional evidence matrix. Egg white and yolk proteins, including ovotransferrin, ovomucin and lysozyme, yield characterized peptides, notably the ovotransferrin tripeptides IRW (Ile-Arg-Trp), IQW (Ile-Gln-Trp) and LKP (Leu-Lys-Pro), and ovomucin hydrolysates, whose activities in cell and animal models are compound-specific: LKP, for example, did not reproduce the effect of IRW on insulin resistance in muscle cells. In humans, one small ileostomy study (n = 5) reports higher ileal protein digestibility for cooked than raw egg, short-term trials show that whole-egg intake raises plasma choline, and an antibiotic-suppression study shows that trimethylamine-N-oxide formation after eggs plus phosphatidylcholine depends on gut microbiota. No study identified shows that IRW, IQW or LKP are generated, survive digestion or reach the circulation after ordinary egg consumption, and only six human studies address egg intake and the gut microbiome. Dose-response, delivery-system and safety data are largely missing, and precision nutrition for egg bioactives remains a research framework. Priorities are human pharmacokinetic confirmation, longer trials with shotgun metagenomics and functional readouts, and independent safety testing.},
}
RevDate: 2026-11-14
CmpDate: 2026-11-14
Differences in Microbial Community Succession and Caproic Acid Metabolic Dynamics in Upper-Layer Fermenting Grains Between Aged and New Pits During Strong-Flavor Baijiu Fermentation.
Foods (Basel, Switzerland), 15(21):.
Caproic acid and its ester ethyl caproate are the characteristic flavor compounds of Chinese strong-flavor Baijiu (CSFB), yet their synthesis and esterification in upper-layer fermenting grains (UFG), and how these processes differ between new and aged pits, remain unclear. Compared with aged-pit UFG, the physicochemical parameters, microbial communities, and metabolite dynamics of new-pit UFG likewise followed a largely similar three-stage pattern: early acidification and starch consumption (2-8 d), mid-stage stabilization (10-20 d), and late secondary acid/ester synthesis (30-60 d). The critical divergence lay in butyric/caproic acid synthesis and the eukaryotic community: new-pit UFG produced lower amounts of butyric and caproic acids, and was dominated by taxa of unclear fermentative relevance, lacking the non-Saccharomyces yeasts (Kazachstania, Candida) enriched in aged-pit UFG, whose abundances correlated with ester accumulation. Specifically, new-pit UFG yielded lower concentrations of three of the four major ethyl esters, whereas ethyl lactate was consistently higher than in aged-pit UFG; yet, notably, ethyl butyrate accumulated despite nearly undetectable butyric acid. Correlation analyses identified candidate caproic acid producers (Lactobacillus, Pediococcus, Weissella) and esterification contributors (Candida, Mucor). These findings highlight the importance of the predicted maturity-driven metabolic-ecological network integrity in UFG, suggesting potential for synthetic-microbiome strategies in new-pit fermentation.
Additional Links: PMID-43027607
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid43027607,
year = {2026},
author = {Zhang, H and Xu, K and Chang, Q and Zhen, L and Li, Y and Wang, T and Wang, B and Liu, Y},
title = {Differences in Microbial Community Succession and Caproic Acid Metabolic Dynamics in Upper-Layer Fermenting Grains Between Aged and New Pits During Strong-Flavor Baijiu Fermentation.},
journal = {Foods (Basel, Switzerland)},
volume = {15},
number = {21},
pages = {},
pmid = {43027607},
issn = {2304-8158},
support = {32302031//National Natural Science Foundation of China/ ; },
abstract = {Caproic acid and its ester ethyl caproate are the characteristic flavor compounds of Chinese strong-flavor Baijiu (CSFB), yet their synthesis and esterification in upper-layer fermenting grains (UFG), and how these processes differ between new and aged pits, remain unclear. Compared with aged-pit UFG, the physicochemical parameters, microbial communities, and metabolite dynamics of new-pit UFG likewise followed a largely similar three-stage pattern: early acidification and starch consumption (2-8 d), mid-stage stabilization (10-20 d), and late secondary acid/ester synthesis (30-60 d). The critical divergence lay in butyric/caproic acid synthesis and the eukaryotic community: new-pit UFG produced lower amounts of butyric and caproic acids, and was dominated by taxa of unclear fermentative relevance, lacking the non-Saccharomyces yeasts (Kazachstania, Candida) enriched in aged-pit UFG, whose abundances correlated with ester accumulation. Specifically, new-pit UFG yielded lower concentrations of three of the four major ethyl esters, whereas ethyl lactate was consistently higher than in aged-pit UFG; yet, notably, ethyl butyrate accumulated despite nearly undetectable butyric acid. Correlation analyses identified candidate caproic acid producers (Lactobacillus, Pediococcus, Weissella) and esterification contributors (Candida, Mucor). These findings highlight the importance of the predicted maturity-driven metabolic-ecological network integrity in UFG, suggesting potential for synthetic-microbiome strategies in new-pit fermentation.},
}
▼ ▼ LOAD NEXT 100 CITATIONS
ESP Quick Facts
ESP Origins
In the early 1990's, Robert Robbins was a faculty member at Johns Hopkins, where he directed the informatics core of GDB — the human gene-mapping database of the international human genome project. To share papers with colleagues around the world, he set up a small paper-sharing section on his personal web page. This small project evolved into The Electronic Scholarly Publishing Project.
ESP Support
In 1995, Robbins became the VP/IT of the Fred Hutchinson Cancer Research Center in Seattle, WA. Soon after arriving in Seattle, Robbins secured funding, through the ELSI component of the US Human Genome Project, to create the original ESP.ORG web site, with the formal goal of providing free, world-wide access to the literature of classical genetics.
ESP Rationale
Although the methods of molecular biology can seem almost magical to the uninitiated, the original techniques of classical genetics are readily appreciated by one and all: cross individuals that differ in some inherited trait, collect all of the progeny, score their attributes, and propose mechanisms to explain the patterns of inheritance observed.
ESP Goal
In reading the early works of classical genetics, one is drawn, almost inexorably, into ever more complex models, until molecular explanations begin to seem both necessary and natural. At that point, the tools for understanding genome research are at hand. Assisting readers reach this point was the original goal of The Electronic Scholarly Publishing Project.
ESP Usage
Usage of the site grew rapidly and has remained high. Faculty began to use the site for their assigned readings. Other on-line publishers, ranging from The New York Times to Nature referenced ESP materials in their own publications. Nobel laureates (e.g., Joshua Lederberg) regularly used the site and even wrote to suggest changes and improvements.
ESP Content
When the site began, no journals were making their early content available in digital format. As a result, ESP was obliged to digitize classic literature before it could be made available. For many important papers — such as Mendel's original paper or the first genetic map — ESP had to produce entirely new typeset versions of the works, if they were to be available in a high-quality format.
ESP Help
Early support from the DOE component of the Human Genome Project was critically important for getting the ESP project on a firm foundation. Since that funding ended (nearly 20 years ago), the project has been operated as a purely volunteer effort. Anyone wishing to assist in these efforts should send an email to Robbins.
ESP Plans
With the development of methods for adding typeset side notes to PDF files, the ESP project now plans to add annotated versions of some classical papers to its holdings. We also plan to add new reference and pedagogical material. We have already started providing regularly updated, comprehensive bibliographies to the ESP.ORG site.
ESP Picks from Around the Web (updated 28 JUL 2024 )
Old Science
Weird Science
Treating Disease with Fecal Transplantation
Fossils of miniature humans (hobbits) discovered in Indonesia
Paleontology
Dinosaur tail, complete with feathers, found preserved in amber.
Astronomy
Mysterious fast radio burst (FRB) detected in the distant universe.
Big Data & Informatics
Big Data: Buzzword or Big Deal?
Hacking the genome: Identifying anonymized human subjects using publicly available data.